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Abstract 
 
Inhibitor of NF-κB kinase 1 (IKK1) and 2 (IKK2) form part of the functional 
IKK complex, necessary for NF-κB signalling. NF-κB is vital for survival, 
development, and function of multiple cell types. The aim of this study was to 
determine the function of NF-κB in thymic development and maintenance of 
the peripheral T cell compartment. For this, we used the Cre-loxP system in 
order to delete one or both of the Ikk1 and Ikk2 genes in T cells.  
 
Developmental deletion of Ikk1 and Ikk2 in CD4 CD8 double negative 
thymocytes revealed that NF-κB signalling was, surprisingly, redundant for 
early stages of thymic development and selection. Instead, late stage 
maturation of single positive thymocytes was abruptly halted in the absence 
of Ikk1 and Ikk2. Double deficient mice had a severe reduction in mature 
HSA low single positive thymocyte numbers and scarcely any peripheral T 
cells. Members of the TNF receptor superfamily (TNFRSF) are potent 
activators of NF-κB. We therefore tested the hypothesis that TNFRSF 
signalling could be regulating developing thymocytes. In vivo blockade of 
TNF in the IKK1/2 double deficient animals resulted in an almost complete 
rescue of thymocyte development. Cell culture experiments revealed that 
IKK1/2 double deficient thymocytes were specifically susceptible to TNF 
induced death. TNF receptor 1 (TNFR1) was identified as the key surface 
receptor, and TNFR1 IKK1/2 triple deficient mice had normal thymic 
development. Although TNFR1 is expressed throughout thymic 
development, transcriptomic analysis revealed cIAP2 and IL-7Rα as key 
targets of NF-κB dependent TNF signalling, but that co-operative 
developmental regulation of RIPK1 and caspase-8 underpinned the 
developmental susceptibility of mature SP thymocytes to TNF induced 
apoptosis. 
 
Our data reveal that developmental tuning of TNFR signalling and response 
genes is critical for normal T cell development and homeostasis.  
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MAPK     Mitogen-activated protein kinase 
MFI     Mean fluorescence intensity 
MHC     Major histocompatibility complex 
MIP-3β/CCL19    Macrophage inflammatory protein-3 beta 
MLKL     Mixed lineage kinase like 
MRC     Medical Research Council 
mRNA     Messenger ribonucleic acid 
mTEC     Medullary thymic epithelial cell 
MyD88  Myeloid differentiation primary response gene 
88 
NEMO/ IKKγ/ IKKAP   NF-κB essential modulator 
NF-κB   Nuclear factor kappa B/nuclear factor of 
kappa light polypeptide gene enhancer in B 
cells  
NFAT     Nuclear factor of activated T cells 
NGS     Next-generation sequencing 
NH4Cl     Ammonium chloride 
NIK     NF-κB-inducing kinase 
NIMR     National Institute for Medical Research 
NK     Natural killer cell 
NLR     NOD-like receptor 
no.     Number 
NODD-LRR  Nucleotide-binding oligomerization domain 
leucine rich repeat 
NP     Influenza virus nucleoprotein 
NP40     Nonidet P-40 
ns     Not significant 
OVA     Ovalbumin 
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OX40L     OX40 ligand 
PAMP     Pathogen associated molecular pattern 
PBMCs    Peripheral blood mononuclear cells 
PBS     Phosphate buffered saline  
PCR     Polymerase chain reaction 
PE Cy5     Phycoerythrin cyanine 5 
PE Cy7     Phycoerythrin cyanine 7 
PE     Phycoerythrin 
PE TR     Phycoerythrin Texas red 
PerCP Cy5.5    Peridinin-chlorophyll protein cyanine 5.5 
PH     Pleckstrin homology 
PIP2     Phosphatidylinositol bisphosphate 
PIP3     Phosphatidylinositol 3, 4, 5-trisphosphate 
PKC-θ     Protein kinase C-theta 
PLC- γ     Phospholipase C-γ 
pLck     Proximal Lck 
PO     Pacific orange  
PRR     Pattern recognition receptor 
PSG     L-glutamine penicillin-streptomycin 
pSMAC  Peripheral supramolecular activation complex 
pTα     Pre-T alpha chain 
R26R Rosa 26 reporter 
rad     Unit of absorbed radiation dose 
RAG     Recombination activating gene 
RANKL     RANK ligand 
Red-IETD-FMK    RED-IETD-fluoromethyl ketone 
RHD     Rel homology domain 
RING     Really interesting new gene 
RIP     Receptor interacting protein 
RIPK1/RIP1    Receptor interacting protein kinase 1 
RIPK2/RIP2   Receptor interacting protein kinase 2 
RIPK3/RIP3    Receptor interacting protein kinase 3  
RLR     RIG-I like receptor 
RNA     Ribonucleic acid 
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RORγt  RAR-related orphan receptor gamma thymus 
RPMI 1640    Roswell Park Memorial Institute 1640 
RTE     Recent thymic emigrant 
RunX3     Runt-related transcription factor 3 
S1P     Sphingosine-1-phosphate 
S1P1     Sphingosine-1-phosphate receptor 1 
SAV     Streptavidin 
SEM     Standard error of the mean 
SH2     Src homology 2 
SHARPIN    SHANK-associated RH domain interactor 
SLC/CCL21    Secondary lymphoid chemokine 
SLE     Systemic lupus erythematosus 
SLP-76  SH2 domain-containing leukocyte protein of 
76kDa 
SMAC     Supramolecular activation complex 
Smac/DIABLO  Second mitochondria-derived activator of 
caspases 
SOCS     Suppressor of cytokine signalling 
SODD     Silencer of death domain 
SP     Single positive  
SPF     Specific pathogen free 
STAT  Signal transducer and activator of 
transcription 
TACE     TNF alpha converting enzyme 
TACI  Transmembrane activator and CAML 
interactor 
TAK1     TGF-β activated kinase 1 
TCR     T cell receptor 
Tfh     T follicular helper cell 
TGF-β     Transforming growth factor beta 
Th     T helper cell 
ThPOK     T helper inducing POZ-Kruppel factor 
TIR     Toll-IL1R 
TLA1/VEGI/TNFSF15   TNF-like protein 1A 
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TLR     Toll-like receptor 
TNF     Tumour necrosis factor 
TNFR     Tumour necrosis factor receptor 
TNFR1/CD120a   Tumour necrosis factor receptor 1 
TNFR2/CD120b   Tumour necrosis factor receptor 2 
TNFRSF     Tumour necrosis factor receptor superfamily 
TNFSF     Tumour necrosis factor superfamily 
tpA    Strong transcriptional termination sequence 
Tr1     Type 1 regulatory 
TRADD     TNFR1 associated death domain protein 
TRAF     TNF receptor associated factor 
TRAIL/TNFSF10   TNF-related apoptosis-inducing ligand 
TRAM     TRIF-related adapter molecule 
Treg     Regulatory T cell 
TRIF  TIR-domain-containing adapter-inducing 
interferon beta 
TWEAK/TNFSF12   TNF-related weak inducer of apoptosis 
V      Variable gene segment 
VCAM-1     Vascular cell adhesion protein-1 
VLA-4     Very late antigen-4 
WT/wt     Wild-type 
XIAP     X-chromosome linked inhibitor of apoptosis 
XL-EDA-ID X-linked anhidrotic ectodermal dysplasia with 
immunodeficiency 
YFP     Yellow fluorescent protein 
Z-FA-FMK  Benzyloxycarbonyl-phenyl-alanyl-fluoromethyl 
ketone 
Z-IETD-FMK    Z-IETD-fluoromethyl ketone  
Zap70     Zeta-chain-associated protein kinase 70 
αCD27L    Anti-CD27 ligand 
αTNF     Anti-TNF 
γc      Common γ-chain 
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Units used in this thesis: 
 
%     Percent 
g     Relative centrifugal force 
hr     Hour 
kDa     Kilodalton 
mg     Milligram 
min     Minute 
mL     Millilitre 
mM     Millimolar 
ng     Nanogram 
nRPKM  Number of reads per kilobase of exon per million 
sequenced reads 
oC     Degrees Celsius 
v/v     Volume/volume 
w/v     Weight/volume 
μg     Microgram 
μL     Microlitre 
μm     Micrometre 
μM     Micromolar 
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Chapter 1 Introduction 
 
1.1 A brief history of Immunology 
 
Immunology is a relatively new discipline. Throughout its short lifespan, periods 
of rapid advance have been interjected with those of slow progress. Over the 
years, immunology has been hugely influenced by international politics, with 
many of its main discoveries taking place in the aftermath of the Franco 
Prussian War of 1870 and of both World Wars. Topics have been hugely and 
sometimes fiercely debated. Often too much attention seems to have been 
focused on one area with the subsequent neglect of the other. Today our 
understanding of the immune system is often accredited to a handful of very 
successful individuals – the heroes or “giants” of immunology. Yet, remarkable 
progress has been made in a short space of time and, for that, we have more 
than a few dedicated immunologists to thank. 
 
1.1.1 Early understanding of disease and immunity 
 
Hippocrates, the Greek physician born around 460 BC, was the first to suggest 
that disease may not be entirely theurgic in nature. He described the existence 
of the four humors – blood, phlegm, yellow bile, and black bile. A humoral 
imbalance, it was believed, could account for all manner of maladies. Practices 
involving the use of leeches, cupping, purgatives, and phlebotomy became 
standard procedure (Silverstein, 2012).  
 
Somewhat remarkably, very little progress was made over the next two 
millennia and the origin of disease remained elusive. Nevertheless, the idea of 
disease as a contagious entity and the concept of immunity as something to be 
acquired did slowly become established. In 1714 Emanuele Timoni and Jacob 
Pylarini presented, to the Royal Society of London, the concept of variolation. 
This was the practice of taking material from a patient infected with smallpox 
and introducing it into a healthy individual. The aim was to produce a less-
severe form of the disease, which, once overcome, would confer on the patient 
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a lasting immunity (Silverstein, 2012). This practice was not new, having been 
used frequently in Eastern medicine. It was, however, met with distrust among 
the peoples of London and Paris, areas where it could have proven of great 
advantage (Silverstein, 2012). It seemed the public were more accepting in 
1796 when Edward Jenner demonstrated a new procedure called vaccination. 
This was essentially the same concept as variolation, but less dangerous as it 
involved infecting patients with the mild disease cowpox in order to protect 
against the deadly smallpox (Murphy, 2011). Concepts of disease and immunity 
were evolving, and in 1858 a great leap was made when Rudolph Virchow 
dared to challenge the humoral theory. He suggested instead, that illness could 
be a result of faulty cells (Silverstein, 2012).  
 
1.1.2 The beginning of Immunology as a discipline 
 
Immunology as a discipline began in the late 1870s, following acceptance of the 
germ theory of disease (Silverstein, 2012). It was Louis Pasteur and Robert 
Koch who finally proved that disease was not an affliction by god or an 
imbalance of humors, but was instead caused by tiny unseen microorganisms 
(Silverstein, 2012). Far from collaborators, however, Pasteur and Koch had an 
open rivalry and, throughout their working lives, would treat one another’s ideas 
with great distain (Davis, 2013; Silverstein, 2012).  
 
In 1890 came the discovery by Emil von Behring and Kitasato Shibasaburo that 
immunisation caused the appearance of a soluble substance in the blood that 
was able to neutralise toxins (Silverstein, 2012). These “antitoxins” were to later 
become known as antibodies. Their presence in the body fluids seemed to 
conform to the ancient Greek system of the humors and consequently, the 
study of antibodies became known as that of humoral immunity. Around the 
same time, Ilya (Elie) Metchnikoff was working on his cellular theory of 
immunity. In 1891 Metchnikoff published his “Lectures on the Comparative 
Pathology of Inflammation”. In these he explained his revolutionary ideas 
regarding the phagocytosis of pathogens by immune cells and the protective 
role of inflammation (Silverstein, 2012).  
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From this point forward, immunologists became divided into those who believed 
that humoral mechanisms best explained immunity and those who championed 
the cell as the body’s guardian. The humoralists came mostly from Germany 
and were led by Koch in Berlin, while the cellularists were from France and 
followed Metchnikoff, who was working at the Pasteur Institute in Paris (Davis, 
2013; Silverstein, 2012).  
 
1.1.3 Early theories of antibody formation – Immunochemistry 
 
A turning point was reached in 1897 when Paul Ehrlich published his paper 
describing the “side-chain theory” of antibody formation. He postulated that 
specific receptors for toxin molecules exist on the surface of certain cells. This 
was the first natural selection theory of antibody formation (Silverstein, 2012). In 
a 1903 paper, Almroth Wright described how humoral antibodies could 
opsonise target pathogens, making them vulnerable to phagocytosis by 
macrophages. Sadly, his results proved unreproducible at the time and were 
largely forgotten (Silverstein, 2012). The cellular theory of immunity became 
unfashionable for many years to come. Consequently, the first half of the 20th 
century saw a decline in cellular research and an almost complete 
preoccupation with the antibody. Antibodies, after all, were much easier to work 
with than cells.  
 
Scientists became convinced that understanding the chemistry and 
thermodynamics of antibodies was the way forward. A new branch of 
immunology was born, that of immunochemistry (Silverstein, 2012). Over the 
next fifty years several incorrect theories of antibody formation were proposed. 
Many, including Linus Pauling, believed in the “instruction” or “template” 
theories – the idea that the antibody moulded itself around the antigen (Pauling 
and Delbrück, 1940; Silverstein, 2012). Others believed that the antibody was 
fashioned from part of the antigen molecule itself (Silverstein, 2012). 
Disagreeing with the instructional theories, Niels Jerne suggested his “natural-
selection theory” in which all manner of different “natural” antibodies pre-existed 
in healthy blood, waiting for foreign molecules to which they could bind (Jerne, 
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1955). Although this theory incorporated many of Ehrlich’s ideas, Jerne did not 
refer to him in his 1955 paper (Jerne, 1955). Frank Macfarlane Burnet liked 
Jerne’s hypothesis. In 1957 Burnet published “A modification of Jerne’s theory 
of antibody production using the concept of clonal selection” (Burnet, 1976). In it 
he described how, upon seeing a molecule to which its antibodies could bind, 
the cell could proliferate and form many clones. One cell would make only one 
shape of antibody. Importantly, Burnet brought the focus away from the 
antibody itself and towards the cell making it.   
 
1.1.4 A return to Immunobiology 
 
From the second half of the 20th century onwards immunology became, once 
again, more medically and biologically orientated. Peter Medawar’s experiences 
with badly burned patients during the Second World War had forced him to 
consider the immunology of transplantation (Davis, 2013). Allografts were 
rejected whilst autografts were not. Suddenly the “self-marker” hypothesis, as 
first described by Burnet and Frank Fenner in 1949, became entirely relevant. 
This was the idea that the immune system’s sole purpose was the 
discrimination of “self” from “non-self” (Davis, 2013). Medawar soon realised 
that the distinction between self and non-self was learned. Immunological 
tolerance, it seemed, was something to be acquired. 
 
However, to the immunologist’s surprise, it was discovered that antibodies were 
not responsible for the rejection of transplanted tissues. In the 1950s and 1960s 
a number of independent groups demonstrated that graft rejection was instead 
due to the differences between the donor and recipient of certain groups of 
“compatibility genes” – those belonging to the major histocompatibility complex 
(MHC) (Davis, 2013).  
 
1.1.5 The discovery of T cells 
 
Removal of the avian bursa of Fabricius (shown in the 1970s to be the 
equivalent of the mammalian bone marrow) resulted in severely reduced 
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antibody formation (Glick et al., 1956; Kincade and Kelsoe, 2003). A similar 
experiment, performed in 1961 and involving removal of the thymus from 
neonatal mice, proved to be of immense importance (Miller, 1961). Remarkably, 
the thymectomized mice were unable to reject skin grafts (Miller, 1961). The 
thymus, previously unappreciated, became an organ of great interest.  
 
Burnet was among the first to recognise the true significance of the thymus. In a 
lecture that he gave in London in 1962, he suggested that the thymus had an 
important role to play in the prevention of self-reactivity (Davis, 2013). It soon 
became understood that there were two types of lymphocytes, B (bursa/bone 
marrow) cells and T (thymus) cells. In 1969 Avrion Mitchson showed that T cells 
cooperate with B cells in the production of antibodies (Silverstein, 2012). A short 
time later, in 1975, Rolf Zinkernagal and Peter Doherty noted that T cells 
recognise antigen only when it is presented as an amino acid sequence bound 
to the surface of an MHC molecule (Silverstein, 2012). In this way, the T cell 
recognises both self and non-self. Suddenly the enigma surrounding transplant 
rejection was solved - the recipient’s T cells could recognise the donor’s MHC 
molecules as foreign and mount an attack.  
  
In the 1970s immunologists started to classify T cells into different subsets, 
depending on their function and surface markers. Helper and cytotoxic T cells 
were described, as were T cells with a suppressor (regulatory) function 
(Gershon and Kondo, 1970; Silverstein, 2012). Today T cell immunology is still 
in its relative infancy. The establishment of the cluster of differentiation (CD) 
nomenclature in 1984 was particularly useful to T cell immunologists (Zola et 
al., 2005). So too was the development of fluorescent antibodies and the 
technique of fluorescence activated cell sorting (FACS) (Herzenberg et al., 
2002). It seems the era of the T cell is still very much upon us. Quite ironic 
really, that it should be the monoclonal antibody that is proving of limitless aid to 
today’s cellular immunologist!    
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1.2 Our current understanding of the immune system 
 
Most infectious organisms are prevented from entering the body by the 
protective epithelial layers of the skin and mucous membranes (Murphy, 2011). 
If however, these barriers are breached then the immune system is activated to 
both contain and clear the infection. The immune system is made up of cells 
and molecules. Essentially, it is comprised of two branches: the innate 
(“natural”) immune system and the adaptive (“acquired”) immune system 
(Fearon and Locksley, 1996). Whilst all multicellular organisms possess some 
form of innate immunity to protect them from invaders, the adaptive immune 
system is found only within vertebrates (Hedrick, 2004). The vertebrate immune 
system must be able to: recognise infection; mount a response via a variety of 
effector mechanisms; regulate itself to prevent damage to the host; and finally, 
provide immunological memory, so that a second response to the same 
infection is both more rapid and of a greater magnitude (Murphy, 2011). 
 
In vertebrates, all immune system cells are derived from pluripotent 
haematopoietic stem cells situated in the bone marrow. Such cells give rise to 
the myeloid and lymphoid lineages of leukocytes (Murphy, 2011). Common 
myeloid progenitors produce dendritic cells (DCs), macrophages, mast cells, 
and granulocytes (neutrophils, eosinophils, and basophils). Macrophages are 
the mature, tissue resident form of monocytes. Common lymphoid progenitors 
produce B and T lymphocytes and natural killer (NK) cells (Murphy, 2011). 
Although most commonly of myeloid lineage, dendritic cells can also arise from 
lymphoid progenitors (Wu and Liu, 2007). The B and T cells are responsible for 
the adaptive immune response and hence for the acquisition of immunological 
memory. All other cell types are classified as belonging to the innate immune 
system, although their actions frequently aid the adaptive response (Murphy, 
2011). Macrophages, granulocytes, and dendritic cells can all internalise 
pathogens by the process of phagocytosis (Aderem and Underhill, 1999). 
 
Cells of the innate immune system possess invariant cell surface and 
intracellular receptors, capable of recognising constituents common to many 
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pathogens. Many secreted molecules of innate immunity are also able to 
recognise repeating microbial structures (Quah and Parish, 2001). In contrast, 
the cell surface receptors of B and T cells are of unlimited variety and are highly 
specific for their cognate antigens (Hedrick, 2004).  
 
In many cases, pathogen clearance requires only the innate immune system. If 
however, innate mechanisms prove insufficient, then the adaptive immune 
system is activated. Some components of the innate response lie resident in 
healthy tissues and are available for immediate use upon infection. Other 
components are induced in response to infection and appear over a matter of 
hours (Murphy, 2011). The innate response works to contain the infection for 
several days, until the adaptive response can be initiated. Crucially, the 
adaptive immune system is reliant on the innate immune system for activation 
(Murphy, 2011). 
 
1.2.1 The early stages of an innate immune response 
 
Upon infection of the tissue, an innate immune response is immediately 
activated. Antimicrobial proteins are present within saliva and tears and can 
also be secreted by epithelial cells and phagocytes. They include defensins, 
cathelicidins, histatins, and lysozyme (Cash et al., 2006; De Smet and 
Contreras, 2005). Such antimicrobial proteins can directly attack the cell walls of 
bacteria, the cell membranes of bacteria and fungi, and the envelopes of some 
viruses (De Smet and Contreras, 2005). The complement system of plasma 
proteins is rapidly activated upon infection. Complement can bind directly to 
pathogen surfaces or it can bind to proteins (e.g. C-reactive protein, mannose-
binding lectin, ficolins, and antibodies) that have previously bound pathogen 
(Gros et al., 2008). Complement binds particularly well to natural antibodies of 
the class IgM, which circulate in the absence of infection (Heyman et al., 1988; 
Rutemark et al., 2012). Complement can either directly lyse pathogens or it can 
opsonise them, thus facilitating their uptake by phagocytes such as 
macrophages (Gros et al., 2008).  
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Macrophages are tissue resident cells and are of immense importance in the 
early stages of the immune response (Quah and Parish, 2001). In addition to 
complement receptors, macrophages also possess a huge variety of receptors 
that can bind to the carbohydrates, lipids, and lipoproteins of pathogen surfaces 
(Aderem and Underhill, 1999). Such receptors are termed pattern recognition 
receptors (PRRs) and the conserved structures they recognise are called 
pathogen associated molecular patterns (PAMPs). Macrophage PRRs include 
Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I like receptors 
(RLRs) (Thompson et al., 2011). They recognise bacterial, viral, and fungal 
constituents. Upon activation of complement receptors or the cell surface TLRs, 
macrophages are triggered to phagocytose the pathogen (Quah and Parish, 
2001).  
 
The macrophage can then be activated by stimulation of cell surface G-protein 
coupled receptors (e.g. the fMet-Leu-Phe receptor) (Lattin et al., 2007). This 
leads to the subsequent killing of phagocytosed pathogens. The G-protein 
coupled receptors can recognise bacterial components, but can also respond to 
the anaphylatoxins (e.g. C5a) produced by activation of the complement 
cascade and to chemokines (Lattin et al., 2007). Upon activation of the 
macrophage, intracellular vesicles containing the phagocytosed pathogens 
(phagosomes) fuse with lysosomes and generate phagolysosomes (Slauch, 
2011). These are highly acidic vesicles that contain lysosomal hydrolases as 
well as reactive oxygen and nitrogen species (Slauch, 2011). The pathogen is 
rapidly degraded within the phagolysosome (Slauch, 2011).  
 
1.2.2 The induced stages of an innate immune response 
 
Within hours of the infection occurring, many innate effector mechanisms will 
have been induced. This induced phase of innate immunity can last over 
several days and is important for containing the infection until the adaptive 
immune response is fully activated. In response to stimulation of their TLRs, 
NLRs, or RLRs, macrophages can activate the NF-κB signalling pathway (Quah 
and Parish, 2001). This results in the production of cytokines and chemokines. 
 
 
31 
Cytokines and chemokines are small proteins that affect the behaviour of 
surrounding cells and are important for the initiation of an inflammatory 
response (Borish and Steinke, 2003). Together with anaphylatoxins, cytokines 
can cause vasodilation and an increase in the permeability of the blood vessels 
(Markiewski and Lambris, 2007).   
 
Cytokines activate endothelial cells and increase their expression of selectins, a 
group of adhesion molecules (Granger and Senchenkova, 2010). The cytokine, 
tumour necrosis factor (TNF), is a particularly good inducer of P-selectin and E-
selectin (Bullard et al., 1996). The selectins of endothelial cells bind weakly to 
sulphated sialyl-Lewisx carbohydrates that are present on the surface of 
circulating neutrophils and monocytes (Murphy, 2011). By binding to selectins, 
leukocytes are able to adhere to the blood vessel wall and roll slowly along it. 
Activated endothelial cells also express intercellular adhesion molecules 
(ICAMs). The ICAMs bind to integrins present on the surface of leukocytes. 
When chemokines bind to the chemokine receptors of leukocytes, a 
conformational change is induced within the integrins (Alon and Feigelson, 
2002). This enables tight binding between ICAMs and the integrins. In response 
to this, the leukocyte then stops rolling and is instead bound tightly to the wall of 
the blood vessel. The leukocyte may then squeeze between the tight junctions 
of adjacent endothelial cells and pass through the underlying basement 
membrane in a process called diapedesis (Johnston and Butcher, 2002). Upon 
completion of diapedesis, leukocytes migrate deeper into the tissue, following 
the chemokine gradient towards the site of infection (Murphy, 2011). The whole 
process of leukocyte movement from the blood vessels into the tissues is 
termed extravasation (Alon and Feigelson, 2002).  
 
In addition to aiding cell migration, vasodilation and increased vascular 
permeability also increase the flow of fluid from the bloodstream into the 
tissues. In this way, plasma proteins, including complement and antibodies, are 
brought to the site of infection and the increased fluid pressure in the tissues 
also encourages lymphatic drainage to the lymph nodes (Murphy, 2011). 
Movement of cells and fluid from the bloodstream and into the tissues is 
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accompanied by heat, redness, swelling, and pain – the clinical markers of an 
inflammatory response (Murphy, 2011).  
 
TNF stimulates endothelial cells to release blood-clotting factors (Granger and 
Senchenkova, 2010). By preventing blood flow in the small, downstream blood 
vessels, the infection is kept localised and prevented from disseminating 
throughout the body. If the infection does reach the bloodstream then sepsis 
may occur. This leads to the activation of macrophages in the liver and spleen, 
which release huge quantities of TNF, causing septic shock (Dellinger, 2003). 
The resulting systemic vasodilation plus increased vascular permeability and 
disseminated intravascular coagulation are very dangerous to the host and 
frequently prove fatal. (Dellinger, 2003)  
 
Following infection, neutrophils are the first cells to extravasate into the tissues. 
They do so in great numbers, following the CXCL8 chemokine gradient 
(Kolaczkowska and Kubes, 2013). Monocytes enter the tissues slightly later, in 
response to the chemokine CCL2 (Kolaczkowska and Kubes, 2013). 
Neutrophils are highly phagocytic. Like macrophages, they possess numerous 
receptors that enable phagocytosis and cell activation (Kolaczkowska and 
Kubes, 2013). Neutrophils contain primary and secondary granules that fuse 
with the phagosome. This subjects the pathogen to killing by antimicrobial 
proteins, enzymes, and the respiratory burst. Neutrophils are short-lived, dying 
after use of their granules (Kolaczkowska and Kubes, 2013).  
 
Many immature dendritic cells lie resident within the tissues, surveying for the 
presence of infection. However, upon activation of the inflammatory response, 
dendritic cells are recruited to the tissues in larger numbers (Shortman and Liu, 
2002). Monocytes extravasating from the bloodstream usually turn into 
macrophages in response to the cytokine, macrophage colony-stimulating factor 
(M-CSF). However, upon exposure to both granulocyte-macrophage colony-
stimulating factor (GM-CSF) and interleukin (IL)-4, monocytes will instead enter 
the tissues as dendritic cells (Palucka et al., 1998; Shortman and Liu, 2002). 
Immature dendritic cells possess many PRRs and complement receptors and 
are capable of phagocytosing pathogens (Lim and Gleeson, 2011). In addition, 
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they can continually take up extracelluar fluid from their surroundings by the 
process of macropinocytosis, which does not require receptor stimulation (Lim 
and Gleeson, 2011). Uptake of pathogens allows the dendritic cell to mature. 
NF-κB signalling occurs downstream of TLRs and NLRs (Quah and Parish, 
2001). This stimulates the production of cytokines and chemokines and also 
leads to increased expression of the co-stimulatory molecules CD80 (B7.1) and 
CD86 (B7.2) on the dendritic cell surface (Shortman and Liu, 2002).     
 
Both macrophages and dendritic cells secrete large amounts of the cytokines 
IL-1β, IL-6, IL-12, and TNF and the chemokine CXCL8 (Murphy, 2011). IL-1β, 
IL-6, and TNF are important activators of the acute-phase response (Murphy, 
2011). They stimulate hepatocytes to release acute-phase proteins (e.g. C-
reactive protein), which assist in the opsonisation of pathogens (Borish and 
Steinke, 2003). TNF can also stimulate mature dendritic cells to enter the 
lymphatic vessels, which carry them to the draining lymph nodes (Förster et al., 
2012). It is these dendritic cells that provide a crucial bridge between the innate 
and adaptive branches of the immune system (Shortman and Liu, 2002). 
 
1.2.3 The adaptive immune system 
 
If an infection cannot be controlled by the innate immune system alone, then 
the adaptive immune system is activated. An adaptive immune response is 
initiated in the secondary lymphoid organs. Mature dendritic cells travel from the 
site of infection and enter the draining lymph nodes, or other nearby lymphoid 
tissues (Shortman and Liu, 2002). They present the pathogen on their cell 
surface in the form of peptide antigens bound to molecules of the major 
histocompatibility complex (MHC) (Shortman and Liu, 2002). In the lymphoid 
organ, the dendritic cells will come into contact with large numbers of naïve T 
cells. If a T cell possesses a cell surface receptor (T cell receptor, TCR) with the 
correct specificity for the peptide:MHC complexes presented by the dendritic 
cell, then the T cell may become activated. The T cell can then undergo clonal 
expansion and differentiate into one of several types of effector T cell.  
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The cytokines produced during the innate stages of the immune response help 
to determine the types of effector T cell that are produced (Murphy, 2011). The 
effector T cells travel from the lymphoid organs and eventually into the 
bloodstream. They circulate in the blood until they encounter endothelial 
activation at the site of infection. They can then extravasate into the infected 
tissue (Murphy, 2011). T cells may either kill infected cells directly or may 
activate other cells of the immune system.   
 
During an infection, complement coated antigens can be transported into the 
secondary lymphoid organs where they can be presented, in their native form, 
on the surface of follicular dendritic cells (FDCs, cells of nonhaematopoietic 
origin) and on specialised macrophages (Batista and Harwood, 2009). Naïve B 
cells enter the lymphoid organs, where they reside initially in the B cell zone, 
also called the primary lymphoid follicle (Batista and Harwood, 2009). Upon 
sensing an antigen (on the FDCs or macrophages) to which their B cell receptor 
(BCR) can bind, the B cells begin to express the chemokine receptor CCR7 
(Okada et al., 2005). This enables the B cell to move, within the secondary 
lymphoid organ, to the edge of the T cell zone (Okada et al., 2005).  
 
During T cell differentiation, a subset of effector T cells, called T follicular helper 
(Tfh) cells, develop. These Tfh cells remain in the secondary lymphoid organs, 
where they may recognise peptide antigens as displayed on MHC class II 
molecules on the surface of the B cell (Ma et al., 2012). If so, then the Tfh cell 
can activate the B cell. Activated B cells are then able to undergo clonal 
expansion and differentiation, and they form a primary focus as they do so 
(Murphy, 2011). After several days, B cells differentiate into plasma cells. Some 
plasma cells stay in the lymphoid organs, while others travel to the bone 
marrow (Radbruch et al., 2006). The plasma cells will secrete large quantities of 
antibody, which enter into the bloodstream and eventually, into the site of 
infection. Antibodies may help opsonise the pathogen; can activate cells such 
as mast cells, eosinophils, and basophils; and can initiate the classical 
complement cascade (Murphy, 2011). 
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The cell-mediated response provided by activated T cells, and the humoral 
response provided by activated B cells work in harmony with the innate immune 
system to clear the infection (Table 1.1). Immunological memory is also 
acquired during the adaptive stage of the primary immune response. This 
involves the production of long-lived memory T and B cells (Farber et al., 2013; 
Radbruch et al., 2006). Immunological memory ensures that a secondary 
infection with the same pathogen can be cleared more rapidly than the first or, 
in some cases, that reinfection is entirely prevented.  
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Table 1.1 Interactions between the innate and adaptive branches of the 
immune system  
 
An immune response takes time to develop and certain immune system 
components or cell types will, by their very nature, become active at earlier or 
later stages during the response. However, this does not mean that their 
actions are confined to a short timeframe. Nor does it mean that there is a true 
dichotomy between the innate and adaptive branches of the immune system. 
As this table shows, the different components and cells of the immune system 
are in constant interaction with one another. For example, T cells form part of 
the adaptive immune system and are not activated until around 4 days after the 
initial infection. Yet a T cell’s actions and the cytokines it secretes can have 
profound influences on cells that were recruited much earlier during the immune 
response. This table shows when the different components of the immune 
system are first activated during the immune response. Activation may occur 
during the early innate (0-4 hours, green boxes), induced innate (4-96 hours, 
blue boxes), or adaptive (>96 hours, purple boxes) phases of the immune 
response (Murphy, 2011). Certain components, such as cytokines and 
chemokines, play a crucial role at all stages of the immune response (orange 
boxes). The table also shows the mechanisms of action of the different immune 
system components and gives examples of how the different components may 
aid one another.    
 
PRR = pattern recognition receptor. PAMP = Pathogen associated molecular 
pattern. MHC = major histocompatibility complex. 
 
Table constructed by myself. Inspiration taken from (Murphy, 2011). 
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Key 
 Early innate response (0-4 hours) 
 
 Induced innate response (4-96 hours) 
 
 Adaptive response (>96 hours) 
 
 Throughout the immune response 
 
Component of the 
immune system 
Mechanism of action Aided by 
Antimicrobial proteins 
(e.g. cathelicidins, 
histatins, lysozyme) 
found in tears & 
saliva & secreted by 
epithelial cells 
Attack cell walls of bacteria, cell 
membranes of bacteria & fungi, & 
envelopes of some viruses. 
Cytokines & 
chemokines 
(activate epithelial 
cells) 
Complement system 
of plasma proteins 
Binds pathogen surfaces directly 
leading to lysis or opsonisation. 
Binds C-reactive protein, 
mannose binding lectin, IgM Ab. 
B cells (IgM 
production) 
 
Macrophages Their PRRs bind PAMPs of 
pathogen surfaces. 
Phagocytose the pathogen. 
Stimulation of a macrophage’s G-
protein coupled receptors leads 
to killing of phagocytosed 
pathogens. 
Complement 
cascade (produces 
anaphylatoxins, 
which stimulate G-
protein coupled 
receptors) 
 
T cells (helper T 
cells activate 
macrophages) 
Mast cells Secrete inflammatory proteins, 
causing smooth muscle 
contraction. 
B cells (IgE 
produced by B 
cells binds the 
surface of mast 
cells and is cross-
linked by antigen, 
thus activating the 
mast cell)  
Cytokines & 
chemokines 
Cause vasodilation & increased 
blood vessel permeability. 
Activate endothelial cells. 
Enable extravastion of leukocytes 
from the blood vessels into the 
Many immune cell 
types, both innate 
& adaptive, 
secrete large 
quantities of 
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tissue. 
Enable the differentiation or 
activation of immune cells. 
cytokines & 
chemokines 
Neutrophils Phagocytose pathogen & kill it 
through use of primary & 
secondary granules. 
Macrophages 
(produce CXCL8, 
enabling neutrophil 
recruitment into 
the tissue) 
Monocytes Recruited to tissues & become 
macrophages (see above entry 
for macrophages). 
Multiple cell types 
produce CCL2, 
which recruits 
monocytes into the 
tissue 
Dendritic cells (DCs) Their PRRs bind PAMPs on 
pathogen surfaces. 
Phagocytose pathogens & 
present them on MHC complexes 
on their cell surface. 
Produce many cytokines & 
chemokines. 
T cells (produce 
IL-4: helping to 
turn infiltrating 
monocytes into 
DCs instead of 
macrophages) 
Complement 
cascade 
(opsonises 
pathogens) 
Natural killer (NK) 
cells 
Release cytotoxic granules 
containing perforin & granzyme, 
leading to lysis of infected cells. 
Produce IFN-γ. 
B cells (antibody 
dependent cellular 
cytoxicity, ADCC, 
occurs when an Ab 
coated target cell 
is recognised and 
lysed by an NK 
cell) 
DCs (plasmacytoid 
DCs produce 
much IFN-α & IFN-
β, which activates 
NK cells) 
Macrophages 
(release IL-12 & 
IL-18, which 
activate NK cells) 
Eosinophils Secrete inflammatory proteins, 
causing smooth muscle 
contraction. 
B cells (IgE 
produced by B 
cells binds the 
surface of 
eosinophils and is 
cross-linked by 
antigen, thus 
activating the 
eosinophil)  
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Mast cells (secrete 
cytokines that 
cause eosinophil 
activation) 
Basophils Secrete inflammatory proteins, 
causing smooth muscle 
contraction. 
B cells (IgE 
produced by B 
cells binds the 
surface of 
basophils and is 
cross-linked by 
antigen, thus 
activating the 
basophil) 
Acute phase proteins 
(e.g. fibrinogen, C-
reactive protein), 
which are released 
by hepatocytes in 
response to IL-1, IL-
6, IL-8, & TNF 
Coagulation of blood vessels.  
Opsonisation of pathogens. 
Macrophages 
(secrete large 
quantities of IL-1, 
IL-6, IL-8, & TNF) 
DCs (secrete large 
quantities of IL-1, 
IL-6, IL-8, & TNF) 
Mast cells (major 
TNF producers) 
T cells Differentiate into one of several 
different types of effector T cell. 
Can either kill infected cells 
directly or can activate other cells 
of the immune system. 
DCs (present 
peptide:MHC to 
the T cell to 
activate it. In 
addition, are major 
producers of 
cytokines 
necessary for T 
cell differentiation)  
Macrophages 
(major producers 
of cytokines 
necessary for T 
cell differentiation) 
NK cells (produce 
IFN-γ, which 
enables production 
of Th1 cells)  
B cells Produce antibodies, which can: 
opsonise pathogens; neutralise 
toxins; activate the complement 
cascade; and activate mast cells, 
NK cells, eosinophils, & 
basophils. 
T cells (Tfh cells 
help to activate B 
cells) 
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1.3 T cell development 
 
1.3.1 The thymus 
 
T cell progenitors arise in the bone marrow, however they must travel to the 
thymus in order to complete their maturation. The thymus is located in the 
thorax or neck of all vertebrates (Pearse, 2006). In humans and mice, it is a bi-
lobed organ, located behind the sternum and in front of the heart. The thymus is 
at its largest early in life, with thymic involution occurring from adolescence 
onwards (Pearse, 2006). Essentially, the thymus is composed of an outer cortex 
and an inner medulla (Schematic 1.1). Immature thymocytes and low numbers 
of macrophages reside in the cortex, whilst more mature thymocytes and large 
numbers of both macrophages and dendritic cells are present within the 
medulla (Pearse, 2006). Epithelial stromal cells within the thymus are important 
for the provision of both survival and differentiation signals to the developing T 
cells (Takahama, 2006).  
 
The thymus of mice has been shown to contain huge numbers of thymocytes 
(approximately 108 to 2 x 108), however, each day, only a small percentage of 
these migrate into the periphery (Pozzesi et al., 2014). In fact, an estimated 
98% of developing T cells will undergo apoptosis within the thymus (Pozzesi et 
al., 2014). It was for this very reason that early immunologists wrongly 
dismissed the thymus as having no real function, other than as a graveyard for 
dead and dying T cells (Miller, 2014). 
 
“We shall come to regard the presence of lymphocytes in the thymus as an 
evolutionary accident of no very great significance”  
Peter Medawar, 1963  
(Medawar's comments were in response to an earlier publication by 
Miller, 1961; as quoted in Miller, 2014) 
 
Today we understand the true importance of the thymus in the production of T 
lymphocytes and the acquisition of immunological tolerance. 
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1.3.2 The double negative stage of development 
 
T cell progenitors travel from the bone marrow to the thymus via the 
bloodstream. They enter the cortico-medullary junction of the thymus through 
the high endothelial venules (HEVs). Once in the thymus, the progenitors 
receive signalling through their Notch1 receptors, thereby triggering their 
commitment to the T cell lineage (Borowski et al., 2002). Of note, the 
conditional deletion of Notch1 in bone marrow precursors results in the 
appearance of B cells in the murine thymus (Wilson et al., 2001). Signalling via 
the Kit and IL-7R cytokine receptors is also important during early thymocyte 
development (Borowski et al., 2002). Their ligands (stem cell factor and IL-7, 
respectively) are both produced by thymic stromal cells (Borowski et al., 2002).  
 
Upon entering the thymus, cells lack expression of the TCR and the CD4 and 
CD8 co-receptors. Due to their absence of both CD4 and CD8, these immature 
thymocytes are referred to as double negative (DN). Around 5% of thymocytes 
are classified as DN (Ceredig and Rolink, 2002). Cells within the DN stage of 
development can be further characterised into developmentally sequential 
subsets (DN1-4) according to their expression of CD44 (an adhesion molecule) 
and CD25 (the IL-2R α-chain). As defined by Godfrey et al.: DN1 thymocytes 
are CD44+CD25-, DN2 thymocytes are CD44+CD25+, DN3 thymocytes are 
CD44-CD25+, and DN4 thymocytes are CD44-CD25- (Godfrey et al., 1993). 
Whilst still in the DN stage, thymocytes migrate from the cortico-medullary 
junction, through the cortex and into the outermost subcapsular region (Benz et 
al., 2004). CCR9 seems to be important for this migration, since, in CCR9 
deficient mice, DN2 and DN3 thymocytes fail to home to the subcapsular region 
and are instead distributed across the cortex (Benz et al., 2004).   
 
In order to protect the host from all potential infectious insults, a huge diversity 
of TCRs is required. However, after it was established that the human genome 
contains only around 25,000 genes, it became apparent that a separate gene 
could not possibly encode for each TCR (Silverstein, 2012). From the mid 
1970s, Susumu Tonegawa demonstrated that the genes encoding for variable 
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regions of the BCR could undergo somatic recombination (Hozumi and 
Tonegawa, 1976). Later this was also shown true for the genes encoding for the 
variable regions of the TCR (Chien et al., 1984). Although the vast majority of 
thymocytes that exit the thymus will express an α:β TCR, a small number (an 
estimated 1-10%) will instead express a γ:δ TCR (Girardi, 2006). Following their 
successful production, an α-chain will combine with a β-chain to form the α:β 
TCR, or alternatively, a γ-chain will combine with a δ-chain to form the γ:δ TCR. 
The TCRβ and TCRδ loci contain variable (V), diversity (D), and joining (J) gene 
segments, whilst the TCRα and TCRγ loci contain only V and J segments 
(Girardi, 2006). The somatic recombination of TCR gene segments requires the 
activity of recombination activating gene 1 (RAG1) and 2 (RAG2) (Schatz and 
Ji, 2011).  
 
During the DN stage of development, the genes encoding for the TCR begin to 
rearrange, and it is at this point that the T cell may enter into either the α:β or 
the γ:δ lineage. At DN1, the TCR genes are still in their germline configuration. 
During the DN2 stage, the TCR β-chain locus begins to rearrange when Dβ 
combines with Jβ (Ceredig and Rolink, 2002). Simultaneously, however, 
rearrangement also occurs at the γ-chain and δ-chain loci (Ceredig and Rolink, 
2002). At DN3, Vβ may combine with DJβ, thus completing rearrangement of the 
TCR β-chain (Ceredig and Rolink, 2002). TCRβ can then be combined with a 
pre-Tα (pTα) chain and subsequently expressed as a pre-TCR on the surface of 
the DN3 thymocyte (Ceredig and Rolink, 2002) Schematic 1.1).  
 
Expression of the pre-TCR results in weak activation of Erk (extracellular signal-
regulated kinase) (Michie et al., 1999). This is necessary to prevent any further 
rearrangements occurring at the γ and δ-loci. If however, the γ and δ-loci 
complete rearrangement before the β-locus, then a γ:δ TCR may be expressed. 
This causes much stronger Erk signalling, which leads to the activation of the 
transcription factor Id3 and prevents further rearrangement of the β-locus 
(Hayes et al., 2005; Kreslavsky et al., 2010). In Id3-/- mice, the development of 
γ:δ T cells is disrupted (Lauritsen et al., 2009). Upon maturation, the γ:δ T cell 
can exit the thymus and enter the periphery. If thymocytes fail to make either a 
functional β-chain, or both a functional γ and δ-chain, then they will undergo 
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apoptosis. In a normal mouse thymus, approximately 20% of DN3 thymocytes 
will express a γ:δ TCR (Serwold et al., 2007). 
 
Cells that reach the DN4 stage of development will possess a functional β-chain 
and be committed to the α:β lineage (Ceredig and Rolink, 2002). During DN4, 
signalling through the pre-TCR allows proliferation and begins production of 
both CD4 and CD8 (Murphy, 2011). Pre-TCR signalling also prevents further 
rearrangement of the β-chain locus, thus enabling allelic exclusion. Allelic 
exclusion is demonstrated in TCRβ transgenic mice, which carry pre-arranged 
β-chain loci in their germline DNA (Uematsu et al., 1988). Nearly all the T cells 
produced from these mice will express the same TCR β-chain on their cell 
surface (Uematsu et al., 1988). 
 
1.3.3 The double positive stage of development 
 
Immediately after passing through the DN4 stage, thymocytes will express cell 
surface CD8, but lack expression of CD4. These cells are known as immature 
single-positive thymocytes (ISPs) (Xiong et al., 2011). Upon gaining CD4, the 
thymocyte progresses into the CD4 CD8 double positive (DP) stage. DP 
thymocytes are found tightly packed within the inner cortex of the thymus 
(Dzhagalov and Phee, 2012). At first, DP thymocytes are large in size and 
proliferate rapidly. They later stop dividing and decrease in size. Whilst in the 
small DP stage, thymocytes begin to rearrange their TCR α-chain locus 
(Murphy, 2011). Once a successful rearrangement has been made, an α-chain 
can be produced and expressed with the β-chain on the surface of the 
thymocyte (Schematic 1.1).  
 
Following α:β TCR expression, rearrangement of the α-chain can continue until 
the DP thymocyte recognises self-peptide:MHC (Borgulya et al., 1992). In the 
mouse, α-chain rearrangement is estimated to occur over a 3 to 4 day period 
(Huesmann et al., 1991). Allelic exclusion does not occur for the TCR α-locus, 
and any one T cell may theoretically express two different α-chains complexed 
 
 
44 
to identical β-chains (Malissen et al., 1988; Padovan et al., 1993). In reality, 
however, it is highly unlikely that both TCRs would be functional.  
 
1.3.3.1 Positive selection 
 
During the small DP stage, thymocytes express only low levels of the α:β TCR 
on their cell surface (Murphy, 2011). Within the inner cortex and making close 
contact with the DP thymocytes, are large numbers of cortical thymic epithelial 
cells (cTECs) (Klein et al., 2014). Such cells are unusual in that they express 
both MHC class I and MHC class II molecules on their cell surface (Klein et al., 
2014). Through interactions with the cTECs, the TCR is checked for self-
reactivity. A successful interaction of the TCR with a self-peptide:MHC molecule 
results in positive selection of the thymocyte, and it is rescued from death (Klein 
et al., 2014). 
 
Positive selection also requires the interaction of a T cell co-receptor with the 
invariant portion of an MHC molecule. When the TCR first interacts with self-
peptide:MHC it will downregulate both CD4 and CD8. CD4 is then re-expressed 
(Lundberg et al., 1995). If the thymocyte is interacting with an MHC class II 
molecule, a strong selection signal is produced, and the thymocyte commits to 
the CD4 linage. If however, the TCR has bound to MHC class I then a weaker 
selection signal is induced, and the thymocyte will lose CD4 and instead gain 
CD8 (Singer et al., 2008).  
 
1.3.3.2 Negative selection 
 
Negative selection can take place in both the cortex and medulla of the thymus 
and may even be carried out later than the DP stage (McCaughtry et al., 2008). 
However, it is thought to occur mostly after positive selection and to be induced 
largely by the interaction of TCR expressing thymocytes with the stromal cells 
and antigen-presenting cells (APCs) of the thymic medulla (Klein et al., 2014). 
During negative selection, thymocytes that recognise self-peptide:MHC with too 
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high an affinity will undergo apoptosis. Crucially, this promotes self-tolerance 
within the immune system (Klein et al., 2014).  
 
Medullary dendritic cells expressing co-stimulatory molecules are important for 
the negative selection of thymocytes (Klein et al., 2014). Medullary thymic 
epithelial cells (mTECs) are also thought to be essential as they can present 
peripheral self-antigen to the thymocytes (Klein et al., 2014). Expression of the 
autoimmune regulator (AIRE) gene by the mTECs enables them to express all 
types of cellular proteins, including ones that are normally restricted to certain 
tissue types (Klein et al., 2014). AIRE deficient mice exhibit severe 
autoimmunity, with similarities to the multi-organ autoimmune disease, 
APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy), 
which develops in humans with a defective form of AIRE (Anderson et al., 
2002). Negative selection is well demonstrated in mice expressing a TCR 
specific for the HY (male) antigen. In male mice, DP cells are negatively 
selected and die by apoptosis, whilst in female mice transgenic T cells populate 
the periphery (Egawa et al., 2008).  
 
1.3.4 The single positive stage of development 
 
Approximately 1-2% of the DP thymocytes will pass positive and negative 
selection and mature into single positive (SP) thymocytes expressing either 
CD4 (CD4SP) or CD8 (CD8SP) (Huesmann et al., 1991). In TCR transgenic 
mice, where most cells express a selectable TCR, around 20% of DP 
thymocytes will enter into the SP stage (Huesmann et al., 1991). Of note, CD8 
precursors are more susceptible to death than CD4 precursors, and this seems 
to explain the high CD4:CD8 ratio (approximately 3:1 in a wild-type mouse) 
present in the thymus (Sinclair et al., 2013). SP thymocytes reside only within 
the thymic medulla (Dzhagalov and Phee, 2012). During the SP stage of 
development, cells increase expression of their TCRs. Nearly all CD4SP cells 
can recognise peptide presented on an MHC class II molecule, whilst nearly all 
CD8SP cells recognise peptide presented by MHC class I (Singer et al., 2008). 
A small percentage of CD4SP thymocytes have high expression of CD25 and 
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CTLA-4 (cytotoxic T-lymphocyte-associated protein 4, an inhibitory receptor for 
B7 molecules) and also express the transcription factor FoxP3 (Maggi et al., 
2005). These cells are known as natural regulatory T (Treg) cells. Treg cells are 
believed to occur when TCR signalling is stronger than that required to produce 
a conventional CD4SP cell, but not strong enough to induce negative selection 
(Jordan et al., 2001). 
 
As thymocytes progress through the SP stage of development, they 
downregulate their expression of the adhesion molecule, heat stable antigen 
(HSA, CD24) (Tian et al., 2001). Hence, cell surface expression of HSA is a 
useful marker for distinguishing between immature and mature SP thymocytes. 
Mature HSAlo SP thymocytes leave the thymus and enter the periphery. In the 
final stages of maturation, thymocytes begin to express S1P1 (a G-protein 
coupled receptor) (Takahama, 2006). This enables them to migrate towards 
sphingosine 1-phosphate (S1P) in the blood and lymph. They also express L-
selectin (CD62L), which allows them to home to the peripheral lymphoid organs 
(Takahama, 2006). Every day 2.6 million CD4SP thymocytes and 0.6 million 
CD8SP thymocytes are estimated to leave the murine thymus (Sawicka et al., 
2014).  
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Schematic 1.1 T cell maturation in the thymus 
 
Early T cell progenitors (ETPs) enter the cortico-medullary junction of the 
thymus through the high endothelial venules (HEVs) (Takahama, 2006). Once 
committed to the T cell lineage, the cells, due to their lack of both CD4 and CD8 
surface markers, are referred to as double negative (DN). As the DN cells 
progress through DN1-DN4, they rearrange their TCR β-chain locus (Ceredig 
and Rolink, 2002) and migrate from the cortico-medullary junction, through the 
cortex, and towards the subcapsular region (Benz et al., 2004). DN3 
thymocytes that express a pre-TCR on their cell surface may pass through the 
β selection checkpoint. After progressing through DN4, thymocytes begin to 
express cell surface CD8, but lack CD4. These cells are referred to as immature 
single positives (ISPs) (Xiong et al., 2011). Once thymocytes gain CD4 they 
enter the double positive (DP) stage of development. DP thymocytes are tightly 
packed within the cortex of the thymus (Dzhagalov and Phee, 2012). At first, 
they are large in size and undergo rapid proliferation, later they become smaller 
and begin rearrangement of their TCR α-chain locus (Murphy, 2011). Small DP 
thymocytes may express the α:β TCR on their cell surface. In the inner cortex, 
cortical thymic epithelial cells (cTECs) make close contact with the small DP 
thymocytes and check the α:β TCRs for self-reactivity. A successful interaction 
between self-peptide:MHC on the cTECs and the α:β TCR on the DP cell 
results in positive selection of the thymocyte (Klein et al., 2014). During positive 
selection, the thymocyte will also commit to either the CD4 or CD8 lineage. 
Successful interaction with MHC class II results in commitment to the CD4 
lineage and the production of a CD4 single positive (SP) thymocyte. 
Alternatively, interaction with MHC class I allows the thymocyte to develop into 
a CD8SP cell. Negative selection may take place in the cortex or medulla of the 
thymus (McCaughtry et al., 2008). Stromal cells and antigen presenting cells 
within the thymus may interact with the α:β TCR expressing thymocytes. If this 
interaction is too strong then negative selection will occur and the thymocyte will 
die by apoptosis (Klein et al., 2014). As thymocytes progress through the SP 
stage of development, they downregulate their expression of heat stable 
antigen (HSA) (Tian et al., 2001). The mature HSAlo thymocytes leave the 
thymus and enter the periphery through the HEVs (Takahama, 2006).  
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mTEC = medullary thymic epithelial cell. DC = dendritic cell.  
 
Schematic drawn by myself. Schematic partially inspired by (Takahama, 2006). 
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1.4 The peripheral T cell compartment 
 
1.4.1 T cell activation  
 
After leaving the thymus, mature T cells enter the bloodstream. Before they 
have encountered their specific antigen, these cells are referred to as naïve. 
They may recirculate between the blood and secondary (peripheral) lymphoid 
organs until they either meet their target antigen or die (Cose, 2007). The 
secondary lymphoid organs are highly organised structures, with B cells and T 
cells residing in distinct compartments. They include the lymph nodes and 
spleen, as well as discrete areas within mucosal linings (including the linings of 
the gut, the nasal and respiratory tracts, and the urogenital tract) (Murphy, 
2011).  
 
Stromal cells, present within the T cells zones of the secondary lymphoid 
organs, secrete the chemokine SLC (secondary lymphoid chemokine, CCL21) 
(Förster et al., 2012). This enables dendritic cells, expressing the SLC receptor, 
CCR7, to enter into the T cell zones (Caux et al., 2000). The dendritic cells 
express more SLC and can also express another chemokine, CCL19 (MIP-3β), 
which is also a ligand for CCR7 (Caux et al., 2000). T cells expressing CCR7 
can then follow the SLC/CCL19 chemokine gradient (Förster et al., 2012). 
CCR7 deficient mice exhibit an accumulation of T cells in the skin and a 
decrease in T cell numbers in the lymph nodes (Sumaria et al., 2011). The T 
cells enter the lymph nodes through the HEVs by the process of extravasation. 
The initial slow rolling of the T cell along the HEV wall is mediated by L-selectin 
on the T cell binding to addressins, such as CD34, on the endothelial cells (Puri 
et al., 1995).  
 
Within the secondary lymphoid organ, the T cell is well placed to make contact 
with dendritic cells. Naïve T cells interact with the surfaces of dendritic cells, 
browsing them for the presence of peptide:MHC to which they can bind 
(Montoya et al., 2002). Respectively, LFA-1 and CD2 on the T cell can bind 
ICAM-1/2 and CD58 on the DC (Montoya et al., 2002). The binding between the 
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DC and the T cell will be weak at first. However, if the T cell recognises 
peptide:MHC complexes on the DC, then the subsequent TCR signalling 
causes a conformational change in LFA-1, increasing the affinity with which it 
binds to the ICAMs (Montoya et al., 2002). If the DC is also able to provide co-
stimulation to the T cell, then the T cell is primed (Murphy, 2011).  
 
The initial interaction of the T cell with the peptide:MHC and co-stimulatory 
molecules of the DC cause the T cell to enter the G1 phase of the cell cycle 
(Acuto and Michel, 2003). During T cell priming, TCR signalling activates the 
NFAT, AP-1 and NF-κB transcription factors, which induce IL-2 transcription 
(Lin and Weiss, 2001). Co-stimulatory signalling also leads to AP-1 and NF-κB 
activation, further increasing IL-2 production (Acuto and Michel, 2003). The 
activated T cell generates the IL-2R α-chain, which combines with the IL-2R β 
and γ-chains already present at the cell surface. This changes the IL-2R into its 
high affinity form, which is capable of responding to even low concentrations of 
IL-2 (Gaffen, 2001). Signalling via this receptor then enables the T cell to 
progress through the cell cycle (Acuto and Michel, 2003). The T cell proliferates 
in the lymph node, producing many identical copies of itself by clonal 
expansion. This occurs over a period of several days, during which an antigen 
specific CD4 T cell is estimated to divide over 20 times (Gudmundsdottir et al., 
1999).  
 
TCR signalling induces expression of CD69 on the activated T cell’s surface. 
This results in the internalisation of S1P1 (Bankovich et al., 2010; Spiegel and 
Milstien, 2011). Removal of S1P1 from the cell surface traps the proliferating T 
cells within the secondary lymphoid organ. After a few days, S1P1 is again 
upregulated and the T cell can leave the lymph node, following the S1P 
gradient into the lymph and blood (Spiegel and Milstien, 2011).  
 
After 4 or 5 days of proliferating, T cells can differentiate into effector T cells, of 
which there are several types (Murphy, 2011; Schematic 1.2). To carry out their 
functions, effector cells must recognise peptide:MHC molecules on target cells, 
but they do not require co-stimulation. Effector cells express higher levels of 
LFA-1 and CD2 than naïve cells (Murphy, 2011). In addition they lack 
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expression of L-selection, meaning that they can no longer recirculate between 
the blood and lymph (Marschner et al., 1999). Instead, they express VLA-4. 
This enables them to bind to VCAM-1 on the endothelial cells of blood vessels 
and enter into the tissues at sites of infection (Murphy, 2011). Memory cells may 
also be generated during the primary immune response and upon the initial 
encounter of a T cell with its specific antigen. Memory T cells respond far more 
quickly to their peptide:MHC targets than do naïve T cells. 
 
At any one time, it is estimated that 1 in 10,000 to 1 in 1,000,000 naïve T cells 
will be specific for any given antigen (Murphy, 2011). This figure is termed the 
precursor frequency. In mice, the precursor frequency of naïve CD8 T cells 
specific for a particular MHC restricted epitope of LCMV (lymphocytic 
choriomeningitis virus) has been estimated to be 1 in 200,000 (Blattman et al., 
2002). However, following LCMV infection, an approximate 1000-fold increase 
in this precursor frequency has been observed (Blattman et al., 2002).  
 
1.4.1.1 Co-stimulation - the CD28 and TNF superfamilies 
 
The B7 molecules expressed on DCs are the most well recognised co-
stimulatory molecules and will interact with CD28 on the surface of T cells 
(Greenwald et al., 2004). However, T cells can express a large variety of co-
stimulatory receptors, in addition to CD28. Most of these receptors belong to 
either the CD28 superfamily or the TNF receptor superfamily (TNFRSF). The 
receptors ICOS (inducible co-stimulator) and CTLA-4 both belong to the CD28 
family (Greenwald et al., 2004). ICOS interacts with ICOSL (B7-H2) on DCs. 
This interaction is believed to promote the differentiation of CD4 helper T cell 
subsets (Greenwald et al., 2004). CTLA-4 binds to the B7 molecules more 
strongly than CD28 and works to inhibit T cell activation (Greenwald et al., 
2004). Activated T cells will immediately increase their surface expression of 
CTLA-4. This enables the DCs to interact preferentially with naïve T cells, as 
opposed to those T cells that have already been primed (Greenwald et al., 
2004).   
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Signalling induced by the TNF family of cytokines can deliver co-stimulation to 
the T cell via the TRAF dependent activation of the transcription factor NF-κB 
(Watts, 2004). CD27, 4-1BBL, and OX40 are members of the TNFRSF and can 
be expressed on T cells (Watts, 2004). T cells also express the TNF 
superfamily (TNFSF) cytokine, CD40L in its membrane-bound form (Lesley et 
al., 2006). CD27 is constitutively expressed on T cells and binds CD27L (CD70) 
on DCs. CD27 deficient mice fail to generate and maintain a memory T cell 
response (Hendriks et al., 2000).  
 
OX40 expression is induced following activation of the T cell and is believed to 
be important in maintaining a T cell response and for the acquisition of 
immunological memory (Watts, 2004). OX40 deficient mice have reduced CD4 
T cell responses to viruses (Kopf et al., 1999). The binding of CD40L to the 
DC’s CD40 and of 4-1BB to 4-1BBL on the DC can induce changes in both the 
T cell and the DC. The T cell receives appropriate co-stimulation, and the DC 
further increases its expression of co-stimulatory molecules (Watts, 2004).  
 
DCs are the main APCs. Occasionally, however, macrophages and B cells can 
also be induced to express co-stimulatory molecules and therefore may act as 
APCs (Murphy, 2011). In the absence of infection, APCs do not express co-
stimulatory molecules. If a naïve T cell recognises peptide:MHC in the absence 
of co-stimulation, then it may become a regulatory T cell, be deleted, or become 
anergic (inactivated) (Schwartz, 2003). In this way peripheral tolerance can be 
induced. Anergy is believed to require blockade of TCR signalling by the 
expression of E3 ubiquitin ligases such as GRAIL and Cbl-b (Lin and Mak, 
2007). Cbl-b-/- mice develop spontaneous autoimmunity, with large numbers of 
activated T and B cells infiltrating many organs (Bachmaier et al., 2000). 
 
1.4.2 T cell differentiation and effector functions 
 
Following activation and proliferation, T cells can differentiate into effector 
subsets (Schematic 1.2). CD8 expressing T cells nearly always become 
cytotoxic T cells (cytotoxic lymphocytes, CTLs) (Weninger et al., 2002). In 
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contrast, CD4 expressing cells may differentiate into one of a variety of helper T 
cell subsets, the most well recognised being Th1, Th2, Th17, and Tfh, or into 
regulatory T (Treg) cells (Schmitt and Ueno, 2015). The different effector subsets 
may be defined by the surface markers they express, the stimuli that induce 
their production, the transcription factors they activate, the cytokines they 
secrete, and the effects they have on their target cells (Schematic 1.2).   
 
Since the TCR is membrane bound, T cells must initiate their effector functions 
via direct cell:cell contact. Upon recognising peptide:MHC complexes, effector T 
cells may bind tightly to their targets. An immunological synapse 
(supramolecular activation complex, SMAC) forms between the T cell and the 
target cell (Grakoui et al., 1999; Ritter et al., 2013). The TCR, co-receptor, and 
peptide:MHC complexes are clustered together in the centre of the synapse 
(central SMAC, cSMAC). Adhesion molecules are present at the outer edge of 
the synapse (peripheral SMAC, pSMAC) (Grakoui et al., 1999; Ritter et al., 
2013). Formation of the immunological synapse triggers a reorganisation of the 
T cell’s cytoskeleton and serves to polarise the T cell so that its effector 
molecules may be directed towards the target (Ritter et al., 2013; Valitutti et al., 
1995).  
 
1.4.2.1 Cytotoxic T cells 
 
CD8 expressing, cytotoxic T cells recognise their specific peptide in the context 
of MHC class I. Within the endoplasmic reticulum, MHC class I molecules 
obtain peptides derived from the cell’s cytoplasm (Russell and Ley, 2003). For 
this reason, cytotoxic T cells are able to assess their target cells for the 
presence of intracytoplasmic pathogens such as viruses. At the site of the 
immunological synapse, the cytotoxic T cell will release cytotoxic granules 
containing perforin and granzyme (Russell and Ley, 2003). These induce 
apoptosis of the target cell and of any intracellular pathogens within it. The 
cytotoxic T cell rapidly dissociates from the dying cell and moves on to its next 
target (Russell and Ley, 2003).   
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1.4.2.2 Helper T cells 
 
CD4 T cells recognise their specific peptide as expressed on an MHC class II 
molecule. MHC class II molecules bind their peptide antigen within intracellular 
endosomal vesicles (Murphy, 2011). CD4 T cells are therefore able to assess 
their target cells for the presence of endocytosed pathogens such as bacteria.  
 
During the innate immune response, DCs and macrophages begin to produce 
IL-12 and NK cells produce IFN-γ (interferon-γ) (Szabo et al., 2003). Among 
activated CD4 T cells, IL-12 and IFN-γ can induce the JAK-STAT (janus kinase-
signal transducer and activator of transcription) signalling pathway, resulting in 
the activation of STAT1 and STAT4. STAT1 then activates the transcription 
factor T-bet (Szabo et al., 2003). T-bet induces the expression of IFN-γ and of 
the IL-12R, thus contributing to the further differentiation of the T cell (Schmitt 
and Ueno, 2015). The CD4 T cell eventually becomes committed to the Th1 
lineage. Upon recognising its target peptide:MHC, the Th1 cell can secrete 
large amounts of IFN-γ. Th1 cells are good activators of pathogen-containing 
macrophages. The IFN-γ produced by the T cell can stimulate the IFN-γ 
receptor present on the macrophage’s surface. In addition, CD40L expressed 
on the Th1 cell can bind CD40 on the macrophage. Activated macrophages 
produce large amounts of TNF (Szabo et al., 2003). The TNF can act in an 
autocrine manner, binding TNFR1 on the macrophage’s surface. TNF signalling 
seems necessary to prevent the Th1 cells from causing apoptosis of the 
macrophage. Mice deficient in TNFR1 fail to contain Mycobacterium avium due 
to Th1 induced macrophage death (Ehlers et al., 2000).   
 
Eosinophils, basophils and mast cells, employed during the early stages of an 
immune response, can secrete IL-4 (Paul and Zhu, 2010). When activated in 
the presence of IL-4, CD4 T cells can signal via STAT6 (Schmitt and Ueno, 
2015). STAT6 can activate GATA3, which induces transcription of IL-4 and IL-
13 (Paul and Zhu, 2010). The T cell then becomes committed to the Th2 
lineage. Th2 cells are important in the killing of extracellular parasites such as 
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helminths. They can active mast cells and eosinophils and they can induce IgE 
production by B cells (Paul and Zhu, 2010).  
 
A CD4 T cell that is activated in the absence of IL-4 and IL-12, but in the 
presence of IL-6 and TGF-β, may differentiate into the Th17 subset (Schmitt 
and Ueno, 2015). Th17 cells are largely defined by their expression of the 
transcription factor RORγt, which enables them to produce cytokines of the IL-
17 family (Littman and Rudensky, 2010). Th17 cells also produce IL-21 and IL-
22. The IL-21 acts in an autocrine manner and causes activation of STAT3 
(Littman and Rudensky, 2010). Signalling through the IL-23R seems necessary 
to keep a T cell committed to the Th17 subset. Th17 cells can induce the 
expression of IL-8 by epithelial cells (Murphy, 2011). This assists in the 
recruitment of neutrophils to the site of infection. In this manner, Th17 cells aid 
the clearance of extracellular bacteria and fungi (Littman and Rudensky, 2010). 
 
Tfh cells provide help to B cells within the follicles of the secondary lymphoid 
organs (Schmitt and Ueno, 2015). In vitro production of Tfh cells has proven 
difficult, and for that reason we know little about how they may be induced. 
However, IL-6 and the Bcl6 transcription factor are believed to be necessary for 
Tfh lineage commitment (Ma et al., 2012). Bcl6 induces transcription of CXCR5, 
which is needed for retention of Tfh within the B cell follicles. ICOS expressed 
on the Tfh cells can interact with ICOSL on B cells, thus sustaining interactions 
between the two cell types (Ma et al., 2012). 
 
Treg cells are important for the suppression of an immune response. Natural Treg 
cells are produced during thymic development (Maggi et al., 2005). In the 
presence of correct stimulation, naïve CD4 T cells may differentiate into induced 
Treg cells. In the absence of IL-6 and other pro-inflammatory cytokines, TGF-β is 
believed to stimulate the production of induced Treg cells (Schmitt and Ueno, 
2015). Both natural and induced Treg cells express the CD4, CD25, and CTLA-4 
surface markers and the FoxP3 transcription factor. FoxP3 can interfere with 
the binding of AP-1 and NFAT to the IL-2 promoter and can prevent the 
production of IL-2 (Schubert et al., 2001; Wu et al., 2006). CTLA-4 on Treg cells 
competes with CD28 on naïve T cells for binding to the B7 molecules of DCs 
 
 
57 
(Acuto and Michel, 2003). Treg cells produce TGF-β and IL-10 (Saraiva and 
O'Garra, 2010). Both these cytokines can inhibit T cell proliferation, and IL-10 
can also inhibit the secretion of IL-12 by DCs (Saraiva and O'Garra, 2010). 
Recently, subsets of regulatory T cells have been described that lack 
expression of FoxP3. These include Th3 and Tr1 cells, neither of which have 
been well characterised (Roncarolo et al., 2001; Saraiva and O'Garra, 2010). 
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Schematic 1.2 T cell subtypes 
 
This schematic illustrates some of the main T cell effector subtypes that arise 
upon activation of a naïve CD4+ or CD8+ T cell. The transcription factors 
responsible for differentiation/maintenance of the T cell subtype are listed inside 
the cell. The cytokines responsible for promoting differentiation into a particular 
T cell subtype are shown on an arrow leading to the cell itself. Arrows leading 
away from the cell show the cytokines that the differentiated cell secretes. 
Boxes list the main effector functions of the T cell subtype. Naïve T cells 
normally require interactions with both peptide:MHC and co-stimulatory 
molecules before they may differentiate into an effector subset. However, if a 
naïve T cell recognises peptide:MHC in the absence of co-stimulation, then it 
may become a regulatory T cell (Schwartz, 2003). 
 
DC = dendritic cell. CTL = cytotoxic T lymphocyte.  
 
Schematic created by myself. Inspiration for schematic taken from (Dong and 
Martinez, 2010).
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1.4.3 T cell homeostasis 
 
In the growing mammal, the lymphocyte pool increases in size, only to be 
maintained at a relatively constant state in the adult by poorly understood 
homeostatic mechanisms (Takada and Jameson, 2009). T lymphocytes are in 
constant production, both by the thymus and by peripheral division in response 
to antigenic stimulation. Quite simply, in order for equilibrium to be maintained, 
one T cell must die for every new T cell that is made. The ready abundance of T 
cells in a lymphoreplete individual means that these cells are in constant 
competition with each other for survival. Essentially, competition for resources 
acts to shape the T cell pool (Takada and Jameson, 2009).  
 
A T cell’s requirement for resources changes throughout its lifespan. This 
means that different T cell types can occupy separate niches and thus can 
avoid being in direct competition with one another for space and survival signals 
(Takada and Jameson, 2009). The thymus, as a primary lymphoid organ and 
the site of T cell development, has a profound influence on the T cell repertoire. 
For correct thymocyte differentiation, contact with thymic epithelial cells is 
necessary and hence, thymic architecture must be maintained. For a thymocyte 
to be positively selected, it must engage in a low affinity interaction with self-
peptide:MHC complexes. Following egress from the thymus, the now mature, 
but naïve T cells continue to require interactions with self-peptide:MHC in order 
to survive (Kirberg et al., 1997).  
 
As a naïve T cell changes to a memory state, its requirement for survival signals 
changes. In contrast to naïve cells, memory T cells are thought not to require 
TCR:self-peptide:MHC interactions in order to survive (Murali-Krishna et al., 
1999; Swain, 2000). Naïve and memory CD8 cells are believed to occupy 
different competitive niches and therefore may not compete for the same 
limiting resources (Freitas and Rocha, 2003). However, there is evidence that 
this is not the case for naïve and CD4 memory cells, particularly in conditions of 
lymphopenia, when integration of TCR and IL-7 signals seems to favour survival 
of both cell types (Seddon et al., 2003).  
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The cytokines that use receptors containing the common γ-chain (γc) are 
particularly important for T cell homeostasis. These consist of IL-2, IL-4, IL-7, IL-
9, IL-15 and IL-21. T cell survival requires signalling through JAK3, and this 
kinase can be activated by all γc receptors (Sohn et al., 1998). Of the γc 
cytokines, IL-7 is the most crucial. IL-7 is non-redundant for both the survival 
and homeostatic proliferation of naïve CD4 and CD8 T cells (Bhatia et al., 1995; 
Freeden-Jeffry et al., 1995), although the exact mechanism through which IL-7 
works is unclear. Under normal circumstances, the levels of IL-7 appear to be 
limiting - if IL-7 is over-expressed, then the size of the T cell pool can increase 
(Geiselhart et al., 2001). Interestingly, once activated, a T cell seems to require 
only one of IL-2, IL-4, IL-7, or IL-15 in order to survive (Vella et al., 1998).  
 
IL-7 is necessary for the survival and homeostatic proliferation of CD4 memory 
cells (Bradley et al., 2005; Seddon et al., 2003). In comparison, generation of 
memory CD8 cells is controlled by both IL-7 and IL-15 (Buentke, 2006). The 
effect that IL-7 has on a T cell is regulated through the expression of the IL-7 
receptor (IL-7R). The IL-7R is absent on thymocytes during positive selection 
and on activated T cells. The strength of TCR signalling during positive 
selection correlates with the upregulation of the IL-7R on SP thymocytes 
(Sinclair et al., 2011). New T cells can further upregulate IL-7R expression as 
they leave the thymus, in a process dependent on activation of the NF-κB 
transcription factor (Silva et al., 2014). 
 
TCR and IL-7R signals have been found to synergize to induce homeostatic 
proliferation (Seddon and Zamoyska, 2002). CD4 and CD8 mature T cells die 
after losing their TCRs (Labrecque et al., 2001; Polic et al., 2001). The TCR 
clearly induces a T cell survival signal. However, the precise nature of these 
homeostatic signals is unknown. The Src family kinases Lck and Zap70 are 
required for homeostatic proliferation (Schim van der Loeff et al., 2014; Seddon 
et al., 2000). Interestingly, while Fyn expression is not sufficient to induce 
proliferation, there is redundancy between Lck and Fyn for survival, suggesting 
that survival and proliferation signals are distinct (Seddon et al., 2000). 
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1.5 Signalling within the immune system 
 
Cells of the innate and adaptive immune system possess a variety of cell 
surface receptors. These receptors sense information about the extracellular 
environment and transduce it to appropriate cell compartments via the 
activation of intracellular signalling pathways. Signalling pathways can vary 
enormously, but essentially, they all rely on protein:protein interactions (Pawson 
and Nash, 2003). In many cases, cell signalling cascades end with the 
activation of a transcription factor. In such instances, gene expression can 
occur and proteins may be synthesised. Alternatively, signalling pathways may 
act upon the cytoskeleton and lead to mobilisation of the cell or changes in 
shape and size (Murphy, 2011).  
 
Cell surface receptors have an extracellular region to sense the environment 
and usually, an intracellular region (cytoplasmic tail) to activate the signalling 
cascade. If the receptor itself lacks the intracellular region, then it must closely 
associate with a second protein boasting such a region. In order to function, a 
signalling cascade must employ the activity of enzymes. Protein kinases are an 
important class of these enzymes (Pawson and Nash, 2003). They add 
phosphate groups to tyrosine, serine, or threonine amino acid residues. Often 
protein kinases are associated with the receptor (e.g. the B and T cell 
receptors) and can be activated rapidly upon ligand binding to the receptor’s 
extracellular portion. Occasionally, the receptor itself has an intrinsic kinase 
activity within its intracellular region (e.g. the transforming growth factor-β, TGF-
β receptor). Such receptors belong to the group of receptor tyrosine kinases or 
receptor serine/threonine kinases (Pawson and Nash, 2003). Protein kinases 
tend to activate themselves upon dimerization, before phosphorylating their 
other protein substrates (Murphy, 2011).  
 
Phosphorylated proteins can easily interact with other proteins. Phosphorylation 
is also important for activation of many proteins, including enzymes, and for the 
activation of transcription factors (Murphy, 2011). Dephosphorylation of a 
protein involves removal of phosphate groups by protein phosphatases and can 
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be important for terminating or regulating a signalling pathway. Proteins 
involved in signalling cascades usually contain protein-interaction domains. 
Such domains, e.g. Src homology 2 (SH2) domains, frequently bind to 
phosphorylated tyrosines (Pawson and Nash, 2003).  
 
Scaffolds and adaptors are very important components of signalling cascades. 
They lack any enzymatic activity of their own, but serve to bring other proteins 
into close proximity with each other (Jordan et al., 2003). Scaffolds are large 
and can recruit multiple proteins, whilst adaptors are smaller and tend to bring 
only two other proteins together (Murphy, 2011).  
 
Small GTPases (e.g. Ras, Rac, Rho and Cdc42) can bind to GTP and GDP and 
are important for signalling downstream of tyrosine kinase associated receptors 
(Cantrell, 2003). The small GTPases are activated (bind GTP) in response to 
receptor stimulation. However, they do not stay active for long, and this tight 
regulation helps to control the magnitude of the signalling response (Cantrell, 
2003).  
 
Phosphatidylinositol is an important lipid component of cell membranes 
(Lemmon, 2003). During receptor signalling it is often phosphorylated, 
transforming into one of a variety of phosphoinositides (e.g. phosphatidylinositol 
3, 4, 5-trisphosphate; PIP3) (Lemmon, 2003). The phosphoinositides are 
recognised by the domains of proteins and hence serve to recruit other 
signalling components to the cell membrane.  
 
Ubiquitination is the process by which ubiquitin chains are added to the lysine 
residues of protein substrates by ubiquitin ligases. It plays a significant role in 
many signalling pathways. Polyubiquitination at the K48 residue marks the 
protein for proteasomal degradation. This aids signal termination (Liu et al., 
2005). Conversely, polyubiquitination at the K63 residue can help to propagate 
the signal by further promotion of protein:protein interactions (Liu et al., 2005).  
 
Within many signalling pathways, enzymatic activity may result in second 
messenger production. Second messengers enable amplification of the signal 
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by activation of protein substrates (Lin and Weiss, 2001). Within immune 
system cells, calcium ions (Ca2+) are important second messengers, which, 
when released, can lead to activation of the protein calmodulin (Murphy, 2011).  
 
1.5.1 Signalling downstream of the T cell receptor 
 
The T cell receptor (TCR) remains membrane bound, unlike the B cell receptor 
(BCR), which may be secreted as immunoglobulin. Consequently, for a T cell to 
fulfil its effector functions, it first requires stimulation of the TCR and activation 
of downstream signalling cascades.  
 
The TCR is activated when it binds to a peptide:MHC complex on the surface of 
an APC. Exactly how this first activating signal is transmitted is however, still a 
matter of some debate. It may involve the clustering of two or more TCRs. It has 
been proposed that “pseudo-dimeric” MHC:peptide complexes could form on 
the APC’s surface. These complexes would be composed of one non-self-
peptide:MHC molecule and one self-peptide:MHC molecule (Murphy, 2011). In 
recognising the complex, two separate TCRs may come together and form a 
dimer. The clustering together of many TCRs (microcluster formation) is also a 
possibility, although it is unclear whether this could be frequently induced by 
peptide:MHC complexes (Murphy, 2011; Smith-Garvin et al., 2009). A slightly 
different possibility is that, upon peptide:MHC binding, the TCR may undergo a 
conformational change that would help to propagate the signal (Smith-Garvin et 
al., 2009). During the DN stage of thymocyte development, signalling through 
the pre-TCR is constitutive and is thought to occur in the absence of ligand 
(Aifantis et al., 2001). 
 
The TCR α and β-chains (or γ and δ-chains) have only very short cytoplasmic 
tails. Hence, in order to transmit its signal intracellularly, the TCR must 
associate closely with the CD3 complex (composed of CD3γ, CD3δ and CD3ε) 
and with the zeta (ζ) chain (Wucherpfennig et al., 2010) Schematic 1.3). 
Together, the TCR, CD3 complex, and ζ chain form the TCR complex 
(Wucherpfennig et al., 2010). CD3γ, CD3δ, CD3ε, and the ζ chain all contain 
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immunoreceptor tyrosine-based activation motifs (ITAMs) in their intracellular 
regions. The ITAMs each possess two tyrosine residues that, following 
activation of the TCR, can be phosphorylated by Lck (a member of the Src 
family of protein tyrosine kinases) (Wucherpfennig et al., 2010). Lck is 
associated with the CD4 and CD8 co-receptors. For this reason, the binding of 
CD4 and CD8 to the invariant portions of MHC molecules is a crucial step in 
TCR signalling (Li et al., 2004). It serves to bring Lck into close proximity to the 
ITAMs of the TCR complex.  
 
In Lck deficient mice, thymocyte development can progress through the DN 
stage, but is severely blocked at the DP stage (Molina et al., 1992). Lck 
signalling is also thought to be important for determining CD4/CD8 lineage 
commitment during thymocyte development. Stronger or more sustained TCR 
signalling, mediated by Lck, is believed to lead to CD4 T cell development by 
enabling expression of the transcription factor ThPOK (He et al., 2005; Singer et 
al., 2008; Sun et al., 2005). Conversely, it is thought that a weak TCR signal is 
unable to induce ThPOK, allowing instead for the expression of a second 
transcription factor, Runx3 and resulting in commitment to the CD8 lineage 
(Saini et al., 2010; Sinclair et al., 2015). 
 
Once phosphorylated by Lck, the tyrosines residues within the ITAMs of the 
TCR complex are able bind the SH2 domains of Zap70 (a cytoplasmic protein 
tyrosine kinase) (Iwashima et al., 1994). Zap70 can then undergo 
autophosphorylation and can also be phosphorylated by Lck (Chan et al., 
1995). In this activated form, Zap70 may phosphorylate LAT (linker of activated 
T cells, a scaffold protein) and SLP-76 (an adaptor protein) (Huse, 2009). PIP3, 
present in the T cell’s cytoplasmic membrane, recruits phospholipase C-γ (PLC-
γ) by binding to its PH (pleckstrin homology) domain. Once at the membrane, 
PLC-γ binds to LAT and SLP-76 and may then be activated by Itk (a 
membrane-associated protein tyrosine kinase) (Samelson, 2003). In naïve T 
cells, activation of PLC-γ also relies on signals received through the co-
stimulatory receptor, CD28 (Murphy, 2011).  
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Activated PLC-γ causes the breakdown of the membrane lipid 
phosphatidylinositol bisphosphate (PIP2) into diacylglycerol (DAG) and 1,4,5-
trisphophate (IP3, a second messenger) (Lin and Weiss, 2001). Ultimately, 
activated PLC-γ can activate three separate downstream signalling pathways. 
In one such pathway, IP3 binds to Ca2+ channels in the endoplasmic reticulum 
(ER). This results in the subsequent release of Ca2+ from the ER and into the 
cytoplasm. The free Ca2+ can then bind calmodulin, which in turn binds and 
activates calcineurin (a serine/threonine phosphatase) (Hogan et al., 2003). 
Calcineurin dephosphorylates the transcription factor NFAT (nuclear factor of 
activated T cells), allowing it to enter the nucleus (Hogan et al., 2003).  
 
A second pathway initiated by PLC-γ involves the activation of the small 
GTPase, Ras by DAG (Lin and Weiss, 2001). Ras then activates Raf (a 
mitogen-activated protein kinase kinase kinase, MAP3K). Raf phosphorylates 
MEK1 (a MAP2K) and MEK1 phosphorylates Erk (a MAPK). Erk leads to 
production of the AP-1 transcription factor (Murphy, 2011). The final pathway 
initiated by PLC-γ involves the recruitment of protein kinase C-theta (PKC-θ) to 
the membrane by DAG (Kishimoto et al., 1980). PKC-θ can phosphorylate 
CARMA1 (a scaffold protein) (Rueda and Thome, 2005). This enables 
recruitment of the CARMA1/Bcl10/MALT1 (CBM) complex to the immunological 
synapse. The CBM complex can then recruit other proteins, including the IKK 
(inhibitor of NF-κB kinase) complex and TRAF6 (Rossman et al., 2006; Thome, 
2004). Activation of the IKK complex ultimately leads to activation of the 
transcription factor NF-κB (Rossman et al., 2006). NFAT, AP-1 and NF-κB can 
all increase the transcription of the cytokine IL-2, which is important for T cell 
proliferation and differentiation (Murphy, 2011).  
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Schematic 1.3 The TCR/CD3 complex 
 
The α:β TCR is composed of an α chain and a β chain, each of which has a 
variable (V) and constant (C) region. The TCR α and β chains have only very 
short cytoplasmic tails. Therefore, in order to transmit a signal intracellularly, 
they must associate with the CD3 complex (composed of CD3ϒ, CD3δ, and 
CD3ε) and with a homodimer of ζ chains. The TCR, CD3, and ζ chains together 
form the TCR complex. CD3ϒ, CD3δ, CD3ε, and the ζ chains all contain 
immunoreceptor tyrosine-based activation motifs (ITAMs, shown as brown 
rectangles) in their intracellular regions.  
 
The MHC class II molecule is composed of an α chain and a β chain, each of 
which has two domains. The amino-terminal domains, α1 and β1 are highly 
polymorphic and form the peptide-binding cleft. The MHC class I molecule (not 
shown) is composed of an α chain (containing three protein domains) bound to 
β2-microglobulin. The CD4 co-receptor is a single chain composed of four Ig-like 
domains. CD4 binds to the β2 domain of the MHC class II molecule (Murphy, 
2011). The CD8 co-receptor (not shown) is made up of of two separate chains 
(an α and a β chain), each composed of a single Ig domain. CD8 binds to the α3 
domain of an MHC class I molecule (not shown) (Murphy, 2011). The Src family 
kinase Lck is associated with the cytoplasmic region of the CD4 (or CD8) co-
receptor (Li et al., 2004). When the TCR and co-receptor bind to the MHC 
molecule, then Lck is brought into close proximity to the ITAMs of the CD3 and 
ζ chains. Lck phosphorylates the two tyrosine residues present in each of the 
ITAMs (Wucherpfennig et al., 2010). Another Src family kinase, Zap-70, can 
then bind to the phosphorylated ITAMs (Iwashima et al., 1994). Zap-70 is 
phosphorylated by Lck and then phosphorylates other downstream signalling 
molecules (not shown).  
 
Schematic drawn by myself, but based on and adapted from figures by (Murphy 
et al., 2011).
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1.5.2 Cytokine signalling - the hematopoietin family 
 
The hematopoietin family of cytokines is very large and among others, includes 
the interleukins 2-7, IL-9, IL-12, and IL-15 (Murphy, 2011). Receptors for the 
hematopoietin family form dimers upon ligand binding. The cytoplasmic 
domains of the hematopoietin family receptors are associated with protein 
tyrosine kinases of the JAK family (Leonard and O'Shea, 1998). Upon cytokine 
binding and consequent dimerization of the receptor, the JAKs are brought into 
close proximity with one another (Leonard and O'Shea, 1998). The JAKs first 
autophosphorylate, before phosphorylating tyrosine residues on the receptor’s 
cytoplasmic tail (Leonard and O'Shea, 1998). The phosphorylated tyrosines of 
the receptor can interact with the SH2 domains of STATs. At the receptor, the 
STATs are phosphorylated by the JAKs. The STATs then dimerize, before 
migrating to the nucleus where they initiate transcription of their target genes 
(Leonard and O'Shea, 1998).  
 
There are several JAK and STAT proteins, particular combinations of which are 
associated with signalling from different cytokine receptors. Of note, STAT1 and 
STAT4 are important for the development of Th1 cells, whilst STAT6 is 
necessary for Th2 production (Schmitt and Ueno, 2015; Szabo et al., 2003). 
Cytokines can have dramatic effects on the immune system, and hence their 
signalling must be tightly regulated. Regulation may be provided by 
phosphatases (e.g. CD45) or by inhibitors such as the suppressor of cytokine 
signalling (SOCS) proteins (Yasukawa et al., 2000).  
 
1.5.2.1 IL-7 signalling 
 
IL-7, although initially identified for its role in B cell development, has proven 
essential to the development and homeostasis of T cells. Il7 and Il7rα knockout 
mice lack both B and T cells (Freeden-Jeffry et al., 1995; Peschon et al., 1994). 
Use of neutralising antibodies towards IL-7 has been shown to reduce T cell 
numbers in the thymus and periphery (Grabstein et al., 1993). Conversely, 
addition of recombinant IL-7 can increase T cell numbers (Geiselhart et al., 
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2001). The IL-7R is composed of the γc and the IL-7R α-chain. JAK3 is 
associated with the γc, whilst JAK1 is associated with the IL-7R α-chain (Palmer 
et al., 2008). This combination of JAKs most frequently leads to activation of 
STAT5 (Palmer et al., 2008). The STAT5 transcription factor can induce 
transcription of B cell leukaemia/lymphoma 2 (Bcl-2) (Hand et al., 2010). Bcl-2 
is an important anti-apoptotic protein and its expression is believed to be crucial 
for T cell survival (Borner, 2003). 
 
1.5.3 Apoptosis 
 
Apoptosis is a form of programmed cell death that plays an important role in the 
immune system. Notably, it is employed in the removal of non-functional or self-
reactive T cells and in the disposal of effector T cells following the resolution of 
an infection (Siegel, 2006). Apoptosis is characterised by plasma membrane 
blebbing, redistribution of membrane lipids, and degradation of nuclear DNA 
(Elmore, 2007). Two main pathways can lead to the induction of apoptosis. 
These are termed the intrinsic and extrinsic pathways (Schematic 1.4). Both 
pathways rely on the activation of aspartic-acid-specific cysteine proteases 
(caspases) (Siegel, 2006). Caspases are produced in an inactive pro-caspase 
form and must be activated by cleavage. Initiator caspases cleave the pro-forms 
of other caspases. Executioner caspases cleave other proteins within the cell, 
leading to chromosomal degradation (Siegel, 2006).   
 
1.5.3.1 The intrinsic apoptosis pathway 
 
The intrinsic apoptosis pathway is triggered in response to a variety of cellular 
insults, such as ultra-violet irradiation, heat, hypoxia, and chemotherapeutic 
drugs, or in response to a lack of survival factors such as IL-7 (Elmore, 2007; 
Strasser, 2005). Members of the Bcl-2 family regulate the intrinsic apoptosis 
pathway. Bcl-2 family members possess Bcl-2 homology (BH) domains (Borner, 
2003). The family contains both pro-apoptotic and anti-apoptotic members. 
Certain pro-apoptotic family members (e.g. Bax, Bak and Bok, also known as 
executioners) can bind to the membrane of mitochondria, causing the 
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mitochondria to swell. This results in the release of cytochrome c from the 
mitochondria and into the cytoplasm (Borner, 2003). Once in the cytoplasmic, 
cytochrome c can bind to Apaf-1 (apoptotic protease activating factor-1). This 
cytochrome c:Apaf-1 complex provides a site for the recruitment of pro-
caspase-9. Pro-caspase-9 is then able to cleave itself into active caspase-9 
(Russell and Ley, 2003). Ultimately, caspase-9 enables activation of the effector 
caspases 3, 6, and 7. Finally, nuclear DNA is cleaved and the cell dies (Russell 
and Ley, 2003) Schematic 1.4).  
 
The anti-apoptotic Bcl-2 family members (e.g. Bcl-2, Bcl-XL, and Bcl-W, also 
known as protectors) work to inhibit the pro-apoptotic members (Borner, 2003). 
The BH3-only members of the Bcl-2 family (e.g. Bim, Bid, Bad, and Bmf, also 
known as sentinels) are a second group of pro-apoptotic proteins (Strasser, 
2005). They do not cause the direct release of cytochrome c, but instead can 
induce cell death by increasing the activity of the executioners and by inhibiting 
the protectors (Murphy, 2011).  
  
1.5.3.2 The extrinsic apoptosis pathway 
 
The extrinsic apoptosis pathway is initiated by the binding of an extracellular 
ligand to a death receptor. The death receptors are death domain (DD) 
containing members of the TNFRSF (Aggarwal, 2003). Within the immune 
system, Fas (CD95) and TNFR1 are particularly important death receptors 
(Russell and Ley, 2003). 
 
1.5.3.2.1 FasL signalling pathway 
 
Fas ligand (FasL) is produced as a trimer and is present in large amounts on 
the surface of cytotoxic T cells (Aggarwal, 2003). FasL can induce the 
trimerization of Fas (Schematic 1.4). This brings the death domains of Fas into 
close contact and enables them to recruit FADD (Fas-associated protein with 
death domain, an adaptor) (Russell and Ley, 2003). Fas and FADD bind to 
each other via their death domains (Chinnaiyan et al., 1995). FADD also 
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contains a death effector domain (DED), which can bind to the DED present in 
pro-caspase-8 and (in humans, but not in mice) pro-caspase-10 (Siegel, 2006). 
The pro-caspases can activate themselves and can then serve to activate the 
effector caspases 3, 6, and 7 (Siegel, 2006). Cell death results.  
 
1.5.3.2.2 TNF signalling pathway 
 
Like Fas, TNF is also produced as a transmembrane trimeric protein. However, 
unlike Fas, it may additionally be released as a soluble form. Cleavage of TNF 
from the cell membrane is performed by TNF alpha converting enzyme (TACE) 
(Black et al., 1997). TNF binding causes timerization of TNFR1. The DDs 
present on the cytoplasmic tails of TNFR1 can then bind to the DDs present on 
TRADD (TNFR1 associated death domain protein, an adaptor) (Hsu et al., 
1995). Via DD to DD binding, TRADD may recruit FADD (Hsu et al., 1996b). 
Once FADD is bound, activation of caspases and cell death can proceed, as for 
the FasL signalling pathway. However, the main function of TNF is not to induce 
apoptosis, but rather to contribute towards inflammation (Aggarwal, 2003). 
Indeed, TNF signalling rarely results in cell death. This is because the binding of 
TRADD to TNFR1 can also initiate a FADD independent signalling pathway 
(Hsu et al., 1996b). This second pathway terminates in NF-κB activation and 
results in the transcription of pro-inflammatory and pro-survival proteins. It is 
believed that the ultimate fate of a TNF stimulated cell depends on the balance 
between these two pathways (Aggarwal, 2003). In addition to the extrinsic 
apoptosis pathway and the NF-κB pathway, TNFR1 can also initiate activation 
of the JUN N-terminal kinase (JNK) and p38 MAPK pathways (Aggarwal, 2003).    
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Schematic 1.4 Extrinsic and intrinsic apoptosis pathways 
 
The extrinsic apoptosis pathway is activated by the binding of an extracellular 
ligand to a death receptor. FasL expressed on the surface of cytotoxic T cells 
can induce trimerization of Fas on the target cell. The death domains (DDs) of 
Fas are then brought into close contact with one another, enabling them to bind 
to the DDs of the adaptor molecule FADD (Russell and Ley, 2003). The death 
effector domain (DED) of FADD can then bind to the DED of pro-caspase-8 
(Siegel, 2006). The bound pro-caspase-8 activates itself by proteolytic cleavage 
(Chang et al., 2003). In turn, the active caspase-8 recruits and activates 
caspase-3, an effector caspase (Siegel, 2006) and can also lead to the 
truncation of Bid (Bruin et al., 2008). Caspase-3 cleaves ICAD (inhibitor of 
caspase activated DNase), mediating the release of CAD and resulting in the 
degradation of genomic DNA and subsequent death of the cell by apoptosis 
(Enari et al., 1998). 
 
The intrinsic apoptosis pathway is triggered in response to environmental 
stress. Stress can either cause direct damage to the mitochondrial membrane 
or can lead to the activation of Bax (Bruin et al., 2008). The extrinsic apoptosis 
pathway can also help to activate Bax. Bax can oligomerize at the outer 
mitochondrial membrane and cause it to swell and leak its contents. Bcl-2 
inhibits Bax, while Bid inhibits Bcl-2 (Murphy, 2011). Cytochrome c leaks out 
from the damaged mitochondria and binds to Apaf-1 present in the cell’s 
cytoplasm. The cytochrome c: Apaf-1 complex can recruit pro-caspase-9. Pro-
caspase-9 cleaves itself into active caspase-9, which then leads to the 
activation of caspase-3 (Russell and Ley, 2003). CAD is released and apoptosis 
ensues as for the extrinsic apoptosis pathway.  
 
Schematic drawn by myself.
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1.6 The NF-κB pathway 
 
1.6.1 An introduction to the NF-κB pathway 
 
Nuclear factor kappa B (NF-κB) was discovered in the laboratory of David 
Baltimore in 1986. It was described as a factor present in the nucleus of B cells, 
bound to the enhancer of the kappa light chain of immunoglobulin (Sen and 
Baltimore, 1986). Later experiments revealed that NF-κB signalling takes place 
in virtually all mammalian cells, being either constitutively active or rapidly 
induced when required. This signalling pathway is very complicated – it is 
activated by numerous stimuli, regulated by many mechanisms, and leads to 
the transcription of many genes. So finely balanced is this cascade that any 
improper regulation will, and frequently does, lead to pathology (Pasparakis et 
al., 2006).  
 
1.6.1.1 The NF-κB/Rel and IκB families  
 
The NF-κB/Rel family of transcription factors consists of RelA (p65), c-Rel, 
RelB, NF-κB1 (p50/p105), and NF-κB2 (p52/p100). These proteins all display a 
300 amino acid long Rel homology domain (RHD) at their N-terminus. Via this 
domain, the proteins form homo or heterodimers with one another, thus creating 
the NF-κB transcription factor (Gerondakis et al., 2013). The dimers are held in 
the cytoplasm by inhibitory proteins, the inhibitors of NF-κB (IκBs). These 
include IκBα, IκBβ, IκBε, and the precursor proteins of p50 and p52 - p105 and 
p100, respectively (Gerondakis et al., 2013). Only when the inhibitory proteins 
are phosphorylated and subsequently ubiquitinated and degraded, are the NF-
κB dimers free to translocate to the nucleus, where they meet their target genes 
(Gerondakis et al., 2013). 
 
1.6.1.2 The IKK complex  
 
Around 10 years after the discovery of NF-κB, groups started to describe the 
existence of a large, multisubunit kinase that could phosphorylate the serine 
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resides of IκBα (Chen et al., 1996; Lee et al., 1997). The kinase activity of the 
large complex was later found to be stimulus induced, and the complex was 
renamed IKK (for IκB kinase) (DiDonato et al., 1997). Today, we know that the 
IKK complex contains two catalytic subunits - IKK1 (IKKα) and IKK2 (IKKβ) - 
and a regulatory subunit - NF-κB essential modulator (NEMO/ IKKγ/ IKKAP) 
(Ghosh and Karin, 2002).  
 
The amino acid sequences of IKK1 and IKK2 are 52% identical to each other 
and even more alike (65%) in their catalytic domains (Ghosh and Karin, 2002). 
Both kinases act upon the two serine residues present in the N-terminal 
regulatory domain of the IκB proteins, with IKK2 being more catalytically active 
than IKK1 (Ghosh and Karin, 2002). IKK1 and IKK2 dimerise via their leucine 
zipper motifs, usually heterodimers are formed, although homodimers are 
possible. IKK1/2 heterodimers have been shown to have greater catalytic 
efficiency than either the IKK1 or the IKK2 homodimer (Huynh et al., 2000). The 
catalytic dimer contains two short motifs, located at each carboxy terminus, 
which allow for interaction with NEMO molecules (Huxford and Ghosh, 2009). 
NEMO is able to link the IKK complex to upstream signalling components via 
the zinc finger motif in its carboxy terminus (Ghosh and Karin, 2002). The large 
size (700-900kDa) of the IKK complex indicates the presence of other proteins, 
for example Cdc37 and Hsp90, the functions of which have not been clearly 
established (Hayden and Ghosh, 2004). Before the IKK complex can become 
functional, it must first be activated by phosphorylation of two serine residues 
located in the “activation loops” of the catalytic subunits (Delhase et al., 1999; 
Ling et al., 1998).  
 
1.6.1.3 The canonical vs noncanonical pathway of NF-κB 
activation  
 
When individual IKK subunits were knocked out in cells it became apparent that 
two different pathways of NF-κB activation exist, the canonical/classical 
pathway and the noncanonical/alternative pathway (Pasparakis et al., 2006) 
Schematic 1.5). The canonical pathway is activated in response to pro-
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inflammatory stimuli, e.g. IL-1, TNF, and LPS. It relies heavily on IKK2 and 
NEMO and principally regulates p50/RelA and p50/c-Rel dimers. The alternative 
pathway is quite different and is stimulated in response to specialist receptors 
(e.g. the BAFF receptor and lymphotoxin-β receptor). It is involved in B cell 
maturation and lymphoid organogenesis (Pasparakis et al., 2006). IKK1 is 
critical to this pathway, which involves the processing of the p100 subunit and 
formation of p52/RelB dimers (Senftleben et al., 2001a). Even in the absence of 
IKK2, cells are still able to respond weakly to pro-inflammatory cytokines, whilst 
IKK1/2 double deficient cells lack any signalling (Li et al., 2000). Hence, IKK1 
can compensate for the loss of IKK2 to a certain extent. The reverse cannot be 
said of the alternative pathway, where IKK1 is essential for stimulation induced 
NF-κB signalling. Thus, it was concluded that the canonical pathway involves an 
IKK1/IKK2/NEMO complex, whist the alternative pathway relies on IKK1 
homodimers (Pasparakis et al., 2006). 
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Schematic 1.5 The canonical and non-canonical pathways of NF-κB 
activation 
 
There are two different pathways of NF-κB activation; the canonical (classical) 
and non-canonical (alternative) pathways. In T cells, the canonical pathway may 
be activated by peptide:MHC binding to the TCR (Hayden et al., 2006). In a 
large variety of cells types, the canonical pathway is frequently activated by 
inflammatory stimuli, including LPS, IL-1, and TNF (Pasparakis et al., 2006). 
The IKK complex, consisting of IKK1, IKK2, and NEMO, is central to the 
canonical pathway of NF-κB activation. In the canonical pathway the IKK kinase 
TAK1 leads to phosphorylation of IKK1 and IKK2 (Sato et al., 2005; Shim et al., 
2005). The activated IKK complex is then able to phosphorylate the IκBs (IκBα 
is shown), allowing for their K48-linked ubiquitination and degradation by the 
proteasome (Ghosh and Karin, 2002). This frees the NF-κB dimers, allowing 
them to translocate to the nucleus. The formation of p50/RelA dimers (shown) 
and p50/c-Rel dimers is common to the canonical pathway (Pasparakis et al., 
2006). Activation of the canonical pathway leads to transcription of cytokines, 
chemokines, and adhesion molecules, thus helping to create a pro-inflammatory 
environment (Lawrence, 2009). In addition, NF-κB activation through this 
pathway stimulates production of many anti-apoptotic proteins (Aggarwal, 
2003). 
 
The non-canonical pathway tends to be activated downstream of a more limited 
number of receptors. In B cells, stimulation of the BAFF receptor (BAFF-R) 
leads to activation of the non-canonical NF-κB pathway (Pasparakis et al., 
2006). The lymphotoxin beta receptor (LTBR) is expressed on a variety of cell 
types (with the exception of T and B cells) and is activated in response to 
stimulation with the membrane bound form of lymphotoxin (LTα1β2). Activation 
of the non-canonical pathway via the LTBR plays a vital role during the 
formation of the peripheral lymphoid organs (Pasparakis et al., 2006). As 
shown, binding of ligand to the co-stimulatory receptor CD40 also activates the 
non-canonical NF-κB pathway. An IKK1 homodimer is central to the non-
canonical pathway. This is activated by the IKK kinase NIK (Senftleben et al., 
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2001a; Xiao et al., 2001). The activated IKK1 homodimer is then able to 
phosphorylate p100 (the inactive precursor product of the nfkb2 gene), allowing 
it to be processed into the functional p52 subunit. In the non-canonical pathway 
p52 often forms a dimer with RelB (shown) and translocates to the nucleus 
(Senftleben et al., 2001a). 
 
Schematic drawn by myself. 
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1.6.2 Activation of the NF-κB pathway 
 
Although a huge variety of signalling pathways lead to activation of NF-κB, 
virtually all these pathways end with the activation of the IKK complex, the 
degradation of IκB proteins, and the binding of NF-κB to its target genes 
(Oeckinghaus et al., 2011). Signalling upstream of the IKK complex varies 
according to the receptor activated. Nevertheless, several of the signalling 
components are common to many NF-κB signalling pathways. For example, 
proteins belonging to the receptor interacting protein kinase (RIPK1, RIP) and 
TNF receptor associated factor (TRAF) families are often employed in pathways 
leading to NF-κB activation (Oeckinghaus et al., 2011). 
 
TRAF proteins are usually involved in both canonical and noncanonical NF-κB 
activation, whilst RIPK proteins seem mostly restricted to the canonical pathway 
(Hayden and Ghosh, 2008). The noncanonical NF-κB pathway is activated by 
specific members of the TNFRSF, including the lymphotoxin-β receptor, the 
BAFF-R, and CD40. In contrast, the canonical NF-κB pathway is activated 
downstream of numerous receptors, including the B and T cell receptors, the 
Toll/IL-1 receptors, and the TNF receptor (Hayden et al., 2006).   
 
1.6.2.1 Common signalling components upstream of IKK 
 
1.6.2.1.1 The TRAF family 
 
TRAF protein family members, of which there are 7, are defined by their C-
terminal TRAF domain. The TRAFs are adaptors, but TRAF family members 2-
7 have a RING domain and are thought capable of functioning as E3 ubiquitin 
ligases (Oeckinghaus et al., 2011). While both TRAF2 and TRAF5 are believed 
to be important in the TNF signalling pathway, TRAF6 has been implicated in 
TCR and Toll/IL-1 signalling (Oeckinghaus et al., 2011). In the noncanonical 
NF-κB pathway, TRAF3 may act as a negative regulator of signalling, requiring 
degradation by other TRAF family members (Hayden and Ghosh, 2008). TRAF 
proteins may recruit the IKK complex by binding directly to IKK1 and IKK2 
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(Devin et al., 2001), however, evidence suggests that other proteins are usually 
also involved in IKK recruitment (Hayden and Ghosh, 2008). For example, 
during TNF signalling, RIPK1 is believed to be important in helping to recruit 
IKK and, during TCR signalling, PKC family members are known to play a role 
in IKK recruitment (Hayden and Ghosh, 2008).  
 
1.6.2.1.2 The RIPK family 
 
In an NF-κB signalling pathway, RIPKs usually work together with TRAFs, or 
upstream of TRAFs, to activate IKK (Hayden and Ghosh, 2008). There are 7 
members of the RIPK family, all of which possess a serine/threonine kinase 
domain. RIPK1 also contains a death domain (DD), which can interact with the 
death domains of adaptors and receptors (Oeckinghaus et al., 2011). RIPK2 
contains a CARD (caspase activation and recruitment) domain and is utilised in 
signalling pathways activated by the NODD-LRR family of intracellular pattern 
recognition receptors (Hayden and Ghosh, 2008). RIPK3 is thought to be 
involved in many NF-κB signalling pathways, and there is evidence that it may 
inhibit RIPK1 induced NF-κB activation (Hayden and Ghosh, 2008). Both RIPK1 
and RIPK2 can recruit the IKK complex through NEMO - RIPK1 binds via its DD 
and RIPK2 via its CARD domain (Hayden and Ghosh, 2008). The kinase 
activity of RIPK1 and RIPK2 seems dispensable for many NF-κB activating 
pathways (Hasegawa et al., 2008; Lee et al., 2004). Instead they seem to 
function mostly as scaffolds to enable IKK activation.  
 
1.6.2.1.3 IKK kinases (IKK-Ks) 
 
IKK kinases (IKK-Ks) are required downstream of RIPKs and TRAFs and are 
necessary for the phosphorylation and subsequent activation of IKK (Hayden 
and Ghosh, 2008). TAK1 (TGF-β activated kinase 1) is the most common IKK-K 
of the canonical NF-κB pathway (Sato et al., 2005; Shim et al., 2005). Notably, 
TAK1 deficient mice lack TNF induced IKK activation (Liu et al., 2006). In the 
noncanonical pathway, NIK (NF-κB-inducing kinase) seems to be the IKK-K 
required for IKK1 activation (Senftleben et al., 2001a; Xiao et al., 2001).  
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1.6.2.2 Important signalling pathways that lead to NF-κB 
activation 
 
1.6.2.2.1 TNF signalling to NF-κB 
 
The TNFSF currently includes 19 cytokines, which bind to 29 receptors 
(Aggarwal et al., 2012). Signalling induced by members of the TNFSF can have 
dramatic effects on the immune system. TNF is the most well characterised 
family member and is a well-known inducer of the canonical NF-κB pathway. In 
most cell types, TNF causes cell activation, inflammatory cytokine production 
and transcription of anti-apoptotic proteins (Aggarwal et al., 2012). However, if 
NF-κB signalling is blocked, then exposure to TNF frequently causes death by 
the extrinsic apoptosis pathway (Aggarwal et al., 2012). Dysregulated TNF 
signalling has been implicated in a number of diseases. For this reason, anti-
TNF antibodies have been developed for clinical use. Today such antibodies 
are proving particularly useful in the treatment of rheumatoid arthritis (Aggarwal, 
2003). However, it is hoped that a better understanding of TNF induced NF-κB 
signalling will lead to improved drug design. 
 
Binding of TNF to TNFR1 induces receptor trimerisation (Schematic 1.6). The 
silencer of death domain (SODD) can then dissociate from the receptor, 
allowing TRADD to bind (Jiang et al., 1999). TRADD recruits TRAFs to the 
receptor complex, with TRAF2 believed to be the most important (Hsu et al., 
1996b). Evidence suggests that TRAF2 recruits the IKK complex to the receptor 
by binding directly to both IKK1 and IKK2 (Devin et al., 2001). RIPK1 is also 
recruited via TRADD (Hsu et al., 1996a). RIPK1 can then bind to the IKK 
complex through NEMO (Zhang et al., 2000). It is believed that, by acting as a 
scaffold, RIPK1 also enables recruitment of TAK1, thus bringing an IKK-K into 
close proximity to IKK (Lee et al., 2004). Evidence suggests that the K63-linked 
ubiquitination of RIPK1 is necessary for recruitment of the IKK complex and 
TAK1 (Ea et al., 2006). It was initially thought that such ubiquitination may be 
provided by TRAF2 (Hayden and Ghosh, 2012), however, more recent 
evidence has implicated cellular inhibitor of apoptosis 1 (cIAP1) and 2 (cIAP2) 
 
 
84 
(Yin et al., 2009). Whilst bound to RIPK1, TAK1 phosphorylates and activates 
IKK. IκB proteins are then degraded, and NF-κB dimers are freed. TNF induced 
degradation of IκB is very rapid and is believed to take around 10 minutes 
(Hayden and Ghosh, 2004).   
 
1.6.2.2.2 TCR signalling to NF-κB 
 
Engagement of the TCR and its co-receptors results in the immediate 
recruitment of Lck and Zap70 and later to the production of DAG. DAG can then 
recruit PKC-θ to the site of the immunological synapse. PKC-θ phosphorylates 
CARMA1 causing activation and oligomerization of the CBM complex, which 
consists of CARMA1, Bcl-10 and MALT1 (McAllister-Lucas et al., 2001). 
CARMA1 and Bcl-10 are both CARD containing proteins, and MALT contains a 
DD. Mice deficient in CARMA1 show poor antigen receptor induced activation of 
NF-κB (Egawa et al., 2003; Wang et al., 2002). 
 
It remains poorly understood precisely how the CBM complex is linked to 
activation of IKK. However, it is believed that clusters of Bcl-10 and MALT1 may 
dissociate from the CBM complex (Schematic 1.6). These clusters are termed 
POLKADOTS and are enriched for the presence of TRAF6 (Rossman et al., 
2006). Activated TRAF6 causes the K63-linked ubiquitination of NEMO (Deng 
et al., 2000). Ubiquitinated NEMO can then recruit TAK1, leading to the 
phosphorylation of IKK2 (Sun et al., 2004). The activated IKK complex 
proceeds as normal, degrading IκB proteins and allowing NF-κB to translocate 
to the nucleus. TCR signalling induced degradation of IκB has been shown to 
require approximately 45 minutes (Hayden and Ghosh, 2004). Of note, co-
stimulatory signals mediated by CD28 can also lead to PKC-θ recruitment and 
hence can increase NF-κB activity within the T cell following APC recognition 
(Gerondakis et al., 2013).   
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1.6.2.2.3 Toll/IL-1 signalling to NF-κB 
 
Toll-like receptor (TLR) induced activation of NF-κB is especially important in 
the early stages of an immune response. Phagocytic cells of the innate immune 
system and epithelial cells are well known carriers of TLRs. However, T cells 
can also express some TLRs. In particular, TLR2, TLR3, TLR5, and TRL9 are 
believed to act as co-stimulatory molecules, which can aid T cell proliferation or 
cytokine production (Kabelitz, 2007). 13 mammalian TLRs have been identified, 
all of which can activate NF-κB (Takeda and Akira, 2015). Since the intracellular 
domain of TLRs is highly homologous to that of the IL-1R, it is referred to as the 
Toll-IL1R (TIR) domain.  
 
In drosophilia, Toll is expressed by hemocytes and fat body cells, both of which 
are phagocytic and form part of the insect’s immune system (Minakhina and 
Steward, 2006). The signalling pathway activated by ligation of Toll shares 
similarities with the Toll/IL-1 signalling pathway of the vertebrate immune 
system and results in the activation of a transcription factor homologous to NF-
κB. Drosophilia have 3 NF-κB homologs: Dorsal, Dif, and Relish, all of which 
contain the Rel homology domain (Minakhina and Steward, 2006). The highly 
conserved nature of NF-κB signalling pathways within the immune system is 
surely indicative of their importance.  
 
Ligand binding causes dimerization of the Toll-IL-1R (Schematic 1.6). This 
brings the intracellular TIR domains into close contact and enables them to 
interact with the TIR domains of adaptor proteins (Murphy, 2011). The adaptors 
downstream of the Toll-IL-1R include MyD88, MAL, TRIF, and TRAM (Honda 
and Taniguchi, 2006). There are two major pathways induced by Toll-IL-1Rs, 
the MyD88-dependent and the TRIF-dependent pathway (Takeda and Akira, 
2015). All receptors, with the exception of TLR3, can activate NF-κB via the 
MyD88 pathway (Takeda and Akira, 2015). The DD of MyD88 recruits the 
serine/threonine kinases IRAK1 and IRAK4 (Hiscott et al., 2006). The activated 
IRAKs can then recruit the E3 ubiquitin ligase TRAF6. TRAF6 acts together with 
the E2 ligase TRICA1, causing K63-liked ubiquitination of TRAF6 and NEMO 
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(Murphy, 2011). TAK1 can bind to the ubiquitin scaffold provided by TRAF6 and 
can be phosphorylated by IRAK (Qian et al., 2001). Activated TAK1 can then 
phosphorylate IKK2 (Sun et al., 2004). The pathway proceeds with degradation 
of the IκBs and NF-κB induced transcription.  
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Schematic 1.6 IL-1R, TCR, and TNFR1 induced activation of the NF-
κB signalling pathway 
 
IL-1 cytokine binding to the IL-1R can activate the NF-κB signalling pathway. IL-
1 binding causes dimerization of the IL-1R, thus bringing the TIR domains of the 
receptor into close contact with one another and allowing them to interact with 
the TIR domains present on the adaptor MyD88 (Murphy, 2011). The death 
domain of MyD88 can then recruit the serine/threonine kinases IRAK1 and 
IRAK4 (Hiscott et al., 2006). The activated IRAKs can recruit the E3 ubiquitin 
ligase TRAF6 (Murphy, 2011). The IKK kinase TAK1 can bind to TRAF6 and 
can be activated by the IRAKs (Qian et al., 2001). TRAF6 can cause the K63-
linked ubiquitination of NEMO (Deng et al., 2000). Ubiquitinated NEMO can also 
recruit TAK1 (Sun et al., 2004). The activated TAK1 can then phosphorylate 
and activate the IKK complex. The activated IKK complex phosphorylates the 
IκBs, leading to the release of NF-κB dimers, which then translocate to the 
nucleus. The intracellular domain of the IL-1R is highly homologous to that of 
the toll-like receptors (TLRs). Thus TLR stimulation can also activate NF-κB 
signalling in this manner.  
 
Peptide:MHC binding to the TCR complex may activate the NF-κB signalling 
pathway. Activation of the TCR complex results in the immediate recruitment of 
the protein tyrosine kinase Lck (closely associated with the CD4 or CD8 co-
receptor - here shown as CD4) to the ITAMs of the TCR complex. The protein 
tyrosine kinase Zap70 is then recruited to the ITAMs and is activated by 
autophosphorylation and phosphorylation by Lck (Chan et al., 1995). Activated 
Zap70 phosphorylates LAT (a scaffold) and SLP-76 (an adaptor) (Huse, 2009). 
PIP3, in the T cell’s cytoplasmic membrane, can recruit PLC-γ, which then binds 
to LAT and SLP-76 at the receptor complex. The protein tyrosine kinase Itk can 
then activate PLC-γ (Samelson, 2003). Activated PLC-γ breaks down the 
membrane lipid PIP2 into DAG and the second messenger IP3 (not shown). 
DAG recruits PKC-θ to the membrane (Kishimoto et al., 1980). PKC-θ then 
phosphorylates the scaffold protein CARMA1, enabling recruitment of the CBM 
(CARMA1/Bcl-10/MALT1) complex to the immunological synapse (McAllister-
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Lucas et al., 2001). Clusters of Bcl-10 and MALT1 (termed POLKADOTS) are 
believed to dissociate from the CBM complex and to be enriched for the 
presence of TRAF6 (Rossman et al., 2006). TRAF6 causes the K63-linked 
ubiquitination of NEMO (Deng et al., 2000). Ubiquitinated NEMO can then 
recruit TAK1 (Sun et al., 2004). TAK1 activates the IKK complex, leading to the 
degradation of the IκBs and the translocation of the NF-κB transcription factor. 
 
TNF cytokine binding to TNFR1 can activate the NF-κB signalling pathway. 
When TNF cytokine binds to TNFR1, conformation changes are induced on the 
receptor. This enables recruitment of TRADD to the death domain of TNFR1 
(Hsu et al., 1995). TRADD then recruits RIPK1 and TRAF2 (Hsu et al., 1996a; 
1996b). TRAF2 interacts with IKK1 and IKK2 of the IKK complex (Devin et al., 
2001), whilst RIPK1 interacts with NEMO (Zhang et al., 2000). RIPK1 also 
interacts with TAK1, bringing TAK1 into close proximity to the IKK complex (Ea 
et al., 2006). cIAP1 and cIAP2 are believed to enable K63-linked ubiquitination 
of RIPK1 (Yin et al., 2009), which is necessary for the recruitment of both the 
IKK complex and TAK1 (Ea et al., 2006). The multi-protein structure formed 
around TNFR1 is called complex I. Complex I mediated activation of the IKK 
complex results in phosphorylation of the IκBs, allowing for their K48-linked 
ubiquitination and degradation by the proteasome. This frees the NF-κB dimers, 
allowing them to translocate to the nucleus.  
 
Schematic drawn by myself.  
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1.6.3 Manipulating the NF-κB pathway in mice 
 
Over the years, mouse models have proved particularly useful for studying the 
NF-κB pathway. Gene knockouts (both conventional and conditional), the 
overexpression of pathway activators and inhibitors, gene knock-ins, and NF-κB 
reporter genes have all contributed to our understanding of the signalling 
cascade (Pasparakis et al., 2006).  
 
1.6.3.1 The embryonic/perinatal lethality of IKK and RelA 
global knockouts 
 
Since the numerous NF-κB signalling pathways all converge upon the IKK 
complex, it was realised that IKK knockout mice could prove useful in studying 
the effects of NF-κB blockade. Rel family member knockout mice have also 
been extensively studied. However, the large amount of redundancy between 
Rel family members means that single knockouts always have an incomplete 
block in NF-κB signalling. 
 
Although Ikk1-/- mice survive gestation, they die shortly after birth due to 
numerous morphological defects. They show poor differentiation of the 
epidermal layer of the skin and skeletal abnormalities, most notably a failure to 
extend their limb buds (Hu et al., 1999; Li et al., 1999a; Takeda et al., 1999). 
Fibroblasts from the Ikk1-/- mice have been reported as having normal NF-κB 
activation in response to IL-1 and TNF (Hu et al., 1999; Takeda et al., 1999), 
although one study did find NF-κB activity to be diminished (Li et al., 1999a). 
Importantly, the Ikk1-/- mice can be rescued by knocking in a mutant IKK1, in 
which the serines of the activation loop have been have been replaced by 
alanines (Cao et al., 2001; Hu et al., 2001). This indicates that the kinase 
activity of IKK1 is not required for its role in skeletal and epidermal 
development, and hence the morphological defects observed in Ikk1-/- mice are 
independent of NF-κB.  
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Ikk2-/- mice die during mid-gestation (around E13-14.5) due to extensive TNF 
induced liver apoptosis (Li et al., 1999c; Tanaka et al., 1999). The lethal 
phenotype of the Ikk2-/- mice can be rescued by blocking TNF signalling via 
deletion of TNFR1 (Li et al., 1999b). Embryonic fibroblasts from Ikk2-/- mice 
show hardly any NF-κB binding activity in response to TNF or IL-1 (Li et al., 
1999c). Such experiments revealed that IKK2 is important for inducing 
canonical NF-κB signalling in response to TNF and for protecting hepatocytes 
from TNF induced death. NEMO deficient mice die around E12.5-13, again due 
to hepatocyte apoptosis. Embryonic fibroblasts from Nemo-/- mice show no NF-
κB activation in response to TNF, IL-1, or LPS (Rudolph et al., 2000). Like 
NEMO knockout mice, IKK1/2 double knockout mice also show a complete lack 
of NF-κB activation and ultimately die at E12 due to liver apoptosis (Li et al., 
2000). However, in addition, they show a defect in neurulation, caused by 
excessive apoptosis of neurons (Li et al., 2000).  
 
RelA-/- mice die at E15-16 due to liver apoptosis (Beg et al., 1995). They can be 
rescued by breeding onto either a TNF deficient (Doi et al., 1999) or TNFR1 
deficient background (Alcamo et al., 2001). However, both RelA/TNF double 
deficient and RelA/TNFR1 double deficient mice die a few weeks after birth due 
to infection (Alcamo et al., 2001; Doi et al., 1999). 
 
1.6.3.2 B cell defects in Rel knockout mice 
 
The lethal phenotypes of the IKK knockout and RelA knockout mice had made it 
difficult for investigators to study the effects of NF-κB deficiency within the 
immune system. However, mice deficient in NF-κB1 (lacking p105 and p50), 
NF-κB2 (lacking p100 and p52), RelB, or c-Rel were all found to be viable. 
Since NF-κB was initially discovered in B cells, early studies of Rel family 
member deficient mice tended to focus on B cell defects.   
 
B cells from NF-κB1 deficient mice were found to have defects in antibody 
production and failed to respond to LPS (Sha et al., 1995). Mice deficient in NF-
κB2 had defects in the architecture of the spleen and Peyer’s patches and 
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improper formation of B cell follicles and germinal centres (Caamano et al., 
1998; Franzoso et al., 1998; Paxian et al., 2002). LTβ induced NF-κB signalling, 
via the noncanonical pathway, is important for secondary lymphoid organ 
development. The phenotype of the NF-κB2 deficient mice served to highlight 
the critical role of the p52 subunit in noncanonical signalling. Like the Nfκb2-/- 
mice, Relb-/- mice also had disturbed lymphoid organogenesis, thus revealing 
RelB’s importance in the noncanonical NF-κB pathway (Paxian et al., 2002; 
Yilmaz et al., 2003). Relb-/- B cells were found to have proliferative defects, but 
to be capable of normal IgM production and class switching (Snapper et al., 
1996). In c-Rel deficient mice, both B and T cells responded poorly to mitogenic 
stimuli (Kontgen et al., 1995). 
 
1.6.3.3 The role of NF-κB in T cell development and 
maintenance  
 
1.6.3.3.1 The tissue specific manipulation of NF-κB  
 
From the second half of the 1990s onwards, a number of studies began to 
make use of a dominant negative, or super-inhibitory form of IκBα, which could 
not be degraded by the IKK complex. At first, this dominant negative IκBα was 
transfected into a variety of cell types, including primary fibroblasts, 
fibrosarcoma cells, and Jurkat cells (Brockman et al., 1995; Van Antwerp et al., 
1996; Wang et al., 1996). These in vitro studies helped to confirm NF-κB’s role 
in the protection of many cell types from TNF induced death (Van Antwerp et 
al., 1996; Wang et al., 1996). Shortly afterwards began the generation of 
transgenic mice, expressing the dominant negative IκBα under the control of 
tissue specific promoters (Boothby et al., 1997; Esslinger et al., 1997).    
 
In 1994 Marth and Rajewsky reported that the Cre-loxP recombination system 
could be reliably used for the conditional targeting of genes in vivo (Gu et al., 
1994). They explained that an enzyme, Cre recombinase, could be placed 
under a cell type specific or developmental stage specific promoter. Mice 
bearing this Cre transgene would then be intercrossed to mice carrying a loxP 
 
 
93 
flanked target gene. In the offspring, Cre-loxP site-dependent recombination 
would occur upon Cre expression, hence leading to deletion of the target gene. 
Such a system would prove useful in situations where a global deletion of the 
target gene would lead to lethality (Gu et al., 1994).   
 
The years that followed resulted in widespread acceptance of the Cre-loxP 
recombination system. A large number of studies have since used the Cre-loxP 
system or the dominant negative IκBα transgene to investigate the role of NF-
κB in specific cell types and/or at specific developmental stages. NF-κB is 
clearly very important to the normal functioning of the immune system, where its 
role has been conserved from drosophilia to mouse and man. Of note, it is a 
downstream target of many receptors of the immune system: antigen-receptor, 
TNFSF receptors, and Toll-IL-1 receptors, among others. In recent years, 
studies have begun to indicate a role for NF-κB signalling in T cell development 
and homeostasis.  
 
Expression of the dominant negative form of IκBα under the control of the CD2 
promoter/enhancer or the proximal Lck (pLck) promoter results in decreased 
numbers of SP thymocytes, particularly among the CD8 lineage (Boothby et al., 
1997; Esslinger et al., 1997; Hettmann and Leiden, 2000). When IKK2 is 
deleted in T cells, by way of CD4Cre or huCD2iCre, the mice reportedly have 
normal thymic development, but reduced numbers of peripheral T cells, 
especially Treg cells (Schmidt-Supprian et al., 2003; Silva et al., 2014). The T 
cell specific, conditional knockout of IKK1 using CD4Cre has recently been 
described. Interestingly, the mice show a large reduction in both thymic and 
peripheral Treg cells (Chen et al., 2015). However, the reduction in peripheral 
Treg cells is not as great as in the IKK2 deficient mice (Chen et al., 2015; 
Schmidt-Supprian et al., 2003). The CD4Cre mediated deletion of NEMO results 
in a dramatic loss of the more mature HSAlo populations of SP thymocytes and 
a loss of the peripheral T cell populations (Schmidt-Supprian et al., 2003). 
Notably, the deletion of TAK1 in T cells, using LckCre or CD4Cre, yielded a similar 
phenotype (Liu et al., 2006; Sato et al., 2006; Wan et al., 2006).  
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1.6.3.3.2 Activating NF-κB in T cells 
 
Assuming that NF-κB is necessary during T cell development and homeostasis, 
then the question arises as to how it may be activated. As we know, activation 
of the NF-κB signalling pathway occurs in response to a huge number of 
different stimuli. Current belief is that ligation of the pre-TCR, or of the TCR and 
(in naïve cells) co-stimulatory receptors, provide the main way of activating NF-
κB throughout the T cell’s lifespan (Gerondakis et al., 2013).     
 
Use of an NF-κB dependent luciferase reporter gene has revealed particularly 
high levels of NF-κB activity during the DN3 and DN4 stages of thymocyte 
development, correlating with expression of the pre-TCR (Voll et al., 2000). 
Furthermore, constitutive pre-TCR signalling has been linked to activation of 
NF-κB, suggesting that NF-κB may be required for beta-selection (Aifantis et al., 
2001). Studies also suggest a role for NF-κB downstream of the TCR during 
positive and negative selection of thymocytes. Notably, mice expressing a 
super-inhibitory, degradation resistant form of IκBα have few CD8SP 
thymocytes (Hettmann and Leiden, 2000). This is believed to be due to reduced 
positive selection. In support of this, mice with a constitutively active form of 
IKK2 show enhanced selection of CD8 lineage cells (Jimi et al., 2008).  
 
In an attempt to explain the phenotype of the TAK1 deficient mice, it was 
suggested that TCR and IL-7R mediated NF-κB activation could be required 
during the SP stage of thymocyte development (Wan et al., 2006). However, 
this seems unlikely, since blocking TCR or IL-7 signalling just before positive 
selection does not result in a similar phenotype (McCaughtry et al., 2012; 
Sinclair and Seddon, 2014). It is possible that a different stimulus is activating 
NF-κB in SP thymocytes.  
 
There is much evidence to suggest that TCR induced activation of NF-κB is 
required during an immune response. In vivo, IKK2 deficient CD4 T cells fail to 
expand to weaker KLH or OVA antigens, responding only to strong, 
superantigen-mediated stimulation (Schmidt-Supprian et al., 2004). Mice 
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expressing a degradation resistant form of IκBβ have shown defects in T cell 
dependent immune responses, including impaired delayed type hypersensitivity 
(DTH) and poor generation of an antibody response (Attar et al., 1998). In a 
study by Tato et al., mice transgenic for a super-inhibitory form of IκBα were 
challenged to Toxoplasma gondii. Upon stimulation, the transgenic CD4+ T cells 
showed reduced proliferation and IFN-γ production, as compared to control 
cells. The authors concluded that the lack of NF-κB mediated TCR and co-
stimulatory signalling may account for the reduced antigen-driven expansion 
among the transgenic T cell population (Tato et al., 2003). Similarly, Schmidt-
Supprian et al. suggested that the lack of memory and regulatory T cells in their 
IKK2 deficient mice could be due to defective antigen-induced T cell activation 
(Schmidt-Supprian et al., 2003). 
 
It has also been postulated that NF-κB signalling is necessary to protect T and 
B cell precursors from artificially high levels of TNF. During the adoptive transfer 
of haematopoietic stem cells into lethally irradiated hosts, excessive amounts of 
TNF cytokine have been noted. If the haematopoietic stem cells are NF-κB 
deficient, then they fail to reconstitute the host, most likely due to their TNF 
induced death (Claudio et al., 2006; Grossmann et al., 1999; Horwitz et al., 
1997; Prendes et al., 2003; Senftleben et al., 2001b). Such observations are 
suggestive of a role for NF-κB downstream of the TNF receptor during the 
development of T cell precursors. Hence, it seems that TNF could also be a 
candidate for NF-κB activation in T cells, although further evidence is required.  
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1.7 Thesis aims 
 
Previous studies have indicated that NF-κB signalling is likely required at 
various stages of T cell development and homeostasis. However, there is still 
uncertainty surrounding the function of NF-κB, particularly within thymocytes. 
During the DP stage of thymocyte development, NF-κB has been suggested to 
promote differentiation as opposed to cell survival (Esslinger et al., 1998; 
Ochoa-Garay et al., 1998). However, it has been noted that an anti-apoptotic 
function of NF-κB during this stage may also be possible and has not yet been 
ruled out (Hettmann and Leiden, 2000). Notably, studies have suggested that 
NF-κB may be more important during the positive selection of the CD8 than the 
CD4 lineage (Hettmann and Leiden, 2000; Jimi et al., 2008; Mora et al., 1999). 
Furthermore, the role of NF-κB in negative selection signalling is controversial, 
with some studies showing it to be redundant (Hettmann and Leiden, 2000), but 
others presenting contradictory findings (Jimi et al., 2008; Mora et al., 2001). 
 
NF-κB does seem to be important during the SP stage of development, as 
indicated by the phenotype of NEMO or TAK1 conditional knockout mice, which 
lack mature HSAlo SP thymocytes. In addition, NF-κB is necessary for the 
upregulation of the IL-7R during the later stages of SP thymocyte development 
and in recent thymic emigrants (Silva et al., 2014). Although IL-7R upregulation 
is not required for cells to leave the thymus (Miller et al., 2014; Silva et al., 
2014), it is needed for the long-term survival of T cells in the periphery (Schluns 
et al., 2000).  
 
Many unanswered questions remain. It is still uncertain as to whether NF-κB 
signalling is required at discrete stages during a T cell’s lifespan, or whether it 
must be constitutively activated. Furthermore, the stimuli required for NF-κB 
activation, especially during the SP stage of development, have not been well 
investigated. Finally, the precise role of NF-κB during thymocyte development, 
whether for differentiation or survival, is unknown.  
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This study aimed to investigate the role of IKK mediated NF-κB signalling in 
thymocyte development and homeostasis. To this aid, we used mice with a 
conditional deletion of both Ikk1 and Ikk2 early in thymocyte development.  
 
Our broad aims were as follows: 
 
1) To assess the impact of a complete loss of IKK subunits on T cell 
development and homeostasis.  
 
2) To investigate the nature of the stimuli activating IKK signalling during SP 
thymocyte development. 
 
3) To understand the signalling pathway/s leading to IKK activation during 
SP thymocyte development. 
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Schematic 1.7 The role of NF-κB signalling during T cell 
development and homeostasis: current understanding and 
unknowns 
 
This schematic reveals our current understanding of the role that NF-κB 
signalling plays during the development and maintenance of T cells. It also 
highlights certain gaps in our knowledge (???) that this study shall aim to 
address. 
 
DTH = delayed type hypersensitivity.
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Chapter 2 Materials and Methods 
 
2.1 Mice 
 
2.1.1 Experimental mice used in this study  
 
Mice used in this study are listed in Table 2.1. All strains were housed in 
conventional, specific pathogen free (SPF) animal facilities at the Medical 
Research Council’s (MRC’s) National Institute for Medical Research (NIMR, 
London, UK). Animal procedures were performed according to strict institutional 
guidelines and adhered to Home Office regulations. Mice were genotyped by 
flow cytometric analysis of lymphocyte populations within peripheral blood, or by 
PCR analysis of DNA obtained from tail or ear biopsies. Genotyping was 
performed by Sim Tung or by Transnetyx Automated Genotyping (Cordova, 
Memphis, Tennessee). Transnetyx protects the intellectual rights of their 
screening process and thus we are not at liberty to share this information. 
Furthermore, the primer sequences used by Transnetyx are private and 
confidential and cannot be shared.  
   
2.1.2 Generation of IKK floxed mice 
 
The Cre-loxP recombination system was used in this study to control 
expression of the IKK genes. The floxed Ikk1 and Ikk2 alleles used were first 
generated in the Pasparakis and Karin laboratories, respectively (Gareus et al., 
2007; Li et al., 2003). LoxP sites surrounded exons 6-8 of the Ikk1 gene and 
exon 3 of the Ikk2 gene (Gareus et al., 2007; Li et al., 2003). The mice used in 
our study had an additional EYFP (enhanced yellow fluorescent protein) 
reporter gene inserted into the Rosa26 locus and preceded by a loxP flanked 
strong transcriptional termination sequence (tpA) (Srinivas et al., 2001).  
 
Mice expressing the floxed alleles were intercrossed with mice expressing 
either codon-improved Cre recombinase (iCre) under the control of the human 
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(hu) CD2 promoter (de Boer et al., 2003) or Cre recombinase under the control 
of the CD4 promoter (Lee et al., 2001). (The codon usage of iCre is optimised 
for eukaryotes (Shimshek et al., 2002). Furthermore, the iCre gene has a much 
reduced frequency of CpG dinucleotides as compared to the Cre gene, making 
it more desirable for use in mammalian cells (Shimshek et al., 2002).) Our 
breeding strategy resulted in a variety of different mouse strains, hetero or 
homozygous for floxed Ikk1 and/or Ikk2 alleles and expressing one of the two 
aforementioned Cre recombinases. Ikk floxed, Cre negative (Cre-) animals were 
also generated and served as “wild-type” (WT) controls.  
 
Table 2.1 Mice used in this study 
 
Mouse strain References 
C57BL/6 (CD45.2/Ly5.2)  
C57BL/6 (CD45.1/Ly5.1)  
F5 Rag1-/- (CD45.2/Ly5.2) (Mamalaki et al., 1993) 
C57BL/6 Rag1-/- (Mombaerts et al., 1992) 
huCD2iCre Ikk1fx/fx R26REYFP Generated in house 
huCD2iCre Ikk2fx/fx R26REYFP 
Generated in house 
(Silva et al., 2014) 
huCD2iCre Ikk1fx/fx Ikk2fx/fx R26REYFP 
(IKKΔTCD2) 
Generated in house 
CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP 
(IKKΔTCD4) 
Generated in house 
CD4Cre Relafx/fx R26REYFP Generated in house 
Nfkb1-/- (Sha et al., 1995) 
CD4Cre Relafx/fx Nfkb1-/- R26REYFP Generated in house 
Tnfrsf1a-/- (Rothe et al., 1993) 
Tnfrsf1a-/- CD4Cre Ikk1fx/fx Ikk2fx/fx 
R26REYFP (Tnfrsf1a-/- IKKΔTCD4) 
Generated in house 
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Schematic 2.1 Cre-loxP recombination 
 
This schematic demonstrates how the Cre-loxP recombination system controls 
expression of the genes for IKK1 and IKK2. LoxP sites surround exons 6-8 of 
the Ikk1 gene and exon 3 of the Ikk2 gene (Gareus et al., 2007; Li et al., 2003). 
An EYFP (enhanced yellow fluorescent protein) reporter gene is present within 
the Rosa26 locus and preceded by a loxP flanked stop sequence (Srinivas et 
al., 2001). Mice expressing the floxed alleles were intercrossed with mice 
expressing codon-improved Cre recombinase (iCre) under the control of the 
human (hu) CD2 promoter (de Boer et al., 2003) or Cre recombinase under the 
control of the CD4 promoter (Lee et al., 2001). huCD2iCre first becomes active at 
the DN2 stage of T cell development, whilst CD4Cre first becomes active at the 
DP stage of T cell development. When activated, the Cre recombinase deletes 
the floxed sections of the conditional Ikk1 and Ikk2 alleles and also deletes the 
stop sequence (tpA) in front of the EYFP gene (allowing expression of EYFP). 
EYFP expression provides a useful determinant of Cre activity. 
 
tpA = strong transcriptional termination sequence. EYFP = enhanced yellow 
fluorescent protein.
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2.2 Media 
 
Phosphate buffered saline (PBS) 
1X PBS was made in house (NIMR’s media kitchen). Dulbecco’s Phosphate 
Buffered Saline (DPBS) was purchased (Gibco). 
 
Fluorescence activated cell sorting (FACS) buffer 
FACS buffer consisted of PBS supplemented with 0.5% (v/v) sodium azide 
(Sigma-Aldrich) and 0.5% (w/v) bovine serum albumin (BSA) (Sigma-Aldrich).   
 
Handling media 
Handling media consisted of air-buffered Iscove’s Modified Dulbecco’s Medium 
(AB-IMDM) (made in house) supplemented with 1% (w/v) BSA.  
 
Complete medium (for in vitro culture)  
Complete medium consisted of Roswell Park Memorial Institute 1640 (RPMI 
1640) medium (Gibco) supplemented with 10% (v/v) fetal calf serum (FCS) 
(Biosera), 50μM β-mercaptoethanol (Sigma-Aldrich), and 1.5% (v/v) L-
glutamine penicillin-streptomycin (PSG) solution (Sigma-Aldrich).  
 
Ammonium-Chloride-Potassium (ACK) lysis buffer (for lysis of red blood cells) 
ACK lysis buffer consisted of distilled H2O (dH2O) with 150mM NH4Cl, 10mM 
KHCO3, and 0.1mM ethylenediaminetetraaceticacid (EDTA).  
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2.3 Preparation of single cell suspensions 
 
2.3.1 Thymus, spleen, and lymph nodes  
 
The thymus, spleen, and lymph nodes (cervical, auxiliary, brachial, inguinal, and 
mesenteric) were dissected from mice of interest before being pressed through 
75μm nylon mesh to produce single cell suspensions. Cells were then washed 
in handling media and pelleted by centrifugation (300g for 4min at 4oC). Cells 
were re-suspended in handling media and cell concentrations were then 
obtained through use of a Scharfe Instruments CASY Counter (Scharfe System, 
Germany). Cells were kept on ice throughout.  
 
2.3.2 Peripheral blood  
 
The lateral tail veins of experimental mice were punctured with needles and 
droplets of blood were drawn into sodium heparinised haematocrit capillary 
tubes (Globe Scientific). Approximately 100μL of blood was collected from each 
mouse. 2mL of ACK lysis buffer was added to the samples to lyse the red blood 
cells. Samples were incubated in the ACK buffer for 3min at room temperature, 
during which they were vortexed periodically. Samples were then washed in ice-
cold FACS buffer and pelleted by centrifugation (300g for 4min at 4oC). 
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2.4 Flow cytometry 
 
2.4.1 Surface staining with primary antibodies 
 
For each sample, between 1 x 106 and 5 x 106 cells were stained with 
saturating concentrations of antibodies (Abs) (Table 2.2) in 100μl of FACS 
buffer. Samples were incubated in the dark with the antibody preparations for at 
least 45min at 4oC. Following surface staining, samples were washed in FACS 
buffer, centrifuged (300g for 4min at 4oC) and re-suspended. Samples were 
then: analysed/sorted immediately by flow cytometry (section 2.4.4; section 
2.4.5), subjected to a secondary staining step (section 2.4.3), or fixed with 
300μL IC fixation buffer (eBioscience). Fixation, if required, took place over 
15min at room temperature or 30min at 4oC. Following fixation, cells were 
washed, centrifuged (300g for 4min at 4oC), and resuspended in 100-300μL 
FACS buffer.  
 
2.4.2 Intracellular staining for RIPK1 
 
Cells were surface stained as described in section 2.4.1. Samples were then 
fixed with 300μL IC fixation buffer for 30min at 4oC. Following fixation, samples 
were washed twice in PBS, before being permeabilised with a 0.1% (v/v) 
solution of nonidet P-40 (NP40) (Igepal ca-630) (Sigma-Aldrich) in PBS for 3min 
at room temperature. Cells were then washed before being stained with anti-
RIPK1 antibody or isotype control for 1hr at 4oC. Following this, samples were 
washed twice before being stained with an anti-rabbit secondary antibody 
(section 2.4.3).  
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Table 2.2 Primary FACS antibodies used in this study 
 
Specificity & 
conjugate 
Manufacturer, clone 
Working 
dilution 
Final 
concentration 
(μg/mL) 
B220 eF450  eBioscience, RA3-6B2 1/200 1 
CD11b PE Cy7 eBioscience, M1/70 1/400 0.5 
CD11c PE eBioscience, N418 1/200 1 
CD19 APC eBioscience, eBio1D3 
(1D3) 
1/100 2 
CD19 PE Cy5 eBioscience, eBio1D3 
(1D3) 
1/400 0.5 
CD2 PE BD Pharmingen, RM2-5 1/800 0.25 
CD23 PE  eBioscience, B3B4 1/300 0.67 
CD25 APC eBioscience, PC61.5 1/400 0.5 
CD25 FITC BD Pharmingen, 3C7 1/400 1.25 
CD25 PE Cy7 eBioscience, PC61.5 1/400 0.5 
CD4 APC eBioscience, RM4-5 1/400 0.5 
CD4 Bio eBioscience, RM4-5 1/400 1.25 
CD4-eF450 eBioscience, RM4-5 1/400 0.5 
CD4 PE TR Invitrogen, RM4-5 1/200 1 
CD4 PO Invitrogen, RM4-5 1/200 0.5 
CD44 APC eBioscience, IM7 1/400 0.5 
CD44 APC-eF780 eBioscience, IM7 1/400 0.5 
CD45.1 APC eBioscience, A20 1/400 0.5 
CD45.1 Bio eBioscience, A20 1/200 2.5 
CD45.1 FITC eBioscience, A20 1/400 1.25 
CD45.1 PE eBioscience, A20 1/400 0.5 
CD45.2 Bio eBioscience, 104 1/400 1.25 
CD45RB APC eBioscience, C363.16A 1/400 0.5 
CD5 APC eBioscience, 53-7.3 1/400 0.5 
CD5 FITC eBioscience, 53-7.3 1/400 1.25 
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CD5 PE Cy7 eBioscience, 53-7.3 1/400 0.5 
CD8α eF450 eBioscience, 53-6.7 1/400 0.5 
CD8α PE Cy7 eBioscience, 53-6.7 1/400 0.5 
CD8α PO Invitrogen, 5H10 1/200 1 
CD93 APC  eBioscience, AA4.1 1/100 2 
HSA (CD24) APC eBioscience, M1/69 1/400 0.5 
HSA (CD24) FITC eBioscience, M1/69 1/400 1.25 
HSA (CD24) PE 
Cy7 
eBioscience, M1/69 1/800 0.25 
IgD Bio eBioscience, 11-26c 1/200 2.5 
IgM PE Cy7 eBioscience, II/41 1/200 1 
IL-7R (CD127) PE eBioscience, A7R34 1/200 1 
Isotype control for 
RIPK1 
Cell Signaling Technology 1/50 Not disclosed 
MHC II eF450 eBioscience, AF6-120.1 1/200 1 
Qa2 Bio BD Pharmingen, 1-1-2 1/200 2.5 
RIPK1 
unconjugated 
Cell Signaling Technology 1/50 Not disclosed 
TCRβ APC eBioscience, H57-597 1/200 1 
TCRβ Bio eBioscience, H57-597 1/200 2.5 
TCRβ PE Cy5 eBioscience, H57-597 1/400 0.5 
TCRβ PerCP 
Cy5.5 
eBioscience, H57-597 1/400 0.5 
 
APC = Allophycocyanin; APC-eF780 = Allophycocyanin e-Fluor 780; Bio = 
Biotin; eF450 = e-Fluor 450; FITC = Fluorescein isothiocyanate; PE = 
Phycoerythrin; PE Cy5 = Phycoerythrin cyanine 5; PE Cy7 = Phycoerythrin 
cyanine 7; PE TR = Phycoerythrin Texas red; PerCP Cy5.5 = Peridinin-
chlorophyll protein cyanine 5.5; PO = Pacific orange.  
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2.4.3 Secondary staining 
 
Where surface staining involved the use of a biotin conjugated primary 
antibody, then a secondary staining step was employed. Biotinylated antibodies 
were detected with streptavidin (SAV) APC (eBioscience) or SAV APC-eF780 
(eBioscience). The working dilution for the SAV fluorochrome conjugates was 
1/200 and the final concentration used was 1μg/mL. When intracellular staining 
for RIPK1 was performed, then a secondary detection step was also required. 
This involved the use of anti-rabbit Alexa Fluor 674 (Cell Signalling 
Technology). The working dilution for the anti-rabbit secondary Ab was 1/1000.  
 
Cells were stained with the SAV conjugates or the anti-rabbit secondary Ab in 
the dark for 45min at 4oC, before being washed, centrifuged (300g for 4min at 
4oC), and re-suspended in 100-300μL FACS buffer. RIPK1 stained samples 
were analysed immediately (section 2.4.4). Biotin:SAV stained samples were 
either analysed immediately or fixed as described in section 2.4.1.  
 
2.4.4 FACS analysis of stained samples 
 
Prepared samples were run on a BD FACSCANTO II (Beckton Dickinson, BD) 
or BD LSRFortessa X-20 (BD) flow cytometer with colour compensations and 
data analysis being performed with FlowJo V9.6.2 software (TreeStar). FACS 
plots shown throughout this study use log and biexponential displays.  
 
2.4.5 Cell sorting 
 
Prior to cell sorting, cells were stained as described in section 2.4.1, but with 
handling media as opposed to FACS buffer. Following surface staining, 
samples were re-suspended in phenol red free AB-IMDM (made in house) or 
phenol red free RPMI 1640 (Gibco). Immediately after staining, sorting was 
carried out using a BD FACSAria (BD) or BD Influx (BD). Sorted cells were 
collected in handling media. Cell sorting was performed by members of the 
NIMR’s Flow Cytometry Team.   
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2.5 Generation of mixed bone marrow chimeras 
 
2.5.1 Extraction and preparation of donor bone marrow 
 
Bone marrow was extracted from the femora and tibiae of suitable mouse 
strains, disrupted, and resuspended in DPBS. Mature T cells were then 
depleted from the cell suspension as follows. TCR biotinylated antibody was 
added to the cell suspension and left to stain for 15min on ice. Streptavidin 
conjugated Dynabeads (Invitrogen) were then added, and the mixture rotated 
for 20min at 4oC. The Dynabeads:antibody:TCR conjugates were then removed 
from the cell suspension through use of the Dyna magnet (Invitrogen). The 
remaining bone marrow cells were washed, centrifuged (300g for 8min at 4oC), 
and resuspended in handling media to a final concentration of between 32 and 
40 million cells per mL.  
 
2.5.2 Irradiation of host mice and reconstitution with donor 
bone marrow 
 
C57BL/6 Rag1-/- host mice were sub-lethally irradiated with 500 rads (caesium 
source) and then treated with Baytril (0.02% (v/v) in H2O) for one month to 
prevent opportunistic infection. Approximately 24hr after irradiation, their lateral 
tail veins were injected with 4-5 million of the prepared bone marrow cells. Mice 
were then left for a minimum of 8 weeks to allow full reconstitution of the 
myeloid and lymphoid compartments. Immune system reconstitution was 
confirmed by phenotypic analysis of peripheral blood. 
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2.6 Intraperitoneal injections of blocking antibody 
 
2.6.1 In vivo blockade of TNF 
 
A blocking antibody towards murine TNF (BioXcell, BE0058) was administered 
to animals of interest via intraperitoneal (I.P.) injection. Each injection contained 
1mg of antibody. Two different regimes were employed. The first took place 
over a one-week period and involved 3 injections in total (days 0, 2, and 4), 
before sacrificing the animal on day 7. The second took place over two weeks 
and involved 6 injections (days 0, 2, 4, 7, 9, and 11), before sacrifice on day 14. 
For control animals, the same protocols were followed, but PBS used in place of 
antibody.  
 
2.6.2 In vivo blockade of CD27L 
 
A blocking antibody towards murine CD27L (BioXcell, BE0022) was 
administered to animals of interest via intraperitoneal (I.P.) injection. Each 
injection contained 1mg of antibody. A total of 3 injections were administered 
(days 0, 2, and 4), before the animal was sacrificed on day 7. For control 
animals, the same protocol was followed, but PBS used in place of antibody.  
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2.7 Cell culturing 
 
2.7.1 Culture conditions 
 
Whole thymus was mashed and liberated cells resuspended in complete 
medium. Cells were then plated in a 24 well plate at a concentration of 1-2.5 
million per mL of media. The thymocytes were cultured with a variety of ligands, 
blocking Abs, or inhibitors (Table 2.3) at 37oC with 5% CO2. Sterile technique 
was practiced throughout. At the end of the culture period, reactions were 
stopped, and cells were washed and stained for later analysis by flow 
cytometry, as described in section 2.4.  
 
2.7.2 Assessing cell death induction  
 
Cell viability was examined through use of the Live/Dead Fixable Dead Cell 
Stains (Invitrogen). These are fluorescent dyes, which react with the amine 
groups on the outside and inside of cells. If a cell is dead, the dye can penetrate 
the cell membrane, resulting in very bright fluorescence. The Live/Dead Fixable 
Near-IR stain (Invitrogen, L10119) or the Live/Dead Fixable Yellow stain 
(Invitrogen, L34959) was used as appropriate. Both stains were used at a 
working dilution of 1/1000. If used, the Live/Dead stain was added to the cells 
during the surface staining step described in section 2.4.1. (If a Live/Dead stain 
was to be used, then it and all antibodies were diluted in PBS, as opposed to 
FACS buffer containing BSA. This was to prevent the Live/Dead dye reacting 
with the amine groups within the BSA.) 
 
For analysis of active caspase-8, the CaspGLOW Red Active Caspase-8 
Staining Kit (BioVision Incorporated, K198-100) was used, with staining carried 
out according to the kit instructions. Briefly, cultured cells (between 1 x 106 and 
4 x 106) were washed, pelleted, and re-suspended in 300μL of PBS. 2μL of 
Red-IETD-FMK was then added, and the cells cultured for 1hr at 37oC with 5% 
CO2. Sterile technique was practiced for the duration of the caspase-8 staining 
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period. Cells were then washed twice in wash buffer (BioVision Incorportated), 
before surface staining was carried out as described in section 2.4.1.  
Table 2.3 Ligands, antibodies, or inhibitors used during cell culture 
 
Ligand/Ab/Inhibitor 
added to culture 
Concentrations 
used 
Source 
Ligand   
APRIL (TNFSF13) 100ng/mL R&D Systems, cat. 
no. 7907-AP-010 
BAFF (TNFSF13B) 100ng/mL R&D Systems, cat. 
no. 2106-BF-010 
CD27L (TNFSF7) 0.41 to 100ng/mL R&D Systems, cat. 
no. 783-CL-050 
GITRL (TNFSF18) 100ng/mL R&D Systems, cat. 
no. 2177-GL 
IL-7 10ng/mL Peprotech, cat. no. 
217-17 
LIGHT (TNFSF14) 100ng/mL R&D Systems, cat. 
no. 1794-LT-025 
TLA1 (TNFSF15) 100ng/mL R&D Systems, cat. 
no. 1896-TL-010 
 
TNF (TNFSF2) 0.1 to 1000ng/mL Peprotech, cat. no. 
315-01A 
TRAIL (TNFSF10) 100ng/mL R&D Systems, cat. 
no. 1121-TL-010 
Blocking Ab   
Anti-TNFR1 (CD120a) 0.78 to 200μg/mL Ebioscience, clone 
55R-170 
Inhibitor   
IKK2 inhibitor BI605906 10μM A gift from Philip 
Cohen, University of 
Dundee 
Birinapant  11.7 to 200μM Selleck Chemicals, 
cat. no. S7015 
GDC-0152 11.7 to 200μM Selleck Chemicals, 
cat. no. S7010 
Necrostatin-1 0.05 to 100μM Santa Cruz 
Biotechnology, cat. 
no. sc-200142 
Z-IETD-FMK (caspase-8 
inhibitor) 
20μM & 40μM 
 
BD, cat. no. 550380 
Z-FA-FMK (negative control for 
caspase inhibitors) 
20μM & 40μM 
 
BD, cat. no. 550411 
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2.8 RNA sequencing 
 
2.8.1 RNA isolation 
 
Thymocytes were sorted as described in section 2.4.4. The purified cell 
populations were then washed and pelleted. RNA was extracted from the cells 
using the Isolate II RNA mini kit (Bioline), following the kit instructions. Briefly, 
the cell pellets were lysed in the presence of guanidinium thiocyanate to 
deactivate endogenous RNases. Ethanol was added and the sample then 
passed through a column containing a silica membrane to which the RNA 
bound. Genomic DNA was removed by an on-column DNase I digestion. The 
sample was washed of impurities (salts, metabolites, and cellular components), 
and the RNA then eluted in RNase-free water. The quality of the extracted RNA 
was checked using a NanoDrop spectrophotometer and an Agilent Bioanalyzer.  
 
2.8.2 Preparation of a cDNA library and cluster generation on 
the Illumina high throughput sequencer 
 
The Illumina Truseq RNA Library Preparation kit (Illumina) was used to prepare 
cDNA libraries for sequencing. Manufacturer’s instructions were followed. 
Briefly, Poly-T oligo-attached magnetic beads were used to extract the poly-A 
containing mRNA from 0.5μg of total RNA. The mRNA was broken into small 
fragments using divalent cations and a high temperature. Reverse transcriptase 
and random primers were used to produce first strand cDNA from the 
fragmented mRNA. DNA Polymerase I and RNase H then enabled synthesis of 
second strand cDNA. Following end repair and addition of a single “A” base, the 
cDNA fragments were ligated to adapters. PCR was used to increase the 
number of cDNA fragments that had adapters ligated to both ends. The quality 
of the cDNA libraries was checked using an Agilent Bioanalyzer. Cluster 
generation on the Illumina Genome Analyser IIx was then performed.  
 
Cluster generation on the Illumina high throughput sequencer was always 
performed by members of the NIMR’s High-Throughput Sequencing Team. 
 
 
115 
cDNA libraries were prepared by the NIMR’s High-Throughput Sequencing 
Team, Charles Sinclair, or by myself.   
 
2.8.3 Analysis of sequencing data 
 
The read sequences obtained from the Illumina high throughput sequencer 
were analysed using Strand NGS software (Strand Genomics, Inc.). First, the 
reads were aligned to build version mm9 of the Mus musculus genome. Then 
the aligned reads were normalised using DEseq (Anders and Huber, 2010), 
before being presented as number of reads per kilobase of exon per million 
sequenced reads (nRPKM) (Mortazavi et al., 2008).  
 
 
Note: 3 independent RNA sequencing experiments are referred to in this study. 
All 3 experiments required a pure population of cells to be sorted prior to RNA 
extraction. Each RNA sequencing experiment made use of either 3 or 4 
independent cell sorts and RNA extraction procedures. However, for each RNA 
sequencing experiment, cluster generation on the Illumina high throughput 
sequencer was performed only once.  
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2.9 Data presentation and statistical tests 
 
2.9.1 Calculation of absolute cell numbers 
 
Data for the calculation of absolute cell numbers was obtained from a Scharfe 
Instruments CASY Counter and from the BD FACSCANTO II or BD 
LSRFortessa X-20. Calculations for absolute cell numbers were performed in 
Microsoft Excel for Mac V14.5.3 (Microsoft Corporation) and R V2.14.1 (The R 
Foundation for Statistical Computing).  
 
Absolute cell numbers were calculated as follows:  
Total single live cell number (obtained from the CASY counter) x Frequency of 
total single live lymphocytes x Frequency of the cell population of interest 
 
R V2.14.1 was used to create and execute a code for the calculation of 
absolute cell numbers. This made the process more efficient and less error-
prone. The code was created by Iren Bains.  
 
2.9.2 Graphs 
 
Bar charts and line graphs were produced using Prism 6 for Mac OS X 
(Graphpad Software, Inc.). FACS density plots and FACS histograms were 
produced using FlowJo V9.6.2. The Student’s t-test was used to identify 
statistical differences between groups. Statistical calculations were performed in 
Microsoft Excel for Mac V14.5.3 and Prism 6 for Mac OS X. 
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Chapter 3 The role of NF-κB signalling 
during T cell development 
 
3.1 Introduction 
 
The strength and duration of TCR signalling is important for selection of 
thymocytes (Hogquist, 2001). During thymocyte development, TCR signalling 
activates many transcription factors, including NF-κB. However, it is unclear 
what role NF-κB plays in thymic maturation (Voll et al., 2000). Interestingly, the 
level of NF-κB signalling has been shown to change during the DN stages of 
thymocyte development (Gerondakis et al., 2013). The use of an NF-κB 
dependent luciferase reporter gene found expression to be highest during DN3 
and DN4 – the same stages during which the pre-TCR is expressed (Voll et al., 
2000). Numbers of DN4 thymocytes were reduced in mice with a super-
inhibitory form of IκBα (IκBα super-repressor), but increased in mice expressing 
a constitutively active form of IKK2 (Voll et al., 2000). Furthermore, the 
proliferative burst that occurs between late DN3 and DN4 was found to be 
decreased in the absence of NF-κB signalling (Aifantis et al., 2001). From such 
data, it seems that NF-κB plays a role in beta selection early in T cell 
development.  
 
The role of NF-κB signalling during positive and negative selection is somewhat 
controversial. Most studies investigating the role of NF-κB in selection have 
made use of mice expressing transgenes for a non-degradable, super-inhibitory 
form of the IκBs and also for TCRs that recognise self-peptides with various 
avidities. When TCR transgenes with an intermediate avidity for self-
peptide:MHC are present, NF-κB has been said to play a role in positive 
selection (Hettmann and Leiden, 2000; Mora et al., 2001) or in positive 
selection of CD8, but not CD4 thymocytes (Jimi et al., 2008). It has been 
suggested that the higher expression levels of the anti-apoptotic protein Bcl-2 
during positive selection of CD4 thymocytes mean that NF-κB induced survival 
signals are not necessary (Gerondakis et al., 2013). The effect of NF-κB 
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signalling on negative selection has been studied in mice expressing TCR 
transgenes with a high avidity for self-peptide:MHC in combination with IκB 
super-repressors. Whilst some studies found NF-κB to be important for negative 
selection (Mora et al., 2001), other studies concluded that it played no role 
(Hettmann and Leiden, 2000). As with positive selection, it has also been 
suggested that NF-κB signalling is important for the negative selection of CD8+, 
but not CD4+ cells (Jimi et al., 2008).  
 
Activation of NF-κB signalling relies on the formation of a functional IKK 
complex. Loss of either NEMO or of both IKK1 and IKK2 together has been 
shown to cause a complete block in canonical NF-κB activation (Li et al., 2000; 
Rudolph et al., 2000). IKK1’s main NF-κB dependent role involves activation of 
the non-canonical pathway in response to lymphotoxin-β (LTβ). LT signalling is 
required for lymphoid organ development, and for this reason IKK1 is often 
cited as being important for the control of adaptive immunity. However, it 
remains unclear as to whether there is a T cell intrinsic requirement of IKK1 for 
normal T cell homeostasis. Through the use of Ikk1-/- bone marrow chimeras, 
IKK1 was found to be necessary for the normal development of mature B cells. 
However, such chimeras were found to contain normal numbers of total 
thymocytes and peripheral T cells (Kaisho et al., 2001; Senftleben et al., 
2001a). Mice expressing a dominant negative form of IKK1, specific to the T cell 
lineage, have been described. They were found to have normal T cell 
development and function (Ren et al., 2002). Such data suggests that IKK1 is 
not necessary for normal T cell homeostasis. More recently, mice with a 
conditional deletion of IKK1 in CD4+ cells were described (Chen et al., 2015). 
These mice were shown to have a significant reduction of Treg cells in the 
thymus and periphery. CD4 cells from these mice also showed poor 
lymphopenia induced expansion in Rag1-/- hosts and reduced responses to in 
vitro stimuli (Chen et al., 2015). Hence, there may indeed be a T cell intrinsic 
requirement for IKK1.  
 
The T cell specific deletion of IKK2 has been described (Schmidt-Supprian et 
al., 2003; Silva et al., 2014), as have mice in which endogenous IKK2 was 
replaced with a kinase dead IKK2 mutant (Ren et al., 2002; Schmidt-Supprian 
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et al., 2003). In one study, the kinase dead form of IKK2 was found to have no 
effect on T cell development. However, the analysis was somewhat superficial, 
since absolute T cell numbers were not calculated (Ren et al., 2002). A 
separate study found that mice carrying the kinase dead form of IKK2 had a 
50% reduction in CD8SP thymocytes and scarcely any peripheral T cells 
(Schmidt-Supprian et al., 2003). Mice with a conditional deletion of IKK2 exhibit 
normal thymic development (Schmidt-Supprian et al., 2003; Silva et al., 2014). 
Whilst some studies report only reductions in the size of regulatory and memory 
T cell populations in the periphery of these mice (Schmidt-Supprian et al., 
2003), others find an additional reduction in naïve cells (Silva et al., 2014).  
 
The conditional deletion of NEMO in T cells using CD4Cre has been described 
by Schmidt-Supprian et al. (Schmidt-Supprian et al., 2003). Although total 
thymocyte numbers were apparently normal, there was a profound reduction in 
the CD8SP population and a small reduction in CD4SPs. In both subsets, 
mature HSAlo thymocytes were almost completely absent, and the periphery 
had scarcely any T cells (Schmidt-Supprian et al., 2003).  
 
Transcriptional activity of NF-κB is mediated by dimers of Rel family proteins, of 
which there are five members: RelA, RelB, c-Rel, NF-κB1, and NF-κB2. The 
NF-κB1 and NF-κB2 genes encode for the large protein precursors p105 and 
p100, respectively. These large proteins are ubiquitinated and eventually 
degraded by the proteasome, allowing p105 to become p50, and p100 to 
become p52. In its most common form, the NF-κB dimer is composed of p50 
and RelA (Ghosh et al., 1998). Many studies involving mice lacking one or more 
Rel family members have not shown any gross defect in lymphocyte 
development, thus arguing redundancy or overlapping functions between 
members. Rela-/- mice were shown to be embryonic lethal (dying at gestation 
day 15-16) due to massive apoptosis of hepatocytes (Beg et al., 1995). 
However, fetal liver cells taken from the Rela-/- mice were able to populate host 
mice and give rise to a T cell repertoire. One such study described formation of 
a completely normal T cell compartment in the hosts following reconstitution 
with Rela-/- fetal liver (Beg et al., 1995), whilst another found the hosts to have 
around 2.5 fold fewer thymic Treg cells than controls (Isomura et al., 2009). 
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Disruption of the RelB gene causes loss of dendritic cells, but does not affect T 
or B cell development (Burkly et al., 1995). T cell development in c-Rel 
knockout mice appears largely normal. However, Treg cell numbers are reduced 
and c-Rel deficient T cells are less able to produce IL-2, thereby showing 
impaired proliferative ability (Isomura et al., 2009; Kontgen et al., 1995). 
 
Nfkb1-/- mice lack both the large inhibitory protein p105 and also the mature p50 
subunit. Initially, Nfkb1-/- mice were described as having no abnormality in T cell 
number or subsets (Sha et al., 1995). However, a more recent study found the 
NF-κB1 family member to be very important for the regulation of CD8 T cell 
development in the thymus (Gugasyan et al., 2012). In Nfkb1-/- mice a 
population of CD8SP thymocytes with memory like properties (CD44hiCD24lo) 
developed and survived to populate the periphery. This phenotype was 
attributed to defects in positive and negative selection. Normal numbers of DN 
and DP thymocytes suggested that early T cell development was not affected 
(Gugasyan et al., 2012). Serines 927 and 933 of NF-κB1 are important 
phosphorylation sites that target the protein for degradation. Mice expressing a 
mutant Nfkb1S927A, S932A knock-in gene produce a proteolytically resistant form of 
p105, which contains alanine instead of serine residues at positions 927 and 
933 (Sriskantharajah et al., 2008). This p105 can undergo constitutive 
processing to p50, but is not degraded by the proteasome and therefore 
continues to mediate NF-κB inhibitory functions. The thymus of Nfkb1S927A, S932A 
mice revealed low numbers of Treg cells and the spleen showed reduced Treg 
cells and CD4+ memory cells. CD4+ T cells from the mutant mice were found to 
have less NF-κB complex formation in response to anti-CD3 and anti-CD28 
stimulation. The authors concluded that, in CD4+ T cells, TCR mediated NF-κB 
activation is reliant on the correct processing of p105 (Sriskantharajah et al., 
2008). Other studies have reported normal thymocyte populations and Treg 
numbers in Nfkb1-/- mice (Isomura et al., 2009). This suggests that the inhibitory 
function of the mutant protein, rather than an absolute requirement for p105 
expression, underlies the phenotype of the Nfkb1S927A, S932A mice. 
 
Functional redundancy between Rel family members is evident in compound 
knockouts. Mice deficient in more than one NF-κB subunit tend to show greater 
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defects in T cell homeostasis. When radiation chimeras were made with bone 
marrow from Nfkb1-/- Rela-/- donors, the hosts reconstituted their T cell 
compartments poorly, but overcompensated for the defect by producing an 
excess of granulocytes. Surprisingly, when mixed chimeras were made (with 
wild-type bone marrow), NF-κB1/RelA double deficient lymphocytes did survive 
to populate the periphery, suggesting that the requirement for NF-κB signalling 
was T cell extrinsic (Horwitz et al., 1997). RelA/c-Rel double deficient 
hematopoietic stem cells show mild maturational defects (Grossmann et al., 
1999). In contrast, cRel/p50 double deficient mice have normal production of 
naïve cells, but lack both memory and regulatory T cells (Zheng et al., 2003).  
 
The cytokine IL-7 is very important for maintaining correct T cell homeostasis. 
Not only is it involved with T cell development, but it is also required for 
maintenance of naïve and regulatory populations in the periphery (Jameson, 
2005). Recent evidence has suggested that tonic NF-κB signalling is required 
for upregulation of the IL-7R as cells leave the thymus and enter the periphery 
(Miller et al., 2014; Silva et al., 2014). IKK2 deficient naïve T cells have a 
reduction in IL-7R expression, correlating with a decrease in Il7r mRNA levels 
(Silva et al., 2014). Mice with a non-degradable form of IκBα have also shown 
reduced IL-7R expression on their naïve T cells (Miller et al., 2014).  
 
The aim of this Chapter was to investigate the role of NF-κB signalling in T cell 
development and maintenance of the peripheral T cell compartment. We 
achieved this by manipulating NF-κB signalling at the level of both the IKK 
complex and expression of Rel family members. Specifically, we examined the 
following:  
 
 The cell intrinsic role of IKK1 in T cells. 
 The impact of a complete loss of IKK subunits on T cell homeostasis. 
 The role of specific Rel family members in T cell development. 
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3.2 Results 
 
3.2.1 Reduced thymic Treg cells in huCD2iCre Ikk1fx/fx R26REYFP 
mice  
 
We first wanted to understand the role of IKK1 in T cell development. In order to 
do this we bred mice with conditional alleles of IKK1 (Ikk1fx/fx) (Gareus et al., 
2007), which expressed the codon-improved Cre recombinase (iCre) (Shimshek 
et al., 2002) under the control of the human CD2 (huCD2) promoter and locus 
control region (de Boer et al., 2003). The mice generated also included a Cre 
reporter enhanced yellow fluorescent protein (EYFP) construct that had been 
targeted to the Rosa26 locus (R26REYFP reporter mice, floxed stop sequence 
proceeding the EYFP gene), thus enabling a read-out of Cre activity (Srinivas et 
al., 2001). The huCD2 locus control region and promoter has been reported to 
drive transgene expression only among cells of the lymphoid lineage (de Boer 
et al., 2003; Zhumabekov et al., 1995). Amongst T cells, huCD2iCre has been 
found to initiate deletion of target genes from the DN2 stage of thymocyte 
development onwards (de Boer et al., 2003). We compared our huCD2iCre 
Ikk1fx/fx R26REYFP (IKK1 deficient) mice with the previously described huCD2iCre 
Ikk2fx/fx R26REYFP (IKK2 deficient) mice (Silva et al., 2014). 
 
Analysis of the thymii of the IKK1 deficient mice revealed normal numbers of 
total thymocytes, DP cells, and SP cells (Figure 3.1). Within the SP thymocyte 
compartments, cells can be further characterised according to their expression 
of heat stable antigen (HSA, CD24). Expression of HSA is lost as SP 
thymocytes mature, enabling us to identify two distinct cell populations, HSAhi 
(immature) and HSAlo (mature), within the SP compartments (Tian et al., 2001). 
We found normal numbers of HSAhi and HSAlo cells in the CD4SP and CD8SP 
populations of IKK1 deficient mice (Figure 3.1). In the IKK2 deficient mice, 
there was a significant increase in cell numbers within the HSAhi subset of both 
CD4SP and CD8SP populations (Figure 3.1B). Strikingly, within the CD4SP 
population, Treg cells (CD25+) were decreased in percentage and number in the 
IKK2 and, to a lesser extent, in the IKK1 deficient mice (Figure 3.1). 
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3.2.2 Reduced memory and Treg cells in the periphery of 
huCD2iCre Ikk1fx/fx R26REYFP mice 
 
To investigate peripheral T cell homeostasis, we examined T cell populations 
within the spleen and lymph nodes (LNs) of IKK deficient strains. In contrast to 
huCD2iCre Ikk2fx/fx R26REYFP mice, the huCD2iCre Ikk1fx/fx R26REYFP mice had 
normal numbers of naïve (CD44loCD25-) T cells (Figure 3.2B). However, both 
IKK1 and IKK2 deficient animals showed a clear reduction in the percentage 
and number of CD4+CD25+ regulatory T cells and CD4+CD44hiCD25- memory 
cells. This reduction was greater in mice lacking IKK2 (Figure 3.2A & B). The 
CD8+ T cell compartment appeared normal in the IKK1 deficient animals, 
whereas IKK2 deficiency resulted in a significant loss of both naïve and memory 
CD8 populations (Figure 3.2B). IKK2 deficient naïve T cells have previously 
been shown to have reduced expression of the IL-7R (Silva et al., 2014). For 
this reason, we investigated IL-7R levels on the naïve cells of IKK1 deficient 
mice. As compared to controls, IKK1 deficient CD4 naïve cells had normal 
expression of the IL-7R, whilst the CD8 naïve cells did show a small, but 
significant, reduction in surface expression (Figure 3.2C). There was no 
significant difference in total peripheral T cell numbers between the IKK1 
deficient mice and the wild-type (WT) mice. However, as expected, the IKK2 
deficient mice were found to have significantly fewer total T cells than the WT 
controls (Figure 3.2B).  
 
In summary, we found that T cell homeostasis was disrupted in the IKK1 
deficient mice, albeit to a lesser extent than observed in the IKK2 deficient mice. 
Thymic development was largely normal in the IKK1 deficient mice, although 
numbers of Treg cells were reduced. In the periphery of the IKK1 deficient 
animals, naïve T cells appeared normal, but CD4+ memory cells and Treg cells 
were significantly reduced.  
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3.2.3 Early thymocyte development is unperturbed in the 
absence of NF-κB activation 
 
There is clear redundancy between IKK1 and IKK2. For this reason, we wished 
to investigate T cells doubly deficient in both IKK1 and IKK2 proteins, which 
would completely lack IKK function (referred to as IKK deficient throughout) and 
would therefore be unable to induce release of NF-κB dimers. We generated 
huCD2iCre Ikk1fx/fx Ikk2fx/fx R26REYFP mice (IKKΔTCD2 hereon) with a Cre 
mediated deficiency of both IKK1 and IKK2 specific to the lymphoid lineage. 
huCD2iCre induces deletion from the DN2 stage of thymocyte development (de 
Boer et al., 2003). In case there were profound blocks in DN thymocyte 
development, we also generated CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP mice 
(IKKΔTCD4). In this strain, Cre recombinase is under the control of the CD4 
enhancer/promoter/silencer, and hence gene deletion does not occur until the 
DP stage of thymocyte development (Lee et al., 2001). By comparing both 
strains of mice we were therefore able to assess the effect of IKK gene deletion 
at early and slightly later stages of thymocyte development.  
 
Within the CD4 CD8 double negative (DN) population, CD44 and CD25 can be 
used to further characterise cells into developmentally sequential DN1 
(CD44+CD25-), DN2 (CD44+CD25+), DN3 (CD44-CD25+), and DN4 (CD44-
CD25-) subsets, as defined by Godfrey et al. (Godfrey et al., 1993). Since 
huCD2iCre initiates deletion in the DN2 stage, we examined the number and 
representation of DN3 and DN4 populations in the IKKΔTCD2 mice. We saw no 
difference in percentage or number of DN3 and DN4 cells between the 
IKKΔTCD2 mice and the Cre- controls (Figure 3.3A & C). YFP expression 
confirmed Cre activation during the DN2 stage of thymocyte development 
onwards. About 50% of DN2 cells were YFP+. This rose to 98% by the time 
thymocytes reached the DN3 stage of development (Figure 3.3B). The fact that 
DN3 and DN4 thymocyte populations seem identical between Cre- and Cre+ 
mouse strains indicates that IKK1 and IKK2 are not required during the late 
double negative stages of development when the TCR is being rearranged. 
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This suggests that NF-κB signalling is not needed for beta selection or DN 
survival or expansion.  
 
Looking within the DP population, we can further define cells at different 
temporal stages of selection according to their expression of CD5 and TCR, as 
previously described (Saini et al., 2010). DP1 cells (TCRloCD5lo) have not yet 
initiated selection, DP2 cells (TCRintCD5hi) are in the early stages of selection of 
CD4 and CD8 lineage cells, and DP3 cells (TCRhiCD5int) are in the late stage of 
DP selection into the CD8 lineage (Saini et al., 2010). All DP populations (DP1-
3) were found to be very similar between IKKΔTCD2 mice and Cre- controls 
(Figure 3.3A & D). In confirmation of this, we also observed no difference in DP 
subsets in the IKKΔTCD4 strain (Figure 3.3D). Therefore, the timing of deletion 
of the IKK complex did not seem to influence DP thymocyte development. Our 
findings suggest that IKK activity is redundant for early T cell development.  
 
3.2.4 Maturation of SP thymocytes is blocked in the absence of 
NF-κB signalling 
 
Next we assessed the potential role of NF-κB signalling in late thymocyte 
development using IKKΔTCD4 mice. Although overall thymus size remained 
unchanged, analysis of SP compartments revealed profound perturbations 
(Figure 3.4A, B & C). Numbers of SP thymocytes were reduced in IKKΔTCD4 
mice, with the reduction being most pronounced among the CD8 lineage. The 
reduction in SP numbers was largely attributed to the loss of the most mature 
HSAlo subpopulations. Interestingly, while numbers of HSAhi CD4SP thymocytes 
appeared normal, HSAhi CD8SPs were significantly reduced in number (Figure 
3.4C). A similar developmental block was also observed in IKKΔTCD2 mice (data 
not shown).  
 
Enumeration of naïve phenotype CD44lo cells in the periphery of IKKΔTCD4 mice 
revealed a substantial reduction in numbers of both CD4 and CD8 lineages. In 
contrast, memory, and regulatory T cells were detectable (Figure 3.5A, B & D). 
However, closer examination revealed these populations were largely YFP 
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reporter -ve, indicating that these may represent cells that had escaped Cre 
mediated deletion of their Ikk genes (Figure 3.5C & D). Similar analysis of 
naïve populations revealed evidence of such deletion escapants in these 
subsets too, particularly among the few CD8 naïve T cells present in the IKK 
deficient mice (Figure 3.5C).  
 
Since absence of either IKK1 or IKK2 alone was shown to lead to a reduction in 
IL-7R expression on naïve, peripheral T cells, we examined IL-7R expression 
by the few naïve T cells present in our IKKΔTCD4 mice. Within the CD4 naïve 
population, IL-7R expression was dramatically reduced on IKK deficient cells as 
compared to WT controls. In contrast, IL-7R expression was only minimally 
reduced on the CD8 naïve IKK deficient cells (Figure 3.5E). However, YFP 
expression indicated that many of these cells may have failed to delete their Ikk 
genes (Figure 3.5C).  
 
Therefore, IKK mediated NF-κB signalling is essential for normal thymic 
development. Our results suggest that, in the absence of NF-κB signalling, 
there is a block in thymocyte maturation between the HSAhi and HSAlo stages of 
development (Figure 3.4D), and a consequential failure to populate the 
peripheral T cell compartment.  
 
3.2.5 The defects in T cell development in IKK deficient mice 
are cell intrinsic  
 
Expression of Cre recombinase, when under the control of the CD4 
enhancer/promoter/silencer, has been reported to be specific to T cells (Lee et 
al., 2001). However, since other cells (for example dendritic cells) have been 
known to express the CD4 antigen, it was possible that gene recombination 
may also occur in these cells. If so, this could mean that the defects seen in the 
NF-κB deficient animals were not T cell intrinsic. To exclude this, we generated 
competitive bone marrow chimeras using T cell depleted bone marrow from 
congenic CD45.1+ mice together with bone marrow from CD4Cre Ikk2fx/fx 
R26REYFP mice (“CD4Cre Ikk2fx/fx” chimeras), IKKΔTCD4 mice (“CD4Cre Ikk1fx/fx 
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Ikk2fx/fx R26REYFP” chimeras) or Cre- littermate mice (“control” chimeras). Bone 
marrow was injected in a 1:1 ratio into the tail vein of irradiated Rag1-/- hosts. 
After successful reconstitution of the host mice, we then calculated the 
percentage of T cells in the thymus and periphery that were CD45.1- (i.e. 
derived from the transgenic donors).  
 
In the control chimeras the percentage of CD45.1- cells remained similar among 
all T cell populations in the thymus and periphery (Figure 3.6). Between the 
control chimeras and the CD4Cre Ikk2fx/fx chimeras, there was no difference 
between the percentage of CD45.1- cells present in the DP, HSAhi, and CD4SP 
HSAlo populations. However, among the CD8 HSAlo population, there was a 
slight reduction in the percentage of CD45.1- cells (Figure 3.6). In the periphery 
of the CD4Cre Ikk2fx/fx chimeras there were very few CD45.1- cells. This was 
especially evident amongst the memory and regulatory populations (Figure 
3.6).  
 
The percentage of CD45.1- cells within the DP and CD4SP HSAhi thymocyte 
populations were similar between the control chimeras and the CD4Cre Ikk1fx/fx 
Ikk2fx/fx R26REYFP chimeras (Figure 3.6). This indicates that there is no selective 
disadvantage in having a block in NF-κB signalling among these cell types. This 
data agrees with the phenotype of the intact IKKΔTCD4 (CD4Cre Ikk1fx/fx Ikk2fx/fx 
R26REYFP) mouse, whereby the DP and CD4SP HSAhi populations appeared 
normal (Figure 3.4). Within the CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP chimeras, the 
CD8SP HSAhi thymocytes that were deficient in IKK (CD45.1-) did seem at a 
competitive disadvantage. However, as predicted from the phenotype of the 
intact IKKΔTCD4 mice, it was the HSAlo SP thymocyte populations that competed 
least well in the absence of IKK (Figure 3.6). In the periphery of the CD4Cre 
Ikk1fx/fx Ikk2fx/fx R26REYFP chimeras, scarcely any CD45.1- cells could be 
detected, again consistent with the phenotype of the intact IKKΔTCD4 animal 
(Figure 3.6; Figure 3.5). From the use of competitive chimeras, we can 
conclude that the phenotype of CD4Cre Ikk2fx/fx R26REYFP mice and IKKΔTCD4 
mice is indeed T cell intrinsic.   
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3.2.6 Evidence that IKK signalling acts quantitatively upon T 
cell development  
 
Quantitative differences in NF-κB activity may be important at different stages in 
T cell development and function. To investigate this, we generated mice with 
different combinations of Ikk1 and Ikk2 allele deletion mediated by huCD2iCre. 
We analysed thymic development and peripheral population of the T cell 
compartment in the different strains. Interestingly, we found evidence of a clear 
gene dose dependent effect of IKK1 and IKK2 signalling on T cell homeostasis. 
In the periphery, enumeration of total and naïve T cell numbers revealed a 
stepwise reduction decreasing in the order: wild-type, Ikk1fx/fx Ikk2wt/wt, Ikk1fx/fx 
Ikk2wt/fx, Ikk1wt/wt Ikk2fx/fx, Ikk1wt/fx Ikk2fx/fx to Ikk1fx/fx Ikk2fx/fx (Figure 3.7A). Total 
numbers of CD4+ memory and Treg cells were dramatically reduced in Ikk1wt/wt 
Ikk2fx/fx mice, but surprisingly began to increase again in Ikk1wt/fx Ikk2fx/fx mice. 
Total numbers of CD8+ memory cells were reduced in Ikk1wt/fx Ikk2fx/fx mice, but 
increased in Ikk1fx/fx Ikk2fx/fx mice (Figure 3.7A). Examining YFP expression 
revealed that the increase in memory and Treg populations was due to the 
presence of YFP- “deletional escapants” (Figure 3.7A). 
 
Our previous results have revealed a decreased expression of the IL-7R on the 
naïve T cells of mice lacking IKK proteins. Compared with the IKK1 deficient 
naïve cells, the IKK2 deficient naïve cells had less IL-7R expression (Figure 
3.2C). Furthermore, the CD4 naïve cells from the IKKΔTCD4 mice were found to 
have scarcely any IL-7R expression (Figure 3.5E). For this reason we chose to 
examine IL-7R expression among cells with different extents and combinations 
of Ikk1 and Ikk2 deletion. We observed a stepwise reduction in IL-7R 
expression in a manner similar to that described for total and naïve T cell 
numbers (Figure 3.7B). As our previous results indicated, the CD8+ naïve T 
cells of Ikk1fx/fx Ikk2fx/fx mice showed surprisingly high IL-7R expression (Figure 
3.5E; Figure 3.7B). However, this is likely due to the presence of deletion 
escapants amongst CD8 naïve cells that would have more normal IL-7R 
expression and therefore survive more efficiently than IKK deficient cells. 
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In conclusion there is clear evidence of a quantitative impact of IKK signalling 
on T cell development. In particular, naïve T cell homeostasis and expression of 
the IL-7R on naïve T cells appeared to closely correlate with the extent of IKK 
signalling.   
 
3.2.7 Normal development, but reduced naïve T cells in the 
absence of RelA and NF-κB1  
 
We next wished to examine the role of different Rel family members in 
development and maintenance of T cells. RelA deficiency is embryonically 
lethal (Beg et al., 1995). Therefore, we examined a T cell specific deletion of 
RelA by using the CD4Cre Relafx/fx R26REYFP strain. In addition, we examined 
Nfkb1-/- mice that lack p105 and p50 (Sha et al., 1995). To examine the effect of 
a compound deficiency of NF-κB1 and RelA, we also examined CD4Cre Relafx/fx 
Nfkb1-/- R26REYFP mice. Both early and late stages of thymic development in 
CD4Cre Relafx/fx Nfkb1-/- R26REYFP mice appeared normal (Figure 3.8). Previous 
studies reveal that Nfkb1-/- mice contain a large population of CD8SP 
thymocytes with a memory like phenotype (Gugasyan et al., 2012). These 
memory like CD8 cells have an HSAloCD44hiCD122hi phenotype. Interestingly, 
in the RelA NF-κB1 double deficient strain this population was absent, 
suggesting that these cells are RelA dependent (Figure 3.8A, bottom row).  
 
Analysing RelA deficient mice revealed a largely normal peripheral T cell 
compartment, except for a small, but significant reduction in Treg cells (Figure 
3.9A & B). NF-κB1 deficient mice also had a trend towards reduced Treg cells 
(Figure 3.9A & B). As expected from the thymic phenotype, and as previously 
described, the Nfkb1-/- mice had a large population of CD8 memory cells in the 
periphery (Figure 3.9B). In contrast, CD4Cre Relafx/fx Nfkb1-/- R26REYFP mice had 
a significantly reduced peripheral T cell compartment, which included a reduced 
CD8+ memory population (Figure 3.9B). The naïve cells of the CD4Cre Relafx/fx 
R26REYFP mice and the Nfkb1-/- mice both had slightly reduced expression of 
the IL-7R. However, naïve T cells from CD4Cre Relafx/fx Nfkb1-/- R26REYFP mice 
had a more substantial reduction in IL-7R expression (Figure 3.9C).   
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3.3 Discussion 
 
We began this chapter by comparing the roles IKK1 and IKK2 play in T cell 
homeostasis. IKK1 and IKK2 are structurally very similar, but have been shown 
to have distinct functions in vivo. This is due to IKK1 having numerous functions 
independent of kinase activity and NF-κB activation (Oeckinghaus et al., 2011). 
Together with NEMO, both IKK1 and IKK2 are components of the IKK complex. 
IKK2 is specific to the canonical NF-κB signalling pathway. However, T cells 
have been found to compensate for its absence, at least to a certain extent, via 
formation of IKK1 homodimers (Schmidt-Supprian et al., 2003). In contrast, 
activation of the NF-κB non-canonical pathway relies on the formation of an 
IKK1 homodimer and involves neither IKK2 nor NEMO. Thus IKK1 is absolutely 
required to activate non-canonical NF-κB signalling, and in its absence this 
pathway is terminated. We hypothesised that IKK1 and IKK2 may have different 
functions in T cell development and homeostasis and sought to test this by way 
of mice with a conditional deletion of either protein.  
 
In the past, the use of IKK1-/- bone marrow chimeras had led to the belief that 
IKK1, although necessary for the normal development of B cells, was 
dispensable for maturation and homeostasis of the T cell compartment (Kaisho 
et al., 2001; Senftleben et al., 2001a). Through the use of huCD2iCre Ikk1fx/fx 
R26REYFP mice, we have shown that thymocyte development was normal in the 
absence of IKK1, except for the production of Treg cells, which appeared 
significantly reduced (Figure 3.1). Furthermore, we have shown a reduction in 
CD4+ memory and Treg cells in the periphery of huCD2iCre Ikk1fx/fx R26REYFP 
mice (Figure 3.2, Table 3.1). A similar phenotype was recently described in 
mice with a CD4Cre mediated deletion of IKK1. These mice were shown to have 
reduced Treg cells and poor expansion of peripheral CD4+ effector cells (Chen et 
al., 2015).    
 
A lymphoid specific deficiency of IKK2 has previously been described to have 
no effect on thymocyte development (Schmidt-Supprian et al., 2003; Silva et al., 
2014). Here, however, we show that thymic Treg cells are reduced in IKK2 
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deficient mice and more dramatically so than in IKK1 deficient animals (Figure 
3.1). Memory and regulatory populations in the periphery have been reported to 
be reduced in the absence of IKK2 (Schmidt-Supprian et al., 2003). Yet while 
some studies have seen reduced naïve cells in IKK2 deficient mice (Silva et al., 
2014), others have described a normal naïve cell compartment (Schmidt-
Supprian et al., 2003). We found the memory and regulatory compartments to 
be the most affected by the loss of IKK2. However, we also noted a loss of 
naïve cells - the reduction being greater among the CD8 than the CD4 lineage, 
as previously reported (Silva et al., 2014).  
 
In previous work, Ren et al., attempted to directly compare the roles of IKK1 
and IKK2 in early T cell development. They stated that IKK2, but not IKK1, 
dependent activation of NF-κB signalling plays a role in the negative selection 
of DP thymocytes. Ultimately then, they concluded that IKK1 and IKK2 may play 
opposite roles in thymocyte development (Ren et al., 2002). Here we show that 
the IKK1 and IKK2 deficient mice present with similar, although not identical, T 
cell phenotypes (Figure 3.1; Figure 3.2, Table 3.1). This seems to suggest 
overlapping roles for IKK1 and IKK2 in the later, if not the earlier, stages of T 
cell development. Past studies suggested that IKK1 and IKK2 are functionally 
redundant with one another, but also emphasised the more potent kinase 
activity of the IKK2 subunit (Yamamoto et al., 2000). Our data suggest that IKK1 
may not be entirely redundant for peripheral T cell function.  
 
In an attempt to uncover the most important NF-κB subunits in T cells, we 
investigated mice with a conditional deletion of RelA, a complete deficiency of 
NF-κB1, and a T cell specific combined deficiency of both RelA and NF-κB1. 
Thymocyte development appeared normal in these mice, with the exception of 
the NF-κB1 single knockout animals which, as previously documented, had a 
large increase in memory like CD8SP cells (Gugasyan et al., 2012). 
Interestingly, in the periphery of all three strains there was a reduction in CD4+ 
Treg cells (Figure 3.9A & B). The most important NF-κB protein for the 
production of Treg cells is believed to be c-Rel, followed secondly by RelA 
(Isomura et al., 2009). Indeed, our results serve to confirm the importance of 
RelA for Treg production.  
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Together our results indicate that Treg cells have a great dependency on NF-κB 
signalling. Loss of IKK1, IKK2, RelA, or NF-κB1 alone all led to a reduction in 
Treg cells (Figure 3.1; Figure 3.2A & B; Figure 3.7A; Figure 3.9A & B). CD4+ 
memory cells also seem to be particularly NF-κB dependent, since loss of either 
IKK1 or IKK2 alone led to a significant reduction of this population in the 
periphery (Figure 3.2A & B; Figure 3.7A). It is generally accepted that the 
production of memory and regulatory cells is dependent on antigen induced 
signalling. IKK2 deficient mice and mice doubly deficient for p50 and c-Rel have 
previously been described as lacking memory and regulatory compartments 
(Schmidt-Supprian et al., 2003; Zheng et al., 2003). In such situations it has 
been proposed that the reduction in these cell types may be due to lack of TCR 
mediated activation of the canonical NF-κB pathway (Schmidt-Supprian et al., 
2003; Zheng et al., 2003). However, loss of IKK1 alone can dramatically reduce 
CD4+ regulatory and memory cell numbers (Chen et al., 2015). Even in the 
absence of IKK1, IKK2 and NEMO are thought to cause full TCR induced 
canonical NF-κB activation (Kaisho et al., 2001; Takeda et al., 1999). Evidence 
suggests that signalling via receptors of the TNF superfamily activates the non-
canonical NF-κB pathway and results in the production and expansion of Treg 
cells (Chen et al., 2013; Coquet et al., 2013; Mahmud et al., 2014). In the 
absence of IKK1 the non-canonical NF-κB pathway is blocked. Hence, 
activation of both canonical and non-canonical NF-κB pathways seems to be 
required for the production of Treg and CD4+ memory cells.  
 
A further aim of this chapter was to assess the effect of a complete block in NF-
κB signalling on T cell development and homeostasis. Mice with a T cell 
specific, conditional deletion of NEMO have been previously described 
(Schmidt-Supprian et al., 2003). However, although T cells from these mice 
would have had a complete block in the canonical pathway of NF-κB activation 
(Rudolph et al., 2000), the non-canonical pathway would have remained intact. 
Here we used mice with a T cell specific deficiency of both IKK1 and IKK2 to 
determine the effect of a complete block in NF-κB signalling. As predicted, the 
IKK deficient mice closely phenocopied the NEMO deficient animal. Both strains 
of mice exhibited a clear block in the later stages of thymocyte development 
and had very few peripheral T cells (Figure 3.4; Figure 3.5; Schmidt-Supprian 
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et al., 2003). Through the use of competitive chimeras we have shown that the 
defects in the IKK deficient mice are indeed T cell intrinsic (Figure 3.6).  
 
The role of NF-κB signalling during thymic selection has proven controversial. 
Virtually all studies into the effects of cell intrinsic NF-κB signalling on thymocyte 
selection have used TCR transgenic mice expressing a super-inhibitory form of 
the IκB proteins. In the T cells of these mice, both TCR alpha and beta chains 
are pre-arranged and therefore expressed early in development - hence leading 
to a rather non-physiological situation. It is possible that these studies have 
been over complicated by the inclusion of the transgenic TCRs. For example, 
positive selection is often measured by CD69 expression (Hettmann and 
Leiden, 2000; Mora et al., 2001). However, it has been suggested that the 
observed reduction in CD69 may not be a direct effect of reduced NF-κB, but 
rather due to defects in TCR signalling that, with a more physiologically relevant 
model, may not have been present (Mora et al., 2001). 
 
We therefore wished to assess the effect of blocking NF-κB signalling early in 
thymocyte development through the use of early deleting Cre recombinases 
and in the absence of any transgenic TCRs. DP thymocytes were present in 
normal numbers in IKK deficient mice (Figure 3.3A & D). Early CD4SP 
populations (HSAhi) were also found to be unchanged between the IKK deficient 
mice and their Cre- littermates (Figure 3.4B & C). This suggests that NF-κB 
signalling is dispensable during positive selection. TCR transgenic mice, with a 
huCD2iCre mediated deficiency of IKK2, have been previously described (Silva 
et al., 2014). The transgenic T cells in these mice also underwent normal 
positive selection, providing further evidence that IKK activity is redundant at 
this stage of T cell development.   
 
The normal numbers of DN3 and DN4 thymocytes in the IKKΔTCD2 mice hints 
that NF-κB is not required for beta-selection (Figure 3.3A & C). We compared 
our huCD2iCre mice to mice with a CD4Cre mediated deficiency of NF-κB 
signalling. Doing so revealed no phenotypic differences between the strains 
(Figure 3.3D; data not shown). Hence it seems of little consequence whether 
Ikk1 and Ikk2 are deleted during the DN stage of thymocyte development (by 
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huCD2iCre) or during the DP stage (by CD4Cre). However, despite our results, we 
cannot state with certainty that there is no function for NF-κB during thymic 
selection stages. To do so would require firstly, proof that NF-κB signals have 
actually been terminated by the late DN stages of development in the huCD2iCre 
mice and secondly, evidence that normal selection has indeed occurred.   
 
Previous studies have shown that IKK2 deficient naïve T cells have reduced 
expression of the IL-7R (Miller et al., 2014; Silva et al., 2014). This has been 
found to correlate with a reduction in Il7r mRNA levels and to be cell intrinsic 
(Silva et al., 2014). When we examined the IKK1 deficient mice we found 
reduced IL-7R expression on the CD8 naïve cells (Figure 3.2C). The IKK1/2 
double deficient mice had scarcely any peripheral cells present, however the 
few remaining CD4 naïve cells showed extremely low levels of the IL-7R 
(Figure 3.5E). In physiological situations, the amount of circulating IL-7 cytokine 
controls the level of IL-7R expression. In the presence of increased IL-7, IL-7Rα 
is down-regulated (Park et al., 2004). However, use of mixed chimeras showed 
that the reduced IL-7R levels on the IKK1/2 double deficient mice were not a 
consequence of increased IL-7 signalling in the lymphopenic environment (data 
not shown).  
 
Evidence suggests that IKK mediated NF-κB signalling is necessary for the 
maturation of new T cells by allowing upregulation of the IL-7R (Miller et al., 
2014; Silva et al., 2014). We therefore looked at IL-7R expression levels on 
mice with different degrees of Ikk1 and Ikk2 deletion. As expected, we found 
that IL-7R levels decreased in mice bred with a progressive loss of Ikk1 and 
Ikk2 alleles (Figure 3.7B). Moreover, we found that loss of naïve cells 
correlated with the loss of IL-7R (Figure 3.7). Surprisingly, IL-7R expression 
remained fairly high on CD8 naïve IKK1/2 double deficient cells (Figure 3.5E; 
Figure 3.7B). It is possible that, due to selection pressures, the few remaining 
cells within the CD8+ naïve population were those expressing the greatest 
amount of IL-7R or were cells that failed to fully delete all Ikk1 and Ikk2 alleles.    
 
IL-7R expression is of particular importance for maintenance of the naïve T cell 
population (Jameson, 2005). Thus we believe that loss of IL-7R expression 
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could provide one, if not the sole explanation for the loss of naïve cells. 
Interestingly, mice deficient in either RelA or NF-κB1 had only a slight defect in 
IL-7R expression and normal numbers of naïve cells (Figure 3.9). The 
combined absence of both RelA and NF-κB1 did result in a more striking 
phenotype (Figure 3.9). However, compared to the IKK1/2 double deficient 
mice, the RelA NF-κB1 double deficient animals were much less affected 
(Figure 3.4; Figure 3.5; Figure 3.8; Figure 3.9). It seemed that the loss of both 
RelA and NF-κB1 resulted in a reduction in NF-κB activity similar to that of the 
IKK2 deficient mice – i.e. partial, but not complete (Figure 3.1; Figure 3.2; 
Figure 3.8; Figure 3.9; Table 3.1). This serves to confirm the redundancy that 
exists between the different members of the Rel protein family.  
 
IKK2 has been noted to have between 20 and 50 fold greater kinase activity for 
IκB than does IKK1 (Yamamoto et al., 2000). Therefore, we anticipated the loss 
of Ikk2 alleles to be of greater significance than the loss of Ikk1 alleles. Our data 
supports this – notably mice with no Ikk1 alleles and only one Ikk2 allele 
(Ikk1fx/fx Ikk2wt/fx) had more T cells and greater IL-7R expression than mice with 
both Ikk1 alleles, but no Ikk2 alleles (Ikk1wt/wt Ikk2fx/fx) (Figure 3.7). IL-7R 
expression appeared to correlate with NF-κB signalling strength. The IKK 
complex can consist of IKK1 or IKK2 homodimers as well as the common 
IKK1/2 heterodimer. The subtle changes in IKK1 and IKK2 expression that 
occur in wt/fx mice are likely to affect the composition and therefore function of 
the IKK complex. Indeed the unique phenotypes of the mice with different 
extents and combinations of Ikk gene deletion provide strong evidence for this 
(Figure 3.7).  
 
Other studies have also shown gene dose dependent effects of NF-κB pathway 
components on T cell homeostasis. In mice overexpressing IκBα, the reduction 
in peripheral T cell number was found to be transgene dose dependent – 
animals expressing 80 copies of IκBα per haploid chromosome complement 
showing more severe phenotypes than those expressing 25 copies (Esslinger 
et al., 1997). Furthermore, whilst hemizygous animals had 3 times fewer CD4+ 
cells and 10 times fewer CD8+ cells than control animals, homozygous animals 
had virtually no peripheral αβ T cells (Esslinger et al., 1997). Such results argue 
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in favour of a threshold level requirement for NF-κB signalling. Furthermore, 
genetic ablation of IKK2 is shown to be better tolerated than replacing IKK2 with 
a kinase dead mutant (Schmidt-Supprian et al., 2003). This suggests that 
compensatory signalling can occur by IKK1 homodimers. In conclusion, we 
believe that there may be clear gene dose dependent effects of IKK1/2 
signalling on T cell development. 
 
A certain threshold of cell intrinsic NF-κB signalling seems to be necessary for 
the maturation and survival of SP thymocytes. When NF-κB signalling is 
completely blocked in T cells, by a deletion of the gene encoding NEMO, or by 
deletion of the genes for both IKK1 and IKK2, there is a significant reduction in 
thymic SP populations (Schmidt-Supprian et al., 2003). The receptor 
responsible for activating NF-κB in this context is not known. However, it 
appears to be independent of the TCR since deletion of Bcl-10, required for 
TCR mediated NF-κB activation, does not prevent maturation of the SP 
population (Ruland et al., 2001; Schmidt-Supprian et al., 2003).  
 
In conclusion, the results presented in this chapter show that there is a T cell 
intrinsic requirement for NF-κB signalling for thymic development and peripheral 
T cell homeostasis. In particular, we have discovered that IKK signalling is 
required during the later stages of thymocyte maturation. In the absence of both 
IKK1 and IKK2, there is a block between the HSAhi and HSAlo stages of SP 
development, similar to the block seen in NEMO deficient animals (Schmidt-
Supprian et al., 2003). The mechanism of this block is unclear, as is the identity 
of the receptor required to activate NF-κB. In Chapter 4 we will therefore 
attempt to address these unknowns.    
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Figure 3.1 Mice with a conditional deletion of either Ikk1 or Ikk2 have a 
reduction in thymic Treg cells 
 
The thymii of 7-25 week old: huCD2iCre Ikk1fx/fx R26REYFP mice, huCD2iCre 
Ikk2fx/fx R26REYFP mice, and their Cre- (WT) littermates were analysed by FACS. 
(A) From top to bottom, density plots show: CD4 vs CD8 expression by total live 
thymocytes; CD25 vs CD44 expression by CD4SP thymocytes; HSA vs TCR 
expression by CD4SP thymocytes; HSA vs TCR expression by CD8SP 
thymocytes. (B) Bar charts display the number of cells within the given thymic 
populations.  
 
Cre- (WT), (n = 14); huCD2iCre Ikk1fx/fx, (n = 14); huCD2iCre Ikk2fx/fx, (n = 9). Data 
was collected from 6 independent FACS experiments. For all density plots, 
numbers represent the percentage of cells in the corresponding gate. Bar 
charts show mean cell number ± SEM. ns = not significant; * = significant at 
P<0.05; ** = significant at P<0.01; *** = significant at P<0.001. 
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Figure 3.2 Mice with a conditional deletion of either Ikk1 or Ikk2 have a 
reduction in CD4+ memory and Treg cells in the periphery  
 
The LNs and spleen were taken from 7-25 week old: huCD2iCre Ikk1fx/fx 
R26REYFP mice, huCD2iCre Ikk2fx/fx R26REYFP mice, and their Cre- (WT) 
littermates and were analysed by FACS. (A) Density plots show LN profiles of 
the indicated mouse strains. From top to bottom, plots show: CD4 vs CD8 
expression by TCR+ cells; CD25 vs CD44 expression by TCR+CD4+ cells; TCR 
vs CD44 expression by TCR+CD8+ cells. (B) For the different T cell populations, 
cell counts within the LN and spleen were combined and displayed via bar 
charts. (C) Within the LNs, IL-7R expression on naïve CD4+ or CD8+ T cells is 
shown for the indicated mice. Bar charts show the mean fluorescence intensity 
(MFI) of IL-7R staining as a percentage of that seen on “WT” cells (Cre- cells 
prepared, stained, and analysed concomitantly).   
 
Cre- (WT), (n = 19); huCD2iCre Ikk1fx/fx, (n = 19); huCD2iCre Ikk2fx/fx, (n = 9). Data 
was collected from 7 independent FACS experiments. For all density plots, 
numbers represent the percentage of cells in the corresponding gate. Bar 
charts show mean cell number ± SEM. ns = not significant; * = significant at 
P<0.05; ** = significant at P<0.01; *** = significant at P<0.001. 
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Figure 3.3 Thymocyte development through the late DN stages and the DP 
stages is unaffected by loss of both Ikk1 and Ikk2 
 
Early thymocyte development was assessed in 12-26 week old: huCD2iCre 
Ikk1fx/fx Ikk2fx/fx R26REYFP (IKKΔTCD2) mice, CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP 
(IKKΔTCD4) mice, and Cre- (WT) littermates. (A) Top row shows CD44 vs CD25 
expression by TCR-CD5- thymocytes within the live population of CD4-CD8- 
thymocytes. DN1 = CD44+CD25-, DN2 = CD44+CD25+, DN3 = CD44-CD25+, 
DN4 = CD44-CD25-. Bottom row shows CD5 vs TCR expression by CD4+CD8+ 
live thymocytes. DP1 = TCRloCD5lo, DP2 = TCRintCD5hi, DP3 = TCRhiCD5int. (B) 
Histograms show YFP expression within the DN populations of IKKΔTCD2 mice 
vs Cre- littermate controls. Bar charts show the percentage of YFP positive cells 
within the DN1-4 populations of IKKΔTCD2 mice. (C) Bar charts show DN cell 
numbers in IKKΔTCD2 (Cre+) mice vs Cre- littermate controls. (D) Bar charts 
show DP cell numbers in IKKΔTCD2 mice vs Cre- littermate controls and 
IKKΔTCD4 mice vs Cre- littermate controls.  
 
IKKΔTCD2 mice, (n = 16); Cre- (WT) littermates of IKKΔTCD2 mice, (n = 15); 
IKKΔTCD4 mice, (n = 15); Cre- (WT) littermates of IKKΔTCD4 mice, (n = 11). 
Numbers on the density plots represent percentages within each gated 
population. Bar charts show mean ± SEM. ns = not significant; * = significant at 
P<0.05; ** = significant at P<0.01.  
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Figure 3.4 Conditional deletion of both Ikk1 and Ikk2 early in T cell 
development leads to a severe block in the later stages of thymocyte 
maturation 
 
The thymii of 10-14 week old CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP (IKKΔTCD4) mice 
and Cre- (WT) littermates were analysed by FACS. (A) Moving from top to 
bottom, density plots show: CD4 vs CD8 expression by total live thymocytes; 
CD5 vs TCR expression by total live thymocytes; CD4 vs CD8 expression by 
TCRhiCD5hi thymocytes. (B) Top row shows HSA vs TCR expression by CD4SP 
thymocytes. Bottom row shows HSA vs TCR expression by CD8SP thymocytes. 
(C) Total numbers of live thymocytes and numbers of HSAhi and HSAlo cells 
within the mature CD4SP and CD8SP populations are shown for IKKΔTCD4 
(Cre+) mice and Cre- littermate controls. For the Cre+ mice, stacked bars are 
used to indicate the numbers of YFP+ and YFP- cells. (D) The block in 
thymocyte development in the IKKΔTCD4 mice is illustrated.  
 
Cre- (WT) mice, (n = 18); Cre+ (IKKΔTCD4) mice, (n = 24). Numbers on the 
density plots represent percentages within each gated population. Bar charts 
show mean cell number ± SEM. ns = not significant; *** = significant at 
P<0.001. 
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Figure 3.5 Conditional deletion of both Ikk1 and Ikk2 early in T cell 
development causes a significant reduction in peripheral T cell numbers 
 
The LNs and spleen of 10-14 week old CD4Cre+ Ikk1fx/fx Ikk2fx/fx R26REYFP 
(IKKΔTCD4) mice and Cre- (WT) littermates were analysed by FACS. (A-C and 
E) The T cell phenotype within the LN is shown. (A) Top row shows CD5 vs 
TCR expression by total live lymphocytes. Bottom row shows CD4 vs CD8 
expression by TCRhiCD5hi cells. (B) Top row shows CD25 vs CD44 expression 
by CD4+ cells. Bottom row shows TCR vs CD44 expression by CD8+ cells. (C) 
Histograms are of YFP expression by WT (Cre-, grey fill) and Cre+ (black line) 
mice. YFP expression within the CD4+ naïve, memory, and regulatory T cell 
populations and the CD8+ naïve and memory T cell populations is shown. 
CD4Cre+ Ikk1wt/wt Ikk2wt/fx R26REYFP mice (top) are controls for IKKΔTCD4 mice 
(bottom). Numbers indicate the percentage of YFP+ cells within the T cell 
populations of Cre+ mice. (D) Peripheral T cell numbers are shown for 
IKKΔTCD4 (Cre+) mice and WT (Cre-) littermates. These represent total T cell 
numbers in the LNs and spleen combined. For the Cre+ mice, numbers include 
both YFP+ and YFP- cells. (E) Histograms show expression of the IL-7R on 
naïve T cells within the LNs. For the Cre+ mice, the naïve cell gates included 
both YFP+ and YFP- subsets.  
 
Cre- (WT) mice, (n = 17); Cre+ (IKKΔTCD4) mice, (n = 22). Numbers on the 
density plots represent percentages within each gated population. Bar charts 
show mean cell number ± SEM. * = significant at P<0.05; *** = significant at 
P<0.001. 
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Figure 3.6 The defects seen in the CD4Cre Ikk2fx/fx R26REYFP mice and the 
IKKΔTCD4 mice are T cell intrinsic 
 
Mixed haematopoietic chimeras were generated by injecting T cell depleted 
bone marrow from two different strains of donor mice into the tail vein of 
irradiated Rag1-/- hosts. In each case, bone marrow from congenic CD45.1+ 
C57BL/6 (WT) mice was combined with bone marrow from CD45.1- mice with 
floxed Ikk alleles. Some Rag1-/- hosts received a 1:1 ratio of CD45.1- CD4Cre 
Ikk2fx/fx R26REYFP bone marrow and CD45.1+ bone marrow – producing CD4Cre+ 
Ikk2fx/fx chimeras. Other hosts received a 1:1 ratio of CD45.1- CD4Cre Ikk1fx/fx 
Ikk2fx/fx R26REYFP (IKKΔTCD4) bone marrow and CD45.1+ bone marrow – 
producing CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP chimeras. The CD45.1- Cre- 
littermates of the Cre+ mice also possessed floxed Ikk alleles, and their bone 
marrow was too combined in a 1:1 ratio with CD45.1+ bone marrow - producing 
control (Cre-) chimeras. For each set of chimeras produced, the percentage of 
CD45.1- (transgenic) cells was compared with the percentage of CD45.1+ (WT) 
cells. The percentage of CD45.1- cells within different T cell subsets in the 
thymus and periphery is shown. The periphery represents T cells in both the 
LNs and spleen. Chimeras were analysed 8 weeks after receiving donor bone 
marrow.  
 
Control chimeras, (n = 4); CD4Cre+ Ikk2fx/fx chimeras, (n = 5); CD4Cre Ikk1fx/fx 
Ikk2fx/fx R26REYFP chimeras, (n = 3). Line graphs show mean percentage ± SEM. 
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Figure 3.7 An apparent gene dose effect of IKK1/2 signalling on T cell 
development and expression of the IL-7R 
 
7-26 week old huCD2iCre mice homozygous or heterozygous for floxed Ikk1 
and/or Ikk2 alleles were examined by FACS. A “+” symbol represents the 
presence of an allele whilst a “-” symbol represents its absence. The first bar of 
each graph shows mice with a complete set of Ikk1 and Ikk2 alleles. These 
mice are the Cre- littermates of the Cre+ mice, they contain varying numbers of 
floxed alleles, but no Cre recombinase. The key below the first graph also 
applies to all other graphs. (A) Graphs show T cell numbers in the LNs and 
spleen of the indicated mice. For the Cre+ mice, stacked bars are used to 
indicate the numbers of YFP+ and YFP- cells. (B) Within the LNs, naïve T cell 
populations were examined for their expression of the IL-7R. For Cre+ cells, the 
mean fluorescence intensity (MFI) of IL-7R staining was expressed as a 
percentage of that seen on “WT” cells (Cre- cells prepared, stained, and 
analysed concomitantly).  
 
Ikk1 ++ Ikk2 ++, (n = 42); Ikk1 -- Ikk2 ++, (n = 16); Ikk1 -- Ikk2 +-, (n = 12); Ikk1 
++ Ikk2 --, (n = 9); Ikk1 +- Ikk2 --, (n = 16); Ikk1 -- Ikk2 --, (n = 13). Bar charts 
show mean ± SEM. 
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Figure 3.8 Mice with a deficiency of both NF-κB1 and RelA have normal 
thymocyte development 
 
Mice with a conditional deficiency of RelA (CD4Cre Relafx/fx R26REYFP) were 
crossed with mice in which NF-κB1 had been knocked out (Nfkb1-/-) to produce 
mice deficient in both RelA and NF-κB1 (CD4Cre Relafx/fx Nfkb1-/- R26REYFP). (A) 
Moving from top to bottom, density plots show: CD4 vs CD8 expression by total 
live thymocytes; HSA vs TCR expression by CD4SP thymocytes; HSA vs TCR 
expression by CD8SP thymocytes; CD44 vs CD122 expression by 
TCRhiCD8SP thymocytes. (B) Bar charts show numbers within each thymocyte 
population for the indicated strains.  
 
Mice are 7-20 weeks old. Cre- (WT), (n = 17); CD4Cre Relafx/fx, (n = 23); Nfkb1-/-, 
(n = 19); CD4Cre Relafx/fx Nfkb1-/-, (n = 17). For all density plots, numbers 
represent the percentage of cells in the corresponding gate. Bar charts show 
mean cell number ± SEM. ns = not significant; * = significant at P<0.05; ** = 
significant at P<0.01. 
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Figure 3.9 Mice with a deficiency of both NF-κB1 and RelA have fewer 
peripheral T cells 
 
Mice with a conditional deficiency of RelA (CD4Cre Relafx/fx R26REYFP) were 
crossed with mice in which NF-κB1 had been knocked out (Nfkb1-/-) to produce 
mice deficient in both RelA and NF-κB1 (CD4Cre Relafx/fx Nfkb1-/- R26REYFP). (A) 
Moving from top to bottom, density plots show: SSc vs TCR expression by total 
live lymphocytes; CD25 vs CD44 expression by CD4+ T cells; TCR vs CD44 
expression by CD8+ T cells. (B) Combined T cell numbers within the LNs and 
spleen are shown for the indicated strains. (C) Within the LNs, naïve T cell 
populations were examined for their expression of the IL-7R. Bar charts show 
the mean fluorescence intensity (MFI) of IL-7R staining expressed as a 
percentage of that seen on “WT” cells (i.e. Cre- cells prepared, stained, and 
analysed concomitantly). Histograms underneath show the intensity of the 
fluorescent staining.  
 
Mice are 7-20 weeks old. Cre- (WT), (n = 17); CD4Cre Relafx/fx, (n = 23); Nfkb1-/-, 
(n = 19); CD4Cre Relafx/fx Nfkb1-/-, (n = 17). For all density plots, numbers 
represent the percentage of cells in the corresponding gate. Bar charts show 
mean ± SEM. ns = not significant; * = significant at P<0.05; *** = significant at 
P<0.001. 
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Table 3.1 -Chapter 3 summary- Mouse T cell phenotypes 
 
This table summarises the T cell phenotypes observed in the different strains of 
mice discussed in Chapter 3. The table refers to cell numbers among the 
different T cell subsets in the thymus and periphery (LN and spleen). An 
exception is made for IL-7R expression, whereby the table refers to the MFI of 
the IL-7R (as determined by FACS). For each mouse strain, the table takes into 
account total T cell numbers, both YFP+ and YFP-, within each T cell subset. 
Relative to wild-type mice, the T cell numbers and IL-7R MFI may either be 
“normal”, increased (shown by one or more up arrows), or decreased (shown by 
one or more down arrows). 
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Chapter 4 A role for TNF signalling in T cell 
development 
 
4.1 Introduction 
 
Inflammatory cytokines activate the canonical pathway of NF-κB signalling, 
typically resulting in the formation of RelA or c-Rel containing complexes 
(Lawrence, 2009). NF-κB may then drive transcription of genes encoding for 
cytokines, chemokines, and adhesion molecules; thus contributing towards a 
pro-inflammatory environment (Lawrence, 2009). The best-documented 
inflammatory cytokines that activate NF-κB are IL-1 and TNF. Both are 
pleiotropic cytokines that mediate a variety of biological functions.  
 
TNF, as first described in the serum of bacillus Calmette Guérin infected mice, 
was found to have anti-tumour effects (Carswell et al., 1975). Today its name 
alone, “tumour necrosis factor”, reminds us of its cytotoxic abilities. However, in 
addition to cell death, TNF can mediate a variety of effects including cell 
survival and proliferation (Varfolomeev and Ashkenazi, 2004). There are two 
receptors for TNF, TNFR1 and TNFR2, and almost every cell type expresses 
one or the other of these (Brenner et al., 2015). TNF is produced as a 
homotrimer and initially expressed as a transmembrane protein, before being 
cleaved into its soluble form. Although both membrane-bound and soluble TNF 
serve to activate TNFR1, TNFR2 responds preferentially to the transmembrane 
form (Naudé et al., 2011).  
 
TNFR1 is believed to be the main mediator of TNF induced signalling, since it is 
more widely expressed than TNFR2 (Naudé et al., 2011). Stimulation of each 
receptor results in initiation of somewhat different signalling cascades, but 
ultimately, ligation of either TNFR1 or TNFR2 can activate NF-κB. Although 
TNFR1 contains a death domain in the intracellular region, this is absent in 
TNFR2. The death domain of TNFR1 allows for recruitment of TNF receptor 
associated-protein with death domain (TRADD). TRADD can then recruit a 
 
 
158 
variety of other proteins, which allows for the formation of the two large 
complexes associated with TNFR1 signalling - complex I and complex II. 
Complex I is pro-survival. It enables recruitment of the IKK complex and leads 
to NF-κB activation. Complex II, however, results in caspase-8 activation and is 
usually pro-apoptotic. (Brenner et al., 2015). Occasionally, receptor-interacting 
protein kinase 3 (RIPK3) may can enter complex II, resulting in the formation of 
complex IIc (or the “necrosome”) and leading to necroptosis (Han et al., 2011). 
The ultimate fate of a TNFR1 stimulated cell depends on the balance between 
the complex I mediated pro-survival and the complex II mediated cell-death 
pathways. TNFR2 lacks a death domain and cannot bind TRADD. Instead it 
may recruit TNFR associated factor 1 (TRAF1) and 2 (TRAF2) and activate NF-
κB in this manner. TNFR2 cannot, however, initiate cell death (Brenner et al., 
2015).  
 
In the absence of NF-κB, many cells are sensitive to TNF induced death. This is 
perhaps best demonstrated in the case of knockout mouse strains. Mice with a 
complete deficiency of RelA, IKK2 or NEMO are all embryonic lethal due to 
massive apoptosis of fetal hepatocytes (Beg et al., 1995; Li et al., 1999b; 
1999c; Rudolph et al., 2000). However, inactivation of the genes for either 
TNFR1 or TNF has been shown to rescue the lethal phenotype of the IKK2 and 
RelA knockout mice, respectively (Doi et al., 1999; Li et al., 1999b; Senftleben 
et al., 2001b). In vitro experiments have shown that fibroblasts, macrophages, B 
cells, and a variety of cell lines, lymphoid and otherwise, are all more sensitive 
to TNF induced death when deficient in NF-κB signalling (Beg and Baltimore, 
1996; Schmidt-Supprian et al., 2000; 2003; Van Antwerp et al., 1996; Wang et 
al., 1996; Wu et al., 1996).  
 
In Chapter 3 we described the phenotype of IKKΔTCD4 mice. They were found 
to have a severe block between the HSAhi and HSAlo stages of SP thymocyte 
development. We hypothesised that the mechanism behind the block was TNF 
dependent. In the absence of NF-κB signalling, thymocytes, like many other cell 
types, are likely to be sensitive to TNF induced death. In Chapter 4 we aimed to 
test this hypothesis by blocking TNF signalling in NF-κB deficient mice in vivo.  
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4.2 Results 
 
4.2.1 In vivo blockade of TNF cytokine restores SP thymocyte 
development in IKKΔTCD4 mice 
 
We wished to test the hypothesis that thymocytes have increased sensitivity 
towards TNF induced apoptosis in the absence of NF-κB signalling. We treated 
IKKΔTCD4 mice with intraperitoneal injections of either an anti-TNF blocking 
antibody (1mg per injection) or PBS, as control, on days 0, 2, and 4, before 
analysing hosts on day 7. CD4SP HSAlo, CD8SP HSAhi and CD8SP HSAlo 
populations were all significantly reduced in the PBS treated IKKΔTCD4 mice as 
compared to the Cre- littermates (Figure 4.1). Remarkably, anti-TNF treatment 
over a one-week period restored thymocyte numbers to near WT levels. 
Numbers of CD8SP HSAlo cells in the anti-TNF treated IKKΔTCD4 mice did, 
however, remain slightly lower than in WT mice (Figure 4.1). Treating the 
IKKΔTCD4 mice with blocking antibody over a two-week period (injections on 
days 0, 2, 4, 7, 9, and 11, followed by analysis on day 14) did not further 
increase SP numbers above those obtained by one week of treatment (Figure 
4.1B).  
 
Since the anti-TNF monoclonal antibody (mAb) was unlikely to be able to 
completely block TNF signalling, we bred IKKΔTCD4 mice onto a Tnfrsf1a-/- 
background. Importantly, Tnfrsf1a-/- mice, sufficient in NF-κB signalling, exhibit 
normal thymocyte development (Figure 4.1). Compared to the IKKΔTCD4 mice, 
the Tnfrsf1a-/- IKKΔTCD4 mice showed significant rescue of the CD4SP HSAlo, 
CD8SP HSAhi and CD8SP HSAlo populations (Figure 4.1). In fact, the Tnfrsf1a-
/- IKKΔTCD4 mice, as compared to their Tnfrsf1a-/- littermates, contained normal 
SP cell numbers, with the exception of the CD8SP HSAlo cells, which remained 
slightly reduced (Figure 4.1). In conclusion, it appears that the reduction in SP 
thymocytes in IKKΔTCD4 mice can be attributed to death induced by TNF via 
TNFR1 dependent signalling.  
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4.2.2 In vivo blockade of TNF signalling in the IKKΔTCD4 mice 
causes a significant increase in naïve, peripheral T cells 
 
We next wished determine if the restoration of SP development in IKKΔTCD4 
mice also allowed the thymic emigration of new SP cells to fill the peripheral T 
cell compartment. We investigated the LNs and spleen of anti-TNF Ab or PBS 
treated IKKΔTCD4 mice. As compared to wild-type controls, the PBS treated 
IKKΔTCD4 mice had scarcely any peripheral T cells (Figure 4.2). After one week 
of anti-TNF Ab treatment, numbers of naïve cells in the IKKΔTCD4 mice were 
increased significantly. However, numbers failed to approach those observed in 
wild-type mice (Figure 4.2B). Anti-TNF Ab treatment had no apparent effect on 
numbers of regulatory or memory cells (Figure 4.2). Surprisingly, more 
prolonged treatment of mice with anti-TNF Ab for two weeks did not result in 
further increases in the naïve cell populations above those seen at the one 
week time point (Figure 4.2B).    
 
Tnfrsf1a-/- mice had a normal peripheral T cell compartment with respect to 
numbers of naïve, memory, and regulatory cells (Figure 4.2). In comparison, 
Tnfrsf1a-/- IKKΔTCD4 mice had fewer naïve and regulatory cells (Figure 4.2). 
Compared to the IKKΔTCD4 mice, the Tnfrsf1a-/- IKKΔTCD4 mice showed 
significant rescue of the naïve cell pool. However, the extent of peripheral T cell 
rescue did not reach WT levels (Figure 4.2). In IKK deficient mice, the in vivo 
blockade of TNF signalling rescued developing T cells from death and allowed 
relatively normal thymic development and egress of new T cells. However, it 
seems that peripheral T cells in IKK deficient mice may have a reduced life 
span as compared to their wild-type counterparts, and this could not be 
corrected by blocking TNF activity.  
 
4.2.3 TNF induced signalling is not essential for NF-κB 
mediated IL-7R upregulation on new T cells  
 
NF-κB activation is necessary for normal expression of the IL-7R on naïve, 
peripheral T cells (Chapter 3; Miller et al., 2014; Silva et al., 2014). Recent 
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evidence suggests that members of the TNF receptor superfamily (TNFRSF) 
can induce IL-7R expression, in an NF-κB dependent way, on SP thymocytes 
(Silva et al., 2014). TNF was found to be particularly good at inducing IL-7R 
upregulation (Silva et al., 2014). Hence, we hypothesized that naïve T cells, 
which had experienced a lack of TNF signalling during development, may 
exhibit reduced IL-7R expression.  
 
To test our hypothesis, we treated C57BL/6 wild-type mice with either anti-TNF 
blocking antibody or PBS control over a one-week period (according to the 
previously described protocol). Cell numbers in the thymus and periphery of the 
wild-type mice were not affected by the anti-TNF Ab treatment (Figure 4.3A; 
data not shown). Furthermore, expression of the IL-7R was not significantly 
reduced by the anti-TNF blockade (Figure 4.3B, top; Figure 4.3C). Next, we 
examined IL-7R levels on naïve T cells that lacked expression of TNFR1. IL-7R 
expression on the naïve T cells of Tnfrsf1a-/- mice was similar to that of wild-
type controls (Figure 4.3B, bottom; Figure 4.3C). Therefore, it seems that TNF 
does not play an essential, non-redundant role in the normal upregulation of the 
IL-7R during T cell development.  
 
We next examined IL-7R expression on the naïve T cells of Tnfrsf1a-/- IKKΔTCD4 
mice and anti-TNF Ab treated IKKΔTCD4 mice. As established in Chapter 3, the 
CD4 naïve cells of IKKΔTCD4 mice have low IL-7R expression, whilst the CD8 
naïve cells have levels near to those of WT cells. Interestingly, when the 
IKKΔTCD4 mice were either treated with anti-TNF blocking Ab or bred onto a 
TNFR1 knockout background, expression of the IL-7R on the CD8 naïve cells 
was further reduced (Figure 4.3B, middle & bottom; Figure 4.3C). Blocking 
TNF signalling in the IKK deficient mice has been shown to significantly 
increase the number of CD8 naïve cells (Figure 4.2). Furthermore, the 
percentage of cells expressing YFP increased greatly as a result of blocking 
TNF signalling (data not shown). This suggests that the naïve CD8 T cells 
detectable in IKKΔTCD4 mice had not completely deleted their Ikk1 and Ikk2 
genes. By blocking TNF signalling with mAb or by deletion of TNFR1, the 
selection pressure for incomplete deletion (i.e. TNF induced death) was 
removed, allowing emergence of IKK deficient CD8 naïve T cells.  
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4.2.4 The TNF dependent block in SP thymocyte development is 
a result of reduced NF-κB activation 
 
In murine embryonic fibroblasts, the IKK complex has been reported to prevent 
TNF induced death in an NF-κB independent manner (Yan et al., 2013). 
Therefore, it was important to determine whether or not the TNF induced death, 
observed in IKKΔTCD4 mice, was truly due to lack of NF-κB activation. pLck-IκB-
PEST mice express a dominant negative form of IκBα under the control of the 
proximal Lck (pLck) promoter, resulting in a T cell specific inhibition of NF-κB 
activity (Voll et al., 2000). Mice expressing a super-inhibitory form of IκBα have 
a significant reduction in CD8SP thymocytes (Boothby et al., 1997; Esslinger et 
al., 1997; Hettmann and Leiden, 2000; Voll et al., 2000). Analysing the thymus 
of pLck-IκB-PEST mice revealed that the reduction in CD8SP numbers was 
actually due to loss of the more mature HSAlo subset (Figure 4.4). We treated 
pLck-IκB-PEST mice with anti-TNF blocking Ab or PBS control for one week. 
Blocking TNF signalling in this manner completely restored the numbers of 
CD8SP HSAlo thymocytes (Figure 4.4). Both IKKΔTCD4 mice and pLck-IκB-
PEST mice exhibit a TNF dependent block in SP thymocyte maturation. 
Together, this suggests that the block in SP development is indeed due to a 
lack of NF-κB activation. 
 
Assessment of the LNs and spleen of pLck-IκB-PEST mice revealed normal 
numbers of CD4+ cells, but a significant reduction in both the CD8 naïve and 
memory populations (Figure 4.5A & B). Treatment of the pLck-IκB-PEST mice 
with anti-TNF blocking Ab for one week failed to rescue peripheral T cell 
numbers (Figure 4.5A & B). Perhaps this is not surprising, as thymic output is 
unlikely to be sufficient over such a short time period to have a significant 
impact on the overall size of the peripheral pool. 
 
The pLck-IκB-PEST mice have previously been described as having reduced 
expression of the IL-7R on their naïve T cells (Silva et al., 2014). We also found 
evidence of this: with IL-7R expression on the CD4 naïve cells reduced to 
approximately 36.8% (± 2.4%) of normal and expression on the CD8 naïve cells 
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reduced to just 28.7% (± 2.7%) of normal. Treatment of pLck-IκB-PEST mice 
with anti-TNF blocking Ab had no effect on IL-7R expression (Figure 4.5C).  
  
4.2.5 In vivo blockade of TNF signalling fails to rescue IKK1 or 
IKK2 deficient B cells 
 
We wondered whether the requirement for NF-κB in T cells reflected a more 
general requirement in developing lymphocytes. Therefore we chose to 
examine the effect of blocking TNF signalling on B cell development in IKK 
deficient mice. The huCD2 promoter and locus control region drive Cre 
mediated recombination of target genes from the DN2 stage of T cell 
development and very early in B cell development (de Boer et al., 2003). To 
investigate the effect of NF-κB deficiency in B cells we examined huCD2iCre 
Ikk1fx/fx R26REYFP mice and huCD2iCre Ikk2fx/fx R26REYFP mice. These strains 
have a deficiency in either IKK1 or IKK2 in both the T and B cell lineages.  
 
Examining the bone marrow of huCD2iCre Ikk1fx/fx R26REYFP mice and huCD2iCre 
Ikk2fx/fx R26REYFP mice revealed that both strains had a severe reduction in the 
number of recirculating and mature B cells (Figure 4.6). Mature B cell numbers 
in the spleens of the IKK1 and IKK2 deficient mice were also reduced due to 
loss of both follicular and marginal zone populations (Figure 4.6B).   
 
The block in T cell development in NF-κB deficient mice can be overcome by in 
vivo blockade of TNF signalling (Figure 4.1). We therefore hypothesized that 
the block in B cell development may also be TNF dependent. To test this we 
treated huCD2iCre Ikk1fx/fx R26REYFP mice and huCD2iCre Ikk2fx/fx R26REYFP mice 
with anti-TNF blocking Ab or PBS control over the course of one week. 
However, blocking TNF signalling had no effect on B cell development. The 
number of IgD+ mature cells in the bone marrow remained equally low, 
regardless of whether the mice had received anti-TNF or not (Figure 4.6). The 
recirculating population of B cells in the bone marrow was also unaffected by 
Ab treatment, as were mature B cell populations in the spleen (Figure 4.6). 
Since the defects in B cell development could not be overcome by TNF 
 
 
164 
blockade, we conclude that B cells have requirements for IKK activity that are 
distinct from T cells.  
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4.3 Discussion 
 
In this chapter we tested the hypothesis that NF-κB activation protects 
developing T cells from TNF induced cell death. TNF signalling was blocked in 
IKKΔTCD4 mice, firstly by treatment with anti-TNF mAb and secondly by deletion 
of TNFR1. In both cases, SP thymocyte development was restored (Figure 
4.1). In comparison, blocking TNF signalling in IKK sufficient mice had no 
noticeable effect. Wild-type mice treated with anti-TNF blocking Ab and 
Tnfrsf1a-/- mice both had normal numbers of SP thymocytes, showing no 
increase in cell number with respect to untreated, wild-type animals (Figure 4.1; 
Figure 4.3A). These results suggest that TNF is indeed killing SP thymocytes, 
but only when activity of the IKK complex is impaired (Schematic 4.1). In 
murine embryonic fibroblasts, the IKK complex has previously been reported to 
prevent TNF induced death in a manner independent of NF-κB (Yan et al., 
2013). Therefore, we used pLck-IκB-PEST mice to further test our hypothesis 
that NF-κB activation protects thymocytes from TNF induced death. pLck-IκB-
PEST mice have a block in NF-κB signalling at the level of IκBα degradation, as 
opposed to at the level of IKK complex formation. As with the IKKΔTCD4 mice, 
blocking TNF signalling in pLck-IκB-PEST mice also restored SP thymocyte 
development (Figure 4.4). Therefore, we are confident that NF-κB activation, 
mediated by IKK complex formation and IκBα degradation, is needed to protect 
developing T cells from TNF induced cell death.  
 
Importantly, TNF induced death in the absence of NF-κB signalling does not 
appear to be a generalised lymphocyte feature. The bone marrow of huCD2iCre 
Ikk1fx/fx R26REYFP mice and huCD2iCre Ikk2fx/fx R26REYFP mice was found to 
contain reduced numbers of mature B cells (Figure 4.6). Blocking TNF 
signalling in these mice failed to rescue cell numbers (Figure 4.6). Hence, in 
IKK deficient mice, the block in B cell development, unlike that in T cell 
development, appeared to be independent of TNF.  
 
IKKΔTCD4 mice had very few peripheral T cells. Initially, we hypothesised that 
the block in SP thymocyte development may alone account for the lack of 
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peripheral cells. Treating IKKΔTCD4 mice for one week with anti-TNF mAb did 
lead to a significant increase in naïve cells, but failed to restore peripheral T cell 
numbers to anywhere near wild-type levels (Figure 4.2). Thymic output was 
unlikely to be great over this short time period; therefore we also treated 
IKKΔTCD4 mice with mAb for two weeks. Surprisingly, treatment for two weeks 
did not further restore peripheral cell numbers beyond those of the one-week 
treated mice (Figure 4.2). Finally, we investigated the peripheral T cell 
compartment of Tnfrsf1a-/- IKKΔTCD4 mice. While total peripheral T cell numbers 
were greater in Tnfrsf1a-/- IKKΔTCD4 mice than anti-TNF Ab treated IKKΔTCD4 
mice, they still remained below those of Tnfrsf1a-/- or WT controls (Figure 4.2). 
In IKK deficient mice, the loss of SP thymocytes can be attributed to TNF 
induced death. However, the loss of peripheral T cells is likely due to a 
combination of factors. Reduced thymic output and possibly also TNF induced 
death of naïve cells can only partially account for low peripheral cell numbers.  
 
A lack of NF-κB signalling during T cell development results in the production of 
naïve cells that are deficient in IL-7R expression (Chapter 3; Miller et al., 2014; 
Silva et al., 2014). Since the maintenance of naïve cells depends heavily on IL-
7 survival signals (Jameson, 2005), the decreased IL-7R expression among this 
population is likely to account for much peripheral cell loss. In addition, IKK2 
deficient cells have been reported to show poor homeostatic proliferation 
(Schmidt-Supprian et al., 2004), and even a slight deficiency in NF-κB signalling 
has been show to reduce CD4+ memory and regulatory cell numbers (Chen et 
al., 2015; Schmidt-Supprian et al., 2003). We conclude that the lack of 
peripheral cells in our NF-κB signalling deficient mice is due to numerous 
factors.   
 
In Chapter 3 we described the generation of mixed bone marrow chimeras, 
whereby we reconstituted Rag1-/- hosts with bone marrow from congenically 
marked WT and IKKΔTCD4 mice. WT T cells showed normal development and 
peripheral expansion. However, the IKK deficient cells were blocked at the SP 
stage of thymocyte development – just as T cells in the intact IKKΔTCD4 mice 
had been. Importantly, this result showed us that the phenotype of the 
IKKΔTCD4 mice was not simply the product of unusually high TNF expression in 
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the thymus (a possibility, although TNF levels were not measured). When 
placed in a normal thymic environment the IKK deficient cells behaved exactly 
the same, whereas wild-type cells were unaffected.   
 
Conventionally, macrophages are the largest producers of TNF (Chen and 
Goeddel, 2002) - although this may not be true in the thymic microenvironment. 
TNF production in the thymic medulla can be mediated by medullary thymic 
epithelial cells, conventional dendritic cells and plasmacytoid dendritic cells 
(Mahmud et al., 2014). Furthermore, in adult mice, evidence suggests that even 
the thymocytes themselves are producers of TNF (Giroir et al., 1992). In the 
periphery, TNF may be synthesized by activated CD4+ and CD8+ T cells 
(Chatzidakis and Mamalaki, 2010).  
 
TNF has been found to induce IL-7R expression on developing T cells in an NF-
κB dependent manner (Silva et al., 2014). This suggests a functional role for 
TNF in the thymus. However, naïve T cells that had matured in the complete 
absence of TNFR1 signalling were found to have normal levels of IL-7R 
expression (Figure 4.3B & C). Of note, TNF is not the only TNFSF member that 
can cause upregulation of the IL-7R (Silva et al., 2014). There is clearly 
potential for a large amount of redundancy among TNFSF members, hence the 
normal IL-7R expression in TNFR1 knockout mice and anti-TNF Ab treated WT 
mice (Figure 4. 3B & C).      
 
NEMO is a key structural component of the IKK complex and an absence of 
NEMO, just like an absence of both IKK1 and IKK2, prevents NF-κB activation. 
Our IKK deficient mice closely phenocopy the previously described NEMO 
deficient mice (Schmidt-Supprian et al., 2003). This suggests that the block in 
SP development in the NEMO deficient animals may also be TNF dependent 
and may similarly be overcome by preventing signalling through TNFR1.  
 
In response to TCR, TLR, or inflammatory cytokine signalling, the MAP3 kinase, 
TGFβ activating kinase 1 (TAK1), can contribute to the activation of the NF-κB 
and JNK pathways. It does this via phosphorylation of the IKK complex or 
MKK6 (Wang et al., 2001). Interestingly, mice with a T cell specific deficiency of 
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TAK1 share a similar phenotype to mice with a T cell specific deficiency of 
NEMO or of both IKK1 and IKK2. The TAK1 deficient mice have a severe 
reduction in numbers of SP thymocytes (largely due to loss of the HSAlo 
subpopulations) and scarcely any peripheral T cells (Liu et al., 2006; Wan et al., 
2006). The reduction in SP thymocytes was attributed to a block in TCR and IL-
7 induced NF-κB activity in the absence of TAK1 expression (Wan et al., 2006). 
However, mice with a conditional loss of either IL-7 or TCR signalling at the DP 
stage of thymocyte development did not phenocopy the TAK1 deficient mice 
(McCaughtry et al., 2012; Sinclair and Seddon, 2014). We speculate that the 
phenotype of the TAK1 deficient mice is also due to TNF induced death.  
 
Senftleben et al. have previously claimed a cell autonomous role for IKK2 in the 
protection of thymocytes from TNF induced apoptosis (Senftleben et al., 
2001b). Ikk2-/- fetal liver stem cells were transferred into irradiated hosts. Six 
weeks later, thymic structure was found to be severely perturbed in the Ikk2-/- 
chimeras, with very few DN and DP cells being present and a complete 
absence of SP cells. However, co-transfer of wild-type bone marrow along with 
the Ikk2-/- stem cells reversed the defect, allowing IKK2 deficient T cells to 
develop and populate the periphery. It was suggested that the presence of the 
WT thymocytes prevented excess TNF production in the donor mice and that 
the IKK2 deficient cells were therefore protected from TNF induced apoptosis. 
Ikk2-/- Tnfr1-/- mice were then analyzed and found to have normal T cell 
development, which the authors claimed to further support a cell autonomous 
role for IKK2 in the protection from TNF (Senftleben et al., 2001b). The 
huCD2iCre Ikk2fx/fx R26REYFP mice that we studied were found to have normal 
thymocyte development, suggesting that a deficiency of IKK2 from the DN2 
stage of thymocyte development onwards does not render thymocytes 
susceptible to TNF induced death. We speculate that the lack of thymocytes in 
the Ikk2-/- radiation chimeras of Senftleben et al. could be due to TNF induced 
death of common lymphoid progenitors. 
 
Mice expressing a lymphoid specific, dominant negative form of IκBα display 
variable phenotypes. The extent of the block in NF-κB signalling in these mice is 
transgene dose dependent: notably, animals expressing 80 copies of IκBα per 
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haploid chromosome complement have more severe phenotypes than those 
expressing 25 copies (Esslinger et al., 1997). The pLck-IκB-PEST mice we 
studied had a severe reduction in CD8SP cells in the thymus, but CD4SP cells 
were not significantly affected (Figure 4.4). This serves to further support the 
pre-existing idea that CD8+ T cells have a greater requirement for NF-κB 
signalling than CD4+ T cells (Boothby et al., 1997; Esslinger et al., 1997; 
Hettmann and Leiden, 2000; Schmidt-Supprian et al., 2003; Silva et al., 2014). 
Perhaps this is to be expected, given that CD8SP thymocytes have more 
transcriptionally active NF-κB than CD4SP thymocytes (Voll et al., 2000).  
 
The reduction in the number of CD8SP thymocytes in mice expressing the 
dominant negative form of IκBα has previously been attributed to poor positive 
selection in the absence of NF-κB (Esslinger et al., 1997; Hettmann and Leiden, 
2000; Jimi et al., 2008). However, through close examination of pLck-IκB-PEST 
mice, we found that the reduction in CD8SP numbers could largely be attributed 
to loss of the more mature HSAlo subset, with the HSAhi subset being hardly 
affected (Figure 4.4). This finding alone suggested that the CD8 lineage had 
undergone normal positive selection. Furthermore, by blocking TNF signalling in 
our pLck-IκB-PEST mice, we were able to completely restore the CD8SP 
population (Figure 4.4). Such evidence suggested that the reduction in CD8SP 
cells, seen in mice expressing the dominant negative form of IκBα, was due to 
TNF induced cell death in the absence of NF-κB signalling. As to whether NF-
κB has any role to play in the positive selection of DP thymocytes remains a 
mystery, with more convincing evidence now required.  
 
The development of a mature T cell requires a series of differentiation steps. 
High levels of NF-κB activation have long been reported in thymocytes, thereby 
suggesting a role for this transcription factor in T cell development (Voll et al., 
2000). This concept is well supported by the phenotype of our IKKΔTCD4 mice, 
in which T cell development is arrested at the late SP stage. Furthermore, it 
seems that TNF and other members of the TNFSF may play an NF-κB 
dependent role in the generation of new T cells (Silva et al., 2014). Signalling 
induced by ligation of the TNFR seems to provide a link to NF-κB activation and 
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subsequent induction of maturational cues, such as IL-7R upregulation (Silva et 
al., 2014). 
 
From experiments performed in this chapter, we cannot definitively state the 
role of NF-κB in developing thymocytes. It seems that there are two 
possibilities. The first is that NF-κB signalling is needed to actively protect 
thymocytes from TNF induced death. The second is that NF-κB signalling is 
required at discrete stages during T cell development in order to produce a 
population of cells resistant to the cytotoxic effects of TNF. In Chapter 5 we 
shall investigate whether an acute (as opposed to developmental) block in NF-
κB signalling can render thymocytes sensitive to TNF induced death. 
Furthermore, the phenotype of our NF-κB deficient mice suggests that certain 
thymocyte subpopulations are more susceptible to the cytotoxic effects of TNF 
than others (Figure 4.1; Figure 4.4). This increased susceptibility may be cell 
intrinsic, or it may be due to the anatomical location of TNF production within 
the thymus. In Chapter 5 we shall investigate this through the use of in vitro 
studies. Finally, we shall investigate the effect of TNF and other TNFSF 
members on thymocytes in vitro, in an attempt to determine possible 
physiological roles for these ligands in T cell development.  
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Figure 4.1 Blocking TNFR signalling in IKKΔTCD4 mice rescues thymocyte 
development 
 
7-18 week old CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP (IKKΔTCD4) mice were treated 
over a period of either 7 days or 14 days with a blocking antibody towards TNF 
or with PBS vehicle. Mice treated for 7 days received, in total, 3mg of antibody 
via three I.P. injections. Mice treated for 14 days received twice the amount of 
antibody and injections. At the end of treatment, animals were culled and 
analysed by FACS. Untreated, Cre- (WT) littermates were analysed in parallel. 
For a more complete block in TNFR signalling, IKKΔTCD4 mice were bred onto a 
TNFR1 knockout background. (A) T cell populations in the thymus were 
examined. Moving from top to bottom, density plots show: CD4 vs CD8 
expression by TCRhiCD5hi thymocytes; HSA vs TCR expression by CD4SP 
thymocytes; HSA vs TCR expression by CD8SP thymocytes. (B) Total numbers 
of CD4SP and CD8SP thymocytes within the HSAhi and HSAlo gated 
populations are shown.  
 
WT, (n = 17); IKKΔTCD4 PBS treated (n = 21); IKKΔTCD4 αTNF treated, 7 days, 
(n = 16); IKKΔTCD4 αTNF treated, 14 days (n = 8); Tnfrsf1a-/- (n = 13); Tnfrsf1a-/- 
IKKΔTCD4 (n = 16). Data are representative of a number of independent 
experiments. For all density plots, numbers represent the percentage of cells in 
the corresponding gate. Bar charts show mean cell number ± SEM. ns = not 
significant; * = significant at P<0.05; ** = significant at P<0.01; *** = significant 
at P<0.001. 
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Figure 4.2 Blockade of TNFR signalling in IKKΔTCD4 mice causes limited 
rescue of peripheral T cell numbers  
 
7-18 week old CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP (IKKΔTCD4) mice were treated 
over a period of either 7 days or 14 days with a blocking antibody towards TNF 
or with PBS vehicle. Mice treated for 7 days received, in total, 3mg of antibody 
via three I.P. injections. Mice treated for 14 days received twice the amount of 
antibody and injections. At the end of treatment, animals were culled and 
analysed by FACS. Untreated, Cre- (WT) littermates were analysed in parallel. 
For a more complete block in TNFR signalling, IKKΔTCD4 mice were bred onto a 
TNFR1 knockout background. (A) T cell populations in the LNs were examined. 
Density plots on top show CD5 vs TCR expression by total live lymphocytes. 
Density plots in the middle show CD25 vs CD44 expression by 
TCRhiCD5hiCD4+ cells. Density plots on the bottom show TCR vs CD44 
expression by TCRhiCD5hiCD8+ cells. (B) Numbers of T cells in the periphery 
(LNs & spleen combined) were calculated for all mice.  
 
WT, (n = 17); IKKΔTCD4 PBS treated (n = 21); IKKΔTCD4 αTNF treated, 7 days, 
(n = 16); IKKΔTCD4 αTNF treated, 14 days (n = 8); Tnfrsf1a-/- (n = 13); Tnfrsf1a-/- 
IKKΔTCD4 (n = 16). Data are representative of a number of independent 
experiments. For all density plots, numbers represent the percentage of cells in 
the corresponding gate. Bar charts show mean cell number ± SEM. ns = not 
significant; * = significant at P<0.05; ** = significant at P<0.01; *** = significant 
at P<0.001. 
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Figure 4.3 TNF induced signalling is not essential for NF-κB mediated IL-
7R upregulation on new T cells 
 
C57BL/6 (WT) mice were treated over a period of 7 days with either anti-TNF 
blocking Ab or PBS vehicle. CD4Cre Ikk1fx/fx Ikk2fx/fx R26REYFP (IKKΔTCD4) mice 
were treated for either 7 days or 14 days with anti-TNF blocking antibody or with 
PBS vehicle. Cre- (WT) littermates of IKKΔTCD4 mice were left untreated, as 
were Tnfrsf1a-/- mice and Tnfrsf1a-/- IKKΔTCD4 mice. (A) Bar charts show 
thymocyte numbers for the 7 day anti-TNF or PBS treated C57BL/6 (WT) mice. 
(B) Histograms show relative expression levels of the IL-7R on the naïve T cells 
within the LNs of the indicated mice. (C) The mean fluorescence intensity (MFI) 
of IL-7R staining on the naïve T cells within the LNs of the indicated mice was 
expressed as a percentage of that seen on “WT” cells (i.e. cells from untreated, 
WT mice prepared, stained, and analysed in parallel). 
 
Mice were 10-23 weeks old upon analysis. C57BL/6 (WT) PBS treated, 7 days, 
(n = 4); C57BL/6 (WT) αTNF treated, 7 days, (n = 4); Cre- (WT), (n = 17); 
IKKΔTCD4 PBS treated (n = 20); IKKΔTCD4 αTNF treated, 7 days, (n = 16); 
IKKΔTCD4 αTNF treated, 14 days (n = 8); Tnfrsf1a-/- (n = 13); Tnfrsf1a-/- 
IKKΔTCD4 (n = 14). Data are representative of a number of independent 
experiments. Bar charts show mean ± SEM. ns = not significant. 
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Figure 4.4 Mice expressing a super-inhibitory form of IκBα have a defect 
in the later stages of CD8SP thymocyte development, which may be 
overcome by blocking TNF  
 
7-16 week old pLck-IκB-PEST mice, which express a super-inhibitory form of 
IκBα under the control of the pLck promoter, were treated for 7 days with an 
anti-TNF blocking antibody or with PBS control. Untreated WT littermates, 
lacking the IκBα super-inhibitor, were analysed in parallel. (A) From top to 
bottom, thymic profiles show: CD4 vs CD8 expression by total live thymocytes; 
CD5 vs TCR expression by total live thymocytes; CD4 vs CD8 expression by 
TCRhiCD5hi thymocytes; HSA vs TCR expression by CD4SP thymocytes; HSA 
vs TCR expression by CD8SP thymocytes. (B) Cell numbers within the 
indicated thymocyte populations are shown.   
 
WT, (n = 4); pLck-IκB-PEST, PBS treated (n = 8); pLck-IκB-PEST, αTNF 
treated (n = 8). The experiment was repeated twice with similar results. Bar 
charts represent data from both experiments. For all density plots, numbers 
represent the percentage of cells in the corresponding gate. Bar charts show 
mean cell number ± SEM. ns = not significant; * = significant at P<0.05; *** = 
significant at P<0.001. 
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Figure 4.5 Blocking TNF signalling in mice expressing a super-inhibitory 
form of IκBα fails to restore peripheral T cell numbers  
 
7-16 week old pLck-IκB-PEST mice, which express a super-inhibitory form of 
IκBα under the control of the pLck promoter, were treated for 7 days with an 
anti-TNF blocking antibody or with PBS control. Untreated WT littermates, 
lacking the IκBα super-inhibitor, were analysed in parallel. (A) From top to 
bottom, LN profiles show: CD5 vs TCR expression by total live lymphocytes; 
CD4 vs CD8 expression by TCRhiCD5hi cells; CD25 vs CD44 expression by 
CD4+ T cells; TCR vs CD44 expression by CD8+ T cells. (B) Peripheral T cell 
numbers (LNs and spleen combined) within the indicated populations are 
shown. (C) The mean fluorescence intensity (MFI) of IL-7R staining on naïve T 
cells from the LNs of the indicated mice was expressed as a percentage of that 
seen on WT cells.  
 
WT, (n = 5); pLck-IκB-PEST, PBS treated (n = 8); pLck-IκB-PEST, αTNF 
treated (n = 8). The experiment was repeated twice with similar results. Bar 
charts represent data from both experiments. For all density plots, numbers 
represent the percentage of cells in the corresponding gate. Bar charts show 
mean ± SEM. ns = not significant; * = significant at P<0.05; ** = significant at 
P<0.01; *** = significant at P<0.001. 
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Figure 4.6 TNF induced apoptosis cannot account for the block in B cell 
development in huCD2iCre Ikk1fx/fx R26REYFP mice and huCD2iCre Ikk2fx/fx 
R26REYFP mice 
 
8 week old huCD2iCre Ikk1fx/fx R26REYFP mice and 7 week old huCD2iCre Ikk2fx/fx 
R26REYFP mice were treated for 7 days with an anti-TNF blocking antibody or 
with PBS vehicle. Cre- (WT) littermates were left untreated. B cell populations in 
the bone marrow and spleen were then assessed. (A) FACS plots show B cell 
populations in the bone marrow of huCD2iCre Ikk2fx/fx R26REYFP mice treated 
with PBS or αTNF and an untreated Cre- littermate. From top to bottom, density 
plots show: B220 vs IgM expression by total live lymphocytes; B220 vs CD19 
expression by total live lymphocytes; IgD vs IgM expression by B220hiCD19hi 
cells; CD2 vs IgM expression by IgD- B cells. The key shows the different B cell 
populations within the bone marrow. (B) Bar charts show B cell numbers within 
the bone marrow (top) or spleen (bottom) of PBS and αTNF treated huCD2iCre 
Ikk1fx/fx R26REYFP mice or huCD2iCre Ikk2fx/fx R26REYFP mice and cell numbers in 
untreated Cre- (WT) littermates. 
 
Cre- (WT) littermates of huCD2iCre Ikk1fx/fx R26REYFP mice, (n = 2); huCD2iCre 
Ikk1fx/fx R26REYFP PBS treated mice, (n = 2); huCD2iCre Ikk1fx/fx R26REYFP αTNF 
treated mice, (n = 3); Cre- (WT) littermates of huCD2iCre Ikk2fx/fx R26REYFP mice, 
(n = 3); huCD2iCre Ikk2fx/fx R26REYFP PBS treated mice, (n = 3); huCD2iCre 
Ikk2fx/fx R26REYFP αTNF treated mice, (n = 3). For all density plots, numbers 
represent the percentage of cells in the corresponding gate. Bar charts show 
mean cell number ± SEM. ns = not significant; * = significant at P<0.05; ** = 
significant at P<0.01; *** = significant at P<0.001. 
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Schematic 4.1 -Chapter 4 summary- A balance between TNF induced 
survival and death 
  
In wild-type, mature SP thymocytes there is a fine balance between TNF 
induced production of pro-survival proteins and TNF induced activation of pro-
death pathways. When NF-κB signalling is intact, TNF does not cause death of 
mature SP thymocytes. However, in IKK deficient, mature SP thymocytes TNF 
induced pro-death pathways cannot be inhibited and the cell dies.  
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Chapter 5 Activation of NF-κB signalling by 
the TNF receptor superfamily regulates 
thymocyte development 
 
5.1 Introduction 
 
NF-κB activation has a major role to play in proliferation, inflammation, and the 
prevention of apoptosis. For this reason, constitutive activation of the NF-κB 
signalling pathway has been held accountable for numerous human maladies, 
including cancer and chronic inflammatory diseases (Hayden and Ghosh, 
2012). Much effort has been devoted to the development of NF-κB inhibitors 
and today over 700 are recognized (Gilmore and Herscovitch, 2006; Kwak et 
al., 2011). Despite the vast number of different inhibitors, they can be broadly 
classed into a few neat categories according to their mode of action. As Gilmore 
and Herscovitch explain: there are those that work upstream of the IKK complex 
(including those that block receptor signalling); those that work at the level of 
the IKK complex or IκB phosphorylation; those that prevent the degradation of 
IκB; those that inhibit the nuclear translocation of NF-κB; those that prevent the 
binding of NF-κB to DNA; and those that inhibit NF-κB dependent gene 
expression itself (Gilmore and Herscovitch, 2006). Due to its very central 
location in the NF-κB signalling pathway, and the fact that it acts to integrate 
numerous upstream signals, the IKK complex is a prime target for inhibition.    
  
The ability of an inhibitor to block NF-κB signalling is usually measured by its 
IC50 value (the concentration of inhibitor required for a 50% inhibition of NF-κB 
activity) (Kwak et al., 2011). This is determined via tissue culture following 
stimulation of cells with a strong inducer of NF-κB activation, such as TNF, IL-1, 
or LPS (Gilmore and Herscovitch, 2006). Indeed, the fact that TNF is such a 
good activator of NF-κB makes it a potential target for inhibition in a number of 
NF-κB related diseases. For example, anti-TNF blocking antibodies are in 
current clinical use for the treatment of inflammatory bowel disease, Crohn’s 
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disease, and arthritis (Gilmore and Herscovitch, 2006). In the clinic, the success 
of TNF inhibitors has generated recent interest in other TNF related cytokines 
and their receptors as potential clinical targets. 
 
The tumour necrosis factor superfamily (TNFSF) consists of 19 cytokines, which 
interact with one or more of 29 receptors belonging to the tumour necrosis 
factor receptor superfamily (TNFRSF) (Aggarwal et al., 2012). The TNFSF 
members, in order of discovery, are: TNF (also known as TNF-α), TNF-β (also 
known as lymphotoxin-α), lymphotoxin-β, CD40L, FasL, CD30L, 4-1BBL, 
CD27L, OX40L, TRAIL, LIGHT, RANKL, TWEAK, APRIL, BAFF, TLA1, EDA-
A1, EDA-A2, and GITRL (Aggarwal et al., 2012). All TNFSF members are pro-
inflammatory, a function at least partially mediated by activation of NF-κB 
(Aggarwal et al., 2012). Other possible outcomes of TNFSF ligation include 
proliferation, angiogenesis, metastasis, morphogenesis, and apoptosis 
(Aggarwal et al., 2012). Blocking antibodies against many TNFSF ligands and 
receptors are in current clinical use. Anti-CD30 antibodies can be used in the 
treatment of cancer, anti-RANKL antibodies are administered in patients with 
osteoporosis, and anti-BAFF antibodies are believed to be beneficial in the 
treatment of systemic lupus erythematosus (SLE) (Croft et al., 2013). 
 
TNFRSF members fall into two main categories – those that contain an 
intracellular death domain (DD) and those that do not (Aggarwal et al., 2012). 
The DD is normally composed of around 45 amino acids and acts to recruit 
various proteins that ultimately lead to the induction of cell death. Six TNFRSF 
members contain the DD: TNFR1 (DR1); Fas (DR2); DR3, which binds VEGI; 
DR4 and DR5, which bind TRAIL; and DR6, which binds no identified ligand 
(Aggarwal et al., 2012). The TNFSF is unusual in that many of its members are 
primarily expressed as transmembrane proteins rather than in their soluble 
forms. FasL, CD27L, CD30L, CD40L, OX40L, and 4-1BBL are all largely 
membrane associated (Aggarwal et al., 2012). For this reason they can engage 
in the act of “reverse signalling”, whereby a signal is transmitted from the 
receptor to the cell expressing the membrane bound ligand (Aggarwal et al., 
2012).  
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Although the TNFSF has known functions in the cardiovascular, pulmonary, 
neurological, and metabolic systems, the highest expression of both ligands 
and receptors is found among cells of the immune system (Aggarwal et al., 
2012). BAFF and APRIL both help to control the survival of peripheral B cells, 
and BAFF plays an additional role in B cell maturation (Mackay and Schneider, 
2009). The receptor CD40 induces inflammatory cytokine production in 
macrophages and dendritic cells (Croft et al., 2013). LIGHT interacts with the 
HVEM receptor on T cells and increases the magnitude of a T cell response 
(Croft et al., 2013). TWEAK and its receptor help to enable interactions between 
immune and non-immune cells (Croft et al., 2013). In fact, every TNFSF 
member contributes, in some respect, to regulation of the immune system (Croft 
et al., 2013).  
 
Perhaps unsurprisingly, TNFRSF members have been shown to be important in 
the thymus. Notably, DR5 deficient mice have enlarged thymii (Aggarwal et al., 
2012). However, arguably the most well described thymic role for TNFRSF 
members is in the production of regulatory T cells. GITR, OX40, TNFR2, and 
CD27 have all been implicated in the development of thymic Treg cells (Coquet 
et al., 2013; Mahmud et al., 2014). Ligands for all of these receptors are 
produced in the thymic medulla by dendritic cells and medullary epithelial cells 
(Coquet et al., 2013; Mahmud et al., 2014). Signalling via CD27 is important 
during the positive selection of thymic Treg cells, when it acts to inhibit the 
mitochondrial apoptosis pathway (Coquet et al., 2013). Consequently, both 
CD27 deficient and CD27L deficient mice have reduced numbers of thymic and 
peripheral Treg cells (Coquet et al., 2013). GITR, OX40, and TNFR2 are all 
upregulated on Treg cells during their thymic development (Mahmud et al., 
2014). Expression of these TNFRSF members by Treg cells was found to 
correlate with the strength of signalling via the TCR (Mahmud et al., 2014). 
While deletion of GITR, OX40, or TNFR2 alone did not cause any reductions in 
Treg cell numbers, the combined inhibition of all three prevented Treg cell 
development (Mahmud et al., 2014). This serves to highlight the biological 
redundancy that exists among the TNFSF.  
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In Chapter 4 we established that our IKKΔTCD4 mice had few HSAlo SP 
thymocytes due to the TNF induced death of this population. TNF is present in 
the thymus, and evidence suggests that it does play a role in T cell 
development (Chatzidakis and Mamalaki, 2010; Mahmud et al., 2014; Silva et 
al., 2014). In this chapter we investigated the effects of TNF and other TNFSF 
members on SP thymocytes in vitro. In Chapter 4 we used a purely genetic 
approach to inhibit NF-κB signalling in T cells in vivo. In this chapter we used a 
combined genetic and pharmacological approach in order to acutely block NF-
κB signalling in thymocytes in vitro. This enabled us to determine whether or not 
NF-κB was actively required for the protection of SP thymocytes from TNF 
induced death. Furthermore, in vitro experiments allowed us to investigate 
whether certain SP subsets were intrinsically more sensitive to TNF induced 
death than others.   
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5.2 Results 
 
5.2.1 Mature thymocytes from IKKΔTCD4 mice are susceptible to 
TNF induced death in vitro 
 
From the phenotype of the intact IKKΔTCD4 mice, it appeared that certain 
thymocyte populations might be more susceptible to TNF induced death than 
others. We hypothesized that the increased susceptibility may either be cell 
intrinsic or may be due to the location of TNF production within the thymus. To 
investigate this we used an in vitro approach. Suspensions of whole, mashed 
thymii were cultured for 24hr in the presence of 30ng/mL recombinant murine 
TNF (Figure 5.1A). This removed any anatomical restrictions, thereby ensuring 
equal availability of the different thymocyte populations to TNF cytokine.  
  
IKKΔTCD4 mice have very few SP thymocytes, which we attributed to TNF 
induced death. We were therefore concerned that the small number of 
remaining SP cells in the IKKΔTCD4 mice would show an uncharacteristically 
high resistance to TNF induced death, not representative of the population as a 
whole. As previously noted, in vivo treatment with anti-TNF Ab rescued the SP 
thymocyte populations in the IKKΔTCD4 mice. Therefore, prior to cell culture, 
IKKΔTCD4 mice and Cre- littermate controls were treated with anti-TNF blocking 
Ab over a period of 7 days. Thymocytes from the treated mice were then 
cultured for 24hr in the presence of PBS, TNF, or IL-7 (Figure 5.1A). The WT 
DP and CD4SP HSAhi populations underwent significantly more death in the 
presence of TNF, as compared to PBS vehicle (Figure 5.1A). Addition of IL-7 
reduced the level of cell death in all WT SP populations (Figure 5.1A). 
Treatment of the donor WT mice with anti-TNF blocking Ab prior to cell culture 
did not alter the subsequent response of thymocytes to either IL-7 or TNF in 
vitro (Figure 5.1A).  
 
DP and CD4SP HSAhi thymocytes from anti-TNF Ab treated IKKΔTCD4 mice 
were no more susceptible to TNF induced death than their WT counterparts. 
However, whilst CD4SP HSAlo, CD8SP HSAhi and CD8SP HSAlo cells from WT 
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thymii were resistant to TNF, these same populations from anti-TNF Ab treated 
IKKΔTCD4 donors were highly sensitive to TNF induced cell death (Figure 5.1A). 
Culture with IL-7 failed to increase the viability of SP cells from the anti-TNF Ab 
treated IKKΔTCD4 donors (Figure 5.1A). Of note, the CD8SP HSAlo cells from 
the anti-TNF Ab treated IKKΔTCD4 mice showed a high level of background 
death when cultured in medium supplemented only with PBS vehicle (Figure 
5.1A).  
 
Thymii from PBS treated IKKΔTCD4 mice were also cultured and compared to 
thymii from their anti-TNF Ab treated counterparts. Whether the NF-κB deficient 
mice had been anti-TNF treated or not, a similar pattern of cell death was 
apparent (Figure 5.1A). However, in response to TNF, the CD4SP HSAlo, 
CD8SP HSAhi, and CD8SP HSAlo cells from the anti-TNF treated IKKΔTCD4 
mice did show a slightly greater induction of cell death (Figure 5.1A). This 
supports the view that the few remaining thymocytes of these subsets in the 
PBS treated IKKΔTCD4 mice are enriched for cells that are TNF resistant.  
 
As additional controls, thymii from Tnfsf1a-/- mice and Tnfrsf1a-/- IKKΔTCD4 mice 
were cultured in the presence of medium containing PBS, TNF, or IL-7. As 
expected, TNF failed to induce a change in viability in any of the populations 
from TNFR1 deficient donors (Figure 5.1A). IL-7 increased viability among the 
SP cells from Tnfsf1a-/- mice, but had no effect on the SP cells from Tnfrsf1a-/- 
IKKΔTCD4 mice (Figure 5.1A).  
 
5.2.2 Subsets of DP thymocytes exhibit similar susceptibility to 
TNF induced death 
 
As previously described, DP thymocytes can be further categorized into DP1-3 
populations (Saini et al., 2010). DP1 cells (TCRloCD5lo) are pre-selection, whilst 
DP2 cells (TCRintCD5hi) are in the early stages of selection into the CD4 and 
CD8 lineages, and DP3 cells (TCRhiCD5int) are in the later stages of selection 
into the CD8 lineage (Saini et al., 2010). Among WT thymii, total DP cells and 
CD4SP HSAhi cells are weakly susceptible to TNF induced death, whereas 
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CD8SP HSAhi cells are resistant (Figure 5.1A). Since CD4SP HSAhi cells 
originate from the DP2 population and CD8SP HSAhi cells originate from the 
DP3 population, we hypothesized that a thymocyte’s susceptibility to TNF may 
well decrease between the DP2 and DP3 stages. To investigate this, we 
cultured WT thymocytes for 24hr in the presence of either 30ng/mL TNF or PBS 
vehicle and measured cell death among the different DP populations. However, 
over the course of a 24hr culture period, DP cells show substantial loss of their 
TCR and CD5 surface markers that hinder the identification of the different DP 
subsets (Figure 5.1B, FACS plots). Therefore we isolated purified populations 
of DP thymocytes by cell sorting. Prior to culture, the purity of the sorted cell 
populations was confirmed (Figure 5.1B, top FACS plots). All three DP 
subsets were found to have a similar, weak susceptibility to TNF induced death 
(Figure 5.1B, bar charts).  
 
5.2.3 IκB super-repressor expression renders CD8SP HSAlo 
cells sensitive to TNF induced death  
 
pLck-IκB-PEST mice express a dominant negative IκBα and have reduced 
numbers of CD8SP HSAlo thymocytes. In Chapter 4 we showed that this 
deficiency could be rescued by in vivo blocking of TNF signalling. This suggests 
that, at physiological concentrations of TNF, only the CD8SP HSAlo population 
is affected, and also that it is likely to be the most TNF sensitive subset. To 
confirm this, we cultured cell suspensions from whole thymii of pLck-IκB-PEST 
mice or transgene negative littermates with increasing concentrations of TNF 
cytokine (Figure 5.2). CD4SP HSAlo, CD8SP HSAhi, and CD8SP HSAlo 
thymocytes from WT mice showed remarkable resistance to even the highest 
TNF concentrations. However, the CD4SP HSAhi subset of WT thymocytes did 
show weak sensitivity to TNF induced cell death (Figure 5.2). The lowest 
concentrations of TNF were enough to induce death among this CD4SP HSAhi 
population, and death was not further increased by use of higher TNF 
concentrations (Figure 5.2).  
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All SP thymocyte populations from pLck-IκB-PEST mice showed considerable 
sensitivity to the highest concentrations of TNF (Figure 5.2). Notably, CD4SP 
HSAhi cells showed a similar amount of TNF induced death regardless of 
whether they were from the pLck-IκB-PEST mice or the WT mice (Figure 5.2). 
CD8SP HSAlo cells from the pLck-IκB-PEST mice did exhibit a higher 
background level of death than the WT cells. However, even the lowest 
concentration of TNF used (0.1ng/mL) was enough to induce significant death 
in the IκBα super-repressor containing CD8SP HSAlo population, whilst higher 
concentrations were required for induction of death among all other populations 
(Figure 5.2). In conclusion, among the pLck-IκB-PEST mice, the CD8SP HSAlo 
population is indeed the most intrinsically sensitive to TNF. 
 
5.2.4 Acute blockade in NF-κB signalling renders WT 
thymocytes susceptible to TNF induced death  
 
Our previous results had indicated that NF-κB was required to protect 
thymocytes from TNF induced cell death. In IKKΔTCD2 or IKKΔTCD4 strains, 
deletion of IKK components occurred as early as the DN2 thymic stage, and yet 
it was mature SPs that were most susceptible to TNF induced cell death. In 
these strains, it was unclear whether NF-κB activity was 1) required to actively 
protect thymocytes from TNF induced death or 2) required at discrete 
developmental stages in order to programme cells to develop that are resistant 
to TNF induced cell death. To investigate these distinct possibilities, we took 
advantage of BI605906, a pharmacological and selective inhibitor of IKK2 
(Clark et al., 2011). This enabled acute blockade of NF-κB signalling in 
thymocytes that had otherwise had NF-κB signalling intact during normal 
development.  
 
As discussed in Chapter 3, IKK1 deficient mice show normal thymocyte 
development, other than a slight reduction in Treg cells. It seems that canonical 
NF-κB signalling remains largely unperturbed in these mice, most likely due to 
the formation of IKK2 homodimers that can compensate for the loss of the IKK1 
subunit. Addition of the IKK2 inhibitor, BI605906, to IKK1 deficient thymocytes 
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in vitro would be expected to prevent formation of the compensatory IKK2 
homodimers and therefore cause a complete and acute block in NF-κB 
signalling.  
  
Thymii from WT or huCD2iCre Ikk1fx/fx R26REYFP mice were cultured with either 
10μM BI605906 (IKK2 inhibitor) or DMSO vehicle, plus increasing 
concentrations of TNF cytokine (Figure 5.3A). When cultured with DMSO 
vehicle, only the CD4SP HSAhi population of WT or IKK1 deficient thymocytes 
showed any TNF induced death. This was at a low level, as previously 
observed (Figure 5.3A; Figure 5.1A; Figure 5.2). In contrast, in the presence 
of the IKK2 inhibitor, TNF induced a high level of cell death in cultures. TNF 
induced higher levels of cell death in cultures of IKK1 deficient cells plus IKK2 
inhibitor than in similar cultures of WT cells (Figure 5.3A). Interestingly, the 
IKK2 inhibitor did not increase cell death among the WT CD4SP HSAhi 
population (Figure 5.3A).  
 
Nonlinear regression was performed on the data collected from the huCD2iCre 
Ikk1fx/fx R26REYFP cells treated with IKK2 inhibitor (Figure 5.3B). This enabled 
calculation of the IC50 values for the different SP subsets. The IC50 values 
revealed the concentrations of TNF required to increase cell death in each of 
the SP subsets to 50% of the maximum death observed. This revealed that 
CD8SP cells were most sensitive to TNF induced death, and that the CD8SP 
HSAlo cells were the most sensitive subset of CD8SPs (Figure 5.3B).   
  
5.2.5 In vitro stimulation with TNF induces IL-7R expression by 
SP thymocytes in an NF-κB dependent manner 
 
In vitro stimulation with TNF cytokine has been shown to induce IL-7R 
expression on TCR transgenic CD8SP thymocytes (Silva et al., 2014). TNF 
induced IL-7R upregulation was reduced when cells were cultured in the 
presence of BI605906, or if the cells had an intrinsic deficiency of IKK2 (Silva et 
al., 2014). We wished to determine whether TNF could also induce IL-7R 
expression on the SP thymocytes of WT, polyclonal mice in an NF-κB 
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dependent manner. Single cell suspensions of thymii were obtained from WT 
mice and cultured for 24hr in the presence of TNF cytokine or PBS vehicle. 
Addition of TNF was found to increase IL-7R expression on some SP thymocyte 
subsets. The CD4SP HSAhi cells showed the lowest increase in IL-7R 
expression, whilst the CD8SP HSAhi cells showed the highest increase (Figure 
5.4A, top histograms). 
 
To confirm that TNF induced IL-7R expression was NF-κB dependent we 
cultured IKKΔTCD4 thymocytes with TNF. Since IKKΔTCD4 mice have few HSAlo 
SP cells, we first treated IKKΔTCD4 donors with anti-TNF blocking Ab over the 
course of one week. As before, this increased the number of SP thymocytes. 
Thymocyte suspensions from the treated IKKΔTCD4 donors were then cultured 
for 24hr in the presence of TNF or PBS vehicle. TNF failed to induce IL-7R 
upregulation on any of the SP populations from the IKKΔTCD4 mice (Figure 
5.4A, bottom histograms).  
 
We wished to confirm that the failure of the IKKΔTCD4 cells to undergo TNF 
induced upregulation of the IL-7R was not due to the presence of residual anti-
TNF blocking Ab in the culture wells. Therefore, we treated WT mice with anti-
TNF blocking Ab or PBS vehicle for one week. As before, thymocyte 
suspensions were then washed before being cultured with TNF or PBS for 24hr. 
SP thymocyte populations from WT mice that had undergone the anti-TNF Ab 
treatment showed no inhibition in their upregulation of the IL-7R (Figure 5.4B). 
This indicated that anti-TNF blocking Ab was not influencing the cell culture. It 
seems that the failure of the IKKΔTCD4 cells to upregulate IL-7R expression was 
indeed cell intrinsic.  
 
5.2.6 Members of the TNFSF induce IL-7R expression on SP 
thymocytes  
 
Notably, TNF does not account for all the NF-κB dependent regulation of IL-7R, 
since Tnfsf1a-/- mice showed normal IL-7R expression. Furthermore, it seems 
that TNF does not account for all the induced death among the IKK deficient, 
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CD8SP HSAlo population, since blocking TNF signalling in IKKΔTCD4 mice could 
not completely restore CD8SP HSAlo numbers. We concluded that there must 
be other ligands regulating both death and IL-7R induction among SP 
thymocytes.  
  
To further investigate the NF-κB dependent regulation of death and IL-7R 
expression in thymocytes, we made use of F5 Rag1-/- (F5) thymocytes. F5 
Rag1-/- mice produce a monoclonal population of CD8+ T cells expressing a 
transgenic, MHC class I restricted TCR specific for the NP68 influenza antigen 
(Mamalaki et al., 1993). F5 cells fail to upregulate the IL-7R after positive 
selection, resulting in a lack of expression during the SP stage of development 
(Schematic 5.1). This failure to initiate IL-7R expression is thought to be a 
consequence of suboptimal TCR signalling by the transgenic TCR during 
positive selection (Sinclair et al., 2011). Consequently, IL-7R expression by T 
cells in this strain is almost entirely NF-κB dependent (Silva et al., 2014; 
Schematic 5.1).  
 
TNF induced upregulation of IL-7R expression has previously been shown in F5 
thymocytes (Silva et al., 2014). We asked whether the level of IL-7R expression 
was dose dependent with respect to TNF added in vitro. Single cell 
suspensions of whole, mashed thymii from F5 Rag1-/- mice were cultured for 
24hr in the presence of increasing concentrations of TNF cytokine or PBS 
vehicle. As the TNF concentration increased from 0 to 10ng/mL, so did 
expression of the IL-7R on the CD8SP HSAhi and CD8SP HSAlo subsets of F5 
SP thymocytes. Between 10ng/mL and 30ng/mL, IL-7R expression remained 
constant (Figure 5.5A).  
 
CD27 ligand (CD27L, CD70, TNFSF7) is a member of the TNFSF. Like TNF, 
CD27L has been shown to induce IL-7R expression on the CD8SP thymocytes 
of F5 Rag1-/- mice (Silva et al., 2014). We chose to examine the effects of 
increasing concentrations of CD27L on IL-7R expression. F5 thymocytes were 
cultured with soluble CD27L at concentrations ranging from 0 to 100ng/mL. As 
the concentration of CD27L increased, so did the level of IL-7R expression on 
the CD8SP HSAhi and CD8SP HSAlo cells (Figure 5.5B).  
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As expected, addition of the highest concentration of TNF (30ng/mL) caused 
significant death among the CD8SP HSAhi cells. Analysing viability in cultures 
stimulated with CD27L (100ng/mL) revealed a slight, but not significant, 
induction of cell death (Figure 5.5C, left). Furthermore, comparison of IL-7R 
expression revealed that CD27L was not as strong an inducer of IL-7R as TNF 
(Figure 5.5C, right).  
 
5.2.7 Regulation of cell death by TNFRSF ligands in WT mice 
 
There are currently 29 recognised members of the TNFRSF (Aggarwal et al., 
2012). CD8SP thymocytes of F5 Rag1-/- mice have previously been shown to 
express the following TNFRSF members: TNFR1, TNFR2, TACI, LIGHTR, 
GITR, TNFRSF25, TNFRSF26, and CD27 (Silva et al., 2014). We also found 
expression of these receptors on the SP thymocytes of WT, polyclonal mice 
(data not shown). For this reason we chose to perform cell culture with the 
following TNFRSF ligands: TNF (ligand for TNFR1 and TNFR2), APRIL and 
BAFF (ligands for TACI), GITRL (ligand for GITR), LIGHT (ligand for LIGHTR), 
TLA1 (ligand for TNFRSF25), and TRAIL (ligand for TNFRSF26).  
 
Thymocytes from WT mice, anti-TNF Ab treated IKKΔTCD4 mice, Tnfrsf1a-/- 
mice, and Tnfrsf1a-/- IKKΔTCD4 mice were cultured in the presence of different 
TNFSF members, or with PBS or IL-7 and, after 24h, cell viability was assessed 
by FACS. TNF was the only ligand to induce significant death among the SP 
thymocytes (Figure 5.6). As expected, the IKK deficient SP cells that express 
TNFR1 were very sensitive to TNF (Figure 5.6). IL-7 was able to reduce cell 
death among IKK sufficient cells, but not cells lacking IKK expression (Figure 
5.6). Strikingly, amongst WT cells, TNF was the only TNFSF member to induce 
significant upregulation of the IL-7R among SP thymocytes (Figure 5.7). Cells 
deficient in TNFR1, or IKK, or both did not change their IL-7R expression in 
response to TNF (Figure 5.7). Although CD27L promoted IL-7R expression by 
F5 thymocytes (Silva et al., 2014; Figure 5.5B & C), we failed to detect any 
noticeable IL-7R upregulation among WT thymocytes (Figure 5.7). Culture with 
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IL-7 caused IL-7R downregulation among all strains of SP thymocytes (Figure 
5.7), as expected (Park et al., 2004).  
 
5.2.8 In vivo blockade of CD27 signalling fails to rescue SP 
thymocyte populations in IKKΔTCD4 mice 
 
Culture experiments using F5 thymocytes had suggested that TNF and CD27L 
might have similar functions in the thymus. Both ligands caused strong 
upregulation of the IL-7R on F5 SP thymocytes (Silva et al., 2014; Figure 5.5). 
Furthermore, there was some evidience to suggest that CD27L, like TNF, may 
have a weak cytotoxicity towards CD8SP HSAhi F5 thymocytes (Figure 5.5C). 
We therefore wished to determine whether blocking CD27 signalling in 
IKKΔTCD4 mice could rescue SP populations. IKKΔTCD4 mice were treated over 
a one-week period with anti-CD27L blocking Ab, injected intraperitoneally on 
days 0, 2, and 4, and numbers of thymic subsets were assessed on day 7. 
Analysing cell counts at day 7 revealed that treatment of IKKΔTCD4 mice with 
anti-CD27L Ab had no detectable effect on those subsets reduced in this strain. 
Numbers of CD4SP HSAlo, CD8SP HSAhi, and CD8SP HSAlo thymocytes were 
not altered by the treatment (Figure 5.8). Furthermore, analyzing numbers of 
naïve cells in the periphery of the IKKΔTCD4 mice revealed no increase upon 
anti-CD27L Ab treatment (Figure 5.8).    
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5.3 Discussion 
 
The aim of this chapter was to investigate factors regulating NF-κB dependent 
cell survival and IL-7R expression in vivo. We, and others, have identified TNF 
as a ligand that works in an NF-κB dependent manner to upregulate IL-7R 
expression in SP thymocytes (Silva et al., 2014; Schematic 5.2A). In the 
absence of IKK mediated NF-κB signalling, TNF induces substantial death 
among the SP population and no increase in IL-7R. 
 
We used a combined genetic and pharmacological approach to acutely block 
NF-κB signalling in thymocytes. IKK1 deficient SP cells are no more sensitive to 
TNF induced death than their WT counterparts (Figure 5.3A). However, in vitro 
addition of an IKK2 inhibitor to the IKK1 deficient thymocytes resulted in much 
TNF induced cell death among all SP subsets (Figure 5.3; Schematic 5.2B). 
Importantly, this indicates that an acute block in NF-κB signalling is sufficient to 
render SP cells susceptible to TNF. We had hypothesized that NF-κB may be 
required at discrete developmental stages, in order to produce a TNF resistant 
population of cells. However, from our results, it seems that NF-κB plays a very 
active, as opposed to developmental, role in protecting SP thymocytes from 
TNF induced death.  
   
In vitro experiments confirmed that, when NF-κB signalling is blocked, 
thymocyte susceptibility to TNF induced death increases in the order: CD4SP 
HSAhi, CD4SP HSAlo, CD8SP HSAhi, CD8SP HSAlo (Figure 5.3). This is 
reflected in the phenotype of the intact IKKΔTCD4 mice. In the intact animals, 
CD8SP thymocytes are decreased relative to CD4SP thymocytes, and the 
HSAlo subsets are more affected than the HSAhi subsets. Through an in vitro 
approach we were able to remove anatomical barriers. Hence we can be 
confident that all SP thymocyte subsets investigated were subjected to the 
same concentration of TNF. Importantly, culture experiments have shown that 
differences in TNF susceptibility among the SP populations are cell intrinsic 
(Figure 5.1; Figure 5.2; Figure 5.3). Nevertheless, it is likely that thymocytes 
are subjected to differing concentrations of TNF as they develop.  
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Maturing thymocytes are highly motile, experiencing many different thymic 
microenvironments as they progress from their least to most mature stages. DN 
thymocytes mature through DN1-4, moving from the cortico-medullary junction, 
through the thymic cortex and towards the subcapsular zone as they do so 
(Takahama, 2006). DP cells are then generated in the cortex of the thymus 
where they interact with peptide:MHC complexes on cortical thymic epithelial 
cells and dendritic cells. A tiny percentage (3-5%) of DP cells undergo positive 
selection and migrate from the cortex to the medulla (Takahama, 2006). DP 
thymocytes may be found in both the outer and inner areas of the cortex, 
depending on whether they are in the early or late stages of positive selection 
(Germain, 2002). Newly generated SP thymocytes reside in the medulla for 
approximately 4 days, undergoing the final stages of maturation, before leaving 
the thymus through the perivascular space (Sinclair et al., 2011; Takahama, 
2006). Reportedly, medullary epithelial cells are constitutive producers of TNF 
(Mahmud et al., 2014). Therefore, it is likely that all SP thymocytes experience 
much TNF induced signalling during their transition from the HSAhi to HSAlo 
stage.  
 
In pLck-IκB-PEST mice, only the CD8SP HSAlo thymocyte population is 
affected by TNF induced death. Via cell culture, we found that 0.1ng/mL TNF 
was enough to induce significant death among CD8SP HSAlo cells from pLck-
IκB-PEST mice, but that all other subsets required at least 1ng/mL before 
significant death was seen (Figure 5.2). This suggests that the physiological 
concentration of TNF in the thymus is likely around 0.1ng/mL or less and not 
more than 1ng/mL. 
 
The presence of TNF in the thymic medulla implies that it plays a role in the 
final stages of thymocyte maturation. Indeed TNFR2 is upregulated on Treg cells 
during their thymic development (Mahmud et al., 2014). Furthermore, we 
showed that the addition of TNF in vitro causes significant upregulation of the 
IL-7R on WT, SP thymocytes (Figure 5.4; Figure 5.7). In addition to its 
presumed role in Treg production, an important role for TNF in the thymus may 
well be to modulate IL-7R expression. During thymocyte development, IL-7R is 
expressed during the DN stage, lost during the DP stage, and re-expressed 
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after positive selection (Sinclair et al., 2011; Sudo et al., 1993). Evidence 
suggests that the strength of TCR signalling during positive selection is 
responsible for the amount of IL-7R re-expression (Sinclair et al., 2011). For this 
reason, F5 thymocytes, which have only weak positive selection signalling via 
their transgenic TCR, normally lack expression of IL-7R during the SP stage 
(Sinclair et al., 2011; Schematic 5.1). However, when TNF was added to a 
culture of F5 thymocytes, the SP cells were able to dramatically increase IL-7R 
expression, in a manner dependent on the concentration of TNF used (Figure 
5.5A). As T cells leave the thymus, to become recent thymic emigrants (RTEs) 
in the periphery, they will continue to upregulate their IL-7R expression (Silva et 
al., 2014).  
 
Runx1 and Runx3 transcription factors are believed to be important for the re-
expression of the IL-7R on CD4 and CD8 SP cells after positive selection 
(Egawa et al., 2007). However, the further upregulation of the IL-7R, as cells 
leave the thymus to become RTEs, is believed to be highly NF-κB dependent 
(Silva et al., 2014). If T cells experience a lack of NF-κB signalling during thymic 
development, they will exhibit reduced lL-7R expression when in their naïve, 
peripheral form (Miller et al., 2014; Silva et al., 2014). Importantly, NF-κB 
signalling does not appear to be required to maintain IL-7R levels on mature, 
naïve cells (Silva et al., 2014), although it may be required to restore IL-7R 
levels following downregulation induced by in vitro addition of IL-7 cytokine 
(Miller et al., 2014). 
 
In IKK2 deficient mice, IL-7R expression is normal among HSAhi SP thymocytes 
and CD4SP HSAlo thymocytes, but significantly reduced among CD8SP HSAlo 
cells (Silva et al., 2014). We also found this to be true for IKKΔTCD4 mice (data 
not shown). However, it seemed that all SP subsets in IKKΔTCD4 mice showed 
some degree of functional deficiency in IL-7R signalling. Whilst, in vitro addition 
of IL-7 cytokine significantly reduced death among NF-κB sufficient SP 
thymocytes, it had limited capacity to promote survival of thymocytes from IKK 
deficient mice (Figure 5.6).  
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In vitro addition of TNF increases the IL-7R levels on SP cells (Silva et al., 
2014; Figure 5.4; Figure 5.5A & C; Figure 5.7). However, if the cells are 
deficient in IKK2, then the extent of upregulation is limited (Silva et al., 2014), 
and if the cells are deficient in both IKK1 and IKK2, then there is no TNF 
induced IL-7R upregulation (Figure 5.4A, bottom; Figure 5.7). Only limiting 
amounts of IL-7 cytokine are available in the thymic microenvironment, so 
regulation of IL-7R expression is particularly important in the thymus (Park et 
al., 2004). TNF may help provide such regulation. It seems that TNF signalling 
may be a useful activator of NF-κB in SP thymocytes - enabling upregulation of 
the IL-7R in the later stages of thymocyte development, just before cells enter 
the periphery as RTEs. Notably, thymocytes that do not upregulate IL-7R 
sufficiently fail to survive in the periphery (Sinclair et al., 2011). Hence, TNF 
induced IL-7R upregulation may ultimately help to shape the T cell repertoire.  
 
As discussed in Chapter 4, T cells from Tnfrsf1a-/- mice have completely normal 
IL-7R expression. It is possible that TNF signalling could still occur in TNFR1 
deficient cells via TNFR2. However, anti-TNF Ab treated WT mice also had 
normal IL-7R expression. These results suggest that TNF signalling is not 
essential for the induction of IL-7R expression in the last stages of T cell 
development (Schematic 5.2A). Of note, there is much redundancy among 
members of the TNFSF – all of which can activate NF-κB signalling. F5 
thymocytes express TNFR1, TNFR2, TACI, LIGHTR, GITR, TNFRSF25, 
TNFRSF26, and CD27 (Silva et al., 2014). Like TNF, CD27L has been shown to 
induce IL-7R expression on the SP thymocytes of F5 Rag1-/- mice (Silva et al., 
2014; Figure 5.5B & C). However, when WT, polyclonal thymocytes were 
cultured with CD27L there was no obvious IL-7R upregulation (Figure 5.7). 
Similarly, culture with other TNFSF members failed to show any dramatic effect 
(Silva et al., 2014; Figure 5.7). However, if NF-κB activation is receptor 
dependent in developing thymocytes, it appears there is redundancy between 
multiple receptors to perform this function (Schematic 5.2A).  
 
Evidence suggests that TNF and CD27L may have similar biological functions 
in the thymus (Coquet et al., 2013; Mahmud et al., 2014; Silva et al., 2014; 
Figure 5.5). However, unlike TNF, CD27L could not induce death among IKK 
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deficient cells in vitro (Figure 5.6). Furthermore, treatment with anti-CD27L 
blocking Ab failed to increase cell numbers in IKKΔTCD4 mice (Figure 5.8). 
CD27 does not contain an intracellular death domain. However, CD27 is able to 
induce cell death via interaction with the death domain containing protein, Siva 
(Prasad et al., 1997). Hence, CD27L induced death, although not observed, 
remains a possibility among thymocytes. Whether TNFSF member (e.g. TNF or 
CD27L) induced apoptosis has any physiological relevance in the WT thymus 
remains to be determined.    
 
In this chapter we discovered that, in the absence of NF-κB signalling, certain 
SP thymocyte populations are intrinsically more susceptible to TNF induced 
death than others. Importantly, we found that NF-κB works to actively protect 
SP cells from TNF. Furthermore, we have speculated that the TNFSF members 
TNF and CD27L may play a functional role in the thymus by contributing to the 
NF-κB dependent upregulation of the IL-7R during the final stages of thymocyte 
maturation. In Chapter 6, we shall further investigate the mechanism behind the 
TNF induced death of SP thymocytes. Ultimately, we hope to determine why 
certain SP subsets show greater susceptibility than others to TNF induced cell 
death in the absence of NF-κB signalling.   
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Figure 5.1 Upon in vitro addition of TNF, mature thymocytes from 
IKKΔTCD4 mice appear highly susceptible to death 
 
(A) Single cell suspensions of whole, mashed thymii from indicated mice were 
cultured for a period of 24 hours. Prior to this, “IKKΔTCD4 αTNF treated” mice 
were treated with an anti-TNF blocking antibody over a period of 7 days, as 
were “WT αTNF treated” mice. “IKKΔTCD4” mice and “WT” mice either received 
no treatment or received PBS vehicle for 7 days prior to culture (PBS injections 
were found to have no measurable effect). “Tnfrsf1a-/-” mice and “Tnfrsf1a-/- 
IKKΔTCD4” mice received no treatment prior to the culture experiments. 
Throughout the culture period, culture medium contained PBS vehicle, TNF 
cytokine (30ng/mL), or IL-7 cytokine (10ng/mL), as indicated. The percentage of 
dead cells within each thymocyte subset is shown. Bar charts display data 
collected from a number of independent experiments. (B) DP1 (TCRloCD5lo), 
DP2 (TCRintCD5hi), and DP3 (TCRhiCD5int) populations were sorted from WT 
thymii. The sorted cells were then cultured for 24hr with medium containing 
either PBS vehicle or TNF cytokine. Density plots show sorted populations 
before culture (0hr) and after culture (24hr). Bar charts display the percentage 
cell death among the DP subsets. Data collected from 2 independent cell sorts 
and culture experiments are shown. 
 
Bar charts show mean ± SEM. ns = not significant; * = significant at P<0.05; ** = 
significant at P<0.01; *** = significant at P<0.001. 
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Figure 5.2 When NF-κB signalling is blocked, via expression of a dominant 
negative form of IκBα, CD8SP HSAlo cells are particularly sensitive to TNF 
induced death  
 
The thymus was taken from a WT mouse and from a pLck-IκB-PEST mouse 
(expressing a super-inhibitory form of IκBα under the control of the proximal Lck 
promoter). Single cell suspensions were made and the thymocytes cultured for 
a 24hr period with increasing concentrations of TNF cytokine. The percentage 
of dead cells within each SP thymocyte population is shown. Error bars show 
mean ± SEM. The Student’s t-test was performed on pLck-IκB-PEST 
thymocytes. ns = not significant; * = significant at P<0.05; ** = significant at 
P<0.01. The experiment was performed once. Duplicate wells were employed. 
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Figure 5.3 When NF-κB signalling is deficient, certain SP thymocyte 
populations show a greater sensitivity to TNF induced death than others 
 
(A) Thymii from 3 huCD2iCre Ikk1fx/fx R26REYFP mice were pooled together, as 
were thymii from 3 Cre- (WT) littermates. Single cell suspensions were made. 
Either the IKK2 specific inhibitor BI605906 (10μM) or DMSO vehicle was added 
to the huCD2iCre Ikk1fx/fx R26REYFP cells or the WT cells. TNF was also present 
in the culture medium at varying concentrations. Cells were cultured for 24 
hours. The percentage of dead cells is shown for each SP thymocyte 
population. Technical replicates were employed by way of duplicate wells. The 
experiment was performed twice. One representative experiment is shown. (B) 
Nonlinear regression was performed on the data collected from the huCD2iCre 
Ikk1fx/fx R26REYFP cells treated with IKK2 inhibitor. Dotted lines represent the 
IC50 values for the different SP subsets. IC50 values are as follows: CD4SP 
HSAhi, 1.3ng/mL; CD4SP HSAlo, 1ng/mL; CD8SP HSAhi, 0.3ng/mL; CD8SP 
HSAlo, 0.03ng/mL. Wild-type cells (treated with DMSO vehicle) are directly 
compared to the huCD2iCre Ikk1fx/fx R26REYFP cells treated with IKK2 inhibitor. 
The experiment was performed twice. One representative experiment is shown.  
 
Line graphs show mean ± SEM. 
 
  
 
 
208 
  
10-4 10-2 100 1020
0
20
40
60
80
100
DMSO vehicle
IKK2 inhibitor
10-4 10-2 100 1020
0
20
40
60
80
100
10-4 10-2 100 1020
0
20
40
60
80
100
10-4 10-2 100 1020
0
20
40
60
80
100
10-4 10-2 100 1020
0
20
40
60
80
100
10-4 10-2 100 1020
0
20
40
60
80
100
10-4 10-2 100 1020
0
20
40
60
80
100
10-4 10-2 100 1020
0
20
40
60
80
100
TNF (ng/mL)
CD4SP 
HSAhi
CD4SP 
HSAlo
CD8SP 
HSAhi
CD8SP 
HSAlo
WT huCD2iCre Ikk1fx/fx
%
 D
e
a
d
 c
e
lls
%
 D
e
a
d
 c
e
lls
%
 D
e
a
d
 c
e
ll
s
%
 D
e
a
d
 c
e
ll
s
10-4 10-2 100 1020
0
20
40
60
80
100
0 102
0
20
40
60
80
100
WT 
TNF (ng/mL)
%
 D
e
a
d
 c
e
lls
huCD2iCre Ikk1fx/fx
 + IKK2 inhibitor
CD4SP HSAhi
CD4SP HSAlo
CD8SP HSAhi
CD8SP HSAlo
A
B
0.0
0.5
1.0
1.5
IC50 values:
huCD2iCre Ikk1fx/fx
 + IKK2 inhibitor
CD4SP 
HS
A
hi
HS
A
lo
CD8SP 
HS
A
hi
HS
A
lo
T
N
F
 (
n
g
/m
L
)
 
 
209 
Figure 5.4 Upon in vitro addition of TNF, mature thymocytes from 
IKKΔTCD4 mice lack induced expression of the IL-7R  
 
(A) IKKΔTCD4 mice were treated over a 7 day period with an anti-TNF blocking 
antibody. This increased the number of IKK1/2 double deficient SP thymocytes 
and also increased the likelihood that the cells present were truly IKK deficient 
(and not “escapants”). Single cell suspensions of whole, mashed thymii from 
these treated mice or from untreated Cre- (WT) littermates were then cultured 
for a 24hr period in medium containing either PBS vehicle or TNF cytokine 
(30ng/mL). SP thymocytes were then analysed for expression of the IL-7R. The 
experiment was repeated a number of times, results shown are representative. 
(B) C57BL/6 (WT) mice were treated over a 7 day period with an anti-TNF 
blocking antibody or PBS vehicle. Single cell suspensions of whole, mashed 
thymii from these mice were then cultured for a 24hr period in medium 
containing either PBS vehicle or TNF cytokine (30ng/mL). SP thymocytes were 
then analysed for expression of the IL-7R. The experiment was repeated twice, 
results shown are representative.  
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Schematic 5.1 Upregulation of the IL-7R during thymocyte 
development 
 
The survival of DN thymocytes relies on signalling through the IL-7R (Peschon 
et al., 1994). By the DP stage, however, thymocytes completely lack cell 
surface expression of the IL-7R (Sudo et al., 1993). During the process of 
positive selection, signalling via the TCR induces upregulation of the IL-7R 
(Sinclair et al., 2011). Hence, by the SP stage, both CD4 and CD8 lineage cells 
show high IL-7R expression. However, in F5 Rag1-/- mice, suboptimal signalling 
via the transgenic TCR means that SP thymocytes continue to lack IL-7R 
expression (Sinclair et al., 2011). As SP thymocytes undergo the final stages of 
maturation and begin to leave the thymus as recent thymic emigrants (RTEs) 
they further increase their IL-7R expression in a manner dependent on 
activation of the NF-κB transcription factor (Silva et al., 2014). IL-7R expression 
by the T cells of F5 Rag1-/- mice is almost entirely NF-κB dependent (Silva et 
al., 2014). In contrast, SP thymocytes deficient in NF-κB signalling will fail to 
upregulate their IL-7R as they exit the thymus, resulting in low IL-7R expression 
among peripheral T cells (Silva et al., 2014). As explored in Chapter 3, the 
greater the block in NF-κB signalling during T cell development, the lower the 
level of IL-7R expression among the naïve T cell population. Maintenance of the 
IL-7R on mature, peripheral T cells is dependent on the Foxo1 transcription 
factor (Kerdiles et al., 2009) and seems independent of NF-κB (Silva et al., 
2014).  
 
Figure drawn by myself, but based on similar diagrams as presented by 
Benedict Seddon.  
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Figure 5.5 In vitro culture with TNF or with CD27L causes upregulation of 
the IL-7R on the CD8SP thymocytes of F5 Rag1-/- mice  
 
Single cell suspensions of whole, mashed thymii from F5 Rag1-/- mice were 
cultured for a period of 24hr in medium containing varying concentrations of 
TNF, CD27L, or PBS control. At the end of the experiment, cells were stained 
and analysed by FACS. (A) IL-7R expression is shown for CD8SP HSAhi (top 
row) and CD8SP HSAlo (bottom row) cells cultured with TNF vs PBS. (B) IL-7R 
expression is shown for CD8SP HSAhi (top row) and CD8SP HSAlo (bottom row) 
cells cultured with CD27L vs PBS. (A & B) Data are representative of biological 
(2 mice) and technical (2 well) replicates. (C) Thymocytes from F5 Rag1-/- mice 
were cultured for 24hr in PBS vehicle, 10ng/mL IL-7, 30ng/mL TNF, or 
100ng/mL CD27L. Following culture, the CD8SP HSAhi thymocyte population 
was assessed for viability (left) and for expression of the IL-7R (right). The 
percentage increase in IL-7R mean fluorescence intensity (MFI) when IL-7, 
TNF, or CD27L was present, as compared to PBS vehicle, was calculated. The 
left bar chart shows data from 5 independent experiments. The right bar chart 
shows data from 3 independent experiments. Bar charts show mean ± SEM. ns 
= not significant; * = significant at P<0.05; *** = significant at P<0.001. 
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Figure 5.6 In contrast to TNF itself, other ligands of the TNF superfamily 
fail to induce death in IKKΔTCD4 cells 
 
Thymocytes from the indicated mouse strains were cultured for 24hr in the 
presence of medium containing a ligand belonging to the TNF superfamily, IL-7 
cytokine, or PBS vehicle. SP thymocyte populations were then gated upon 
using FACS and cells assessed for viability. Prior to culture, “αTNF treated 
IKKΔTCD4” mice were treated over a 7 day period with an anti-TNF blocking 
antibody. “WT” mice were the Cre- littermates of the IKKΔTCD4 mice. They either 
received anti-TNF blocking antibody injections, PBS injections, or no treatment 
prior to cell culture (the injections having no measurable outcome on WT mice). 
“Tnfrsf1a-/-” mice were the Cre- littermates of “Tnfrsf1a-/- IKKΔTCD4” mice. 
Tnfrsf1a-/- mice and Tnfrsf1a-/- IKKΔTCD4 mice were not treated prior to culture. 
The bar charts show data collected from 6 independent experiments. Bar charts 
show mean ± SEM of at least 2 mice. ns = not significant; * = significant at 
P<0.05; ** = significant at P<0.01; *** = significant at P<0.001. IL-7 was used at 
10ng/mL, TNF was used at 30ng/mL, all other TNFSF cytokines were used at 
100ng/mL.  
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Figure 5.7 In contrast to TNF itself, other ligands of the TNF superfamily 
fail to cause upregulation of the IL-7R in NF-κB sufficient, polyclonal mice 
 
Thymocytes from the indicated mouse strains were cultured for 24hr in the 
presence of medium containing a ligand belonging to the TNF superfamily, IL-7 
cytokine, or PBS vehicle. SP thymocyte populations were then gated upon 
using FACS, and live cells were further assessed for their expression of the IL-
7R. The percentage increase in IL-7R mean fluorescence intensity (MFI) when 
the ligand of interest was present, as compared to PBS vehicle, could then be 
calculated. Prior to culture, “αTNF treated IKKΔTCD4” mice were treated over a 7 
day period with an anti-TNF blocking antibody. “WT” mice were the Cre- 
littermates of the IKKΔTCD4 mice. They either received anti-TNF blocking 
antibody injections, PBS injections, or no treatment prior to cell culture (the 
injections having no measurable outcome on WT mice). “Tnfrsf1a-/-” mice were 
the Cre- littermates of “Tnfrsf1a-/- IKKΔTCD4” mice. Tnfrsf1a-/- mice and Tnfrsf1a-
/- IKKΔTCD4 mice were not treated prior to culture. The bar charts show data 
collected from 7 independent experiments. Bar charts show mean ± SEM of at 
least 2 mice. IL-7 was used at 10ng/mL, TNF was used at 30ng/mL, all other 
TNFSF cytokines were used at 100ng/mL.  
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Figure 5.8 Treatment of IKKΔTCD4 mice with an anti-CD27L blocking 
antibody fails to restore T cell development 
 
8-27 week old IKKΔTCD4 mice were treated over a 7 day period with an anti-
CD27L blocking antibody or with an equivalent volume of PBS vehicle. Cre- 
(WT) littermates were left untreated. After the treatment period, mice were 
culled and cell numbers in the thymus (A) and periphery (LNs and spleen 
combined) (B) were calculated.  
 
Cre- (WT), (n = 5); IKKΔTCD4 PBS treated, (n = 6); IKKΔTCD4 αCD27L treated, 
(n = 5). Data is shown from 2 independent experiments. Bar charts show mean 
cell number ± SEM. ns = not significant. 
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Schematic 5.2 -Chapter 5 summary- The consequences of TNF 
signalling within SP thymocytes 
 
(A) TNF works in an NF-κB dependent manner to upregulate IL-7R expression 
during the final stages of SP thymocyte maturation, just before the cells leave 
the thymus as recent thymic emigrants (Silva et al., 2014). However, it seems 
that TNF signalling is not essential for IL-7R upregulation, since naïve, 
peripheral T cells from Tnfrsf1a-/- mice or anti-TNF Ab treated WT mice have 
completely normal IL-7R expression. Our results indicate that other ligands, 
perhaps also belonging to the TNFSF, work in an IKK and NF-κB dependent 
manner to upregulate IL-7R expression on SP thymocytes. 
(B) We used a combined genetic and pharmacological approach to acutely 
block NF-κB signalling in thymocytes. IKK1 deficient SP cells are no more 
sensitive to TNF induced death than their WT counterparts. This is most likely 
due to the formation of IKK2 homodimers that can compensate for the loss of 
the IKK1 subunit. However, addition of the IKK2 inhibitor, BI605906, to IKK1 
deficient thymocytes in vitro caused much TNF induced cell death among all SP 
subsets. We speculate that this is due to a complete and acute block in NF-κB 
signalling. Hence, an acute block in NF-κB signalling is sufficient to render SP 
cells susceptible to TNF.
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Chapter 6 The mechanism of TNF induced 
death in developing T cells 
 
6.1 Introduction 
 
Numerous receptor families cause activation of the NF-κB pathway. Among 
them, the TNFR, TLR, IL-1R, and antigen receptor families have been 
extensively studied (Hayden and Ghosh, 2014). Of note, receptors that activate 
NF-κB signalling tend to lack any enzymatic activity of their own (Aggarwal, 
2003; Hayden and Ghosh, 2014). For this reason, receptor signalling to NF-κB 
relies heavily on the recruitment of adaptor proteins. These adaptors are known 
for their protein:protein interaction domains, which facilitate the formation of 
huge multimeric protein complexes. Death domains (DD), receptor interacting 
protein (RIP) domains, and TNF receptor associated factor (TRAF) domains are 
all important mediators of ligand induced signalling to NF-κB (Hayden and 
Ghosh, 2014). The large, receptor associated complexes will eventually recruit 
proteins with enzymatic activity. Among them is the IKK complex, the activation 
of which leads to the nuclear translocation of NF-κB dimers.  
 
The special relationship between TNF and NF-κB has long been recognised. 
TNF is a strong inducer of NF-κB activation and, in turn, NF-κB promotes TNF 
expression (Mercurio and Manning, 1999; Shakhov et al., 1990). TNFR1 is 
believed to be the main mediator of TNF’s biological functions (Hayden and 
Ghosh, 2014; Vandenabeele et al., 1995). Binding of TNF to TNFR1 can result 
in activation of MAPK, apoptosis, and necroptosis pathways, in addition to the 
NF-κB pathway (Aggarwal, 2003; Vanden Berghe et al., 2014). TNF binding 
induces conformational changes on TNFR1. This allows recruitment of TRADD 
to the DD of TNFR1 (Hsu et al., 1995). TRADD is then able to recruit both 
RIPK1 and TRAF2 to the membrane (Hsu et al., 1996a; 1996b). It is believed 
that RIPK1 may aid TRADD in the recruitment of TRAF2 (Pobezinskaya et al., 
2008). The resulting, multi-protein structure that forms around membrane-bound 
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TNFR1 is called complex I (Brenner et al., 2015; Hayden and Ghosh, 2014; 
Schematic 6.1). It is important for the downstream activation of NF-κB.  
 
TRAF2 can recruit the IKK complex to complex I through a direct interaction 
with both IKK1 and IKK2 (Devin et al., 2001). However, TRAF2 knockout cells 
are not deficient in NF-κB activation (Yeh et al., 1997). This is believed to be 
due to compensation by TRAF5, since TRAF2/5 double knockout cells fail to 
activate NF-κB (Tada et al., 2001). RIPK1 also enables recruitment of the IKK 
complex to TNFR1. This occurs through the direct binding of RIPK1 to NEMO 
(Zhang et al., 2000). Interestingly, the kinase activity of RIPK1 seems to be 
dispensable for IKK recruitment (Lee et al., 2004). Hence, RIPK1 seems to 
adopt somewhat of a scaffold function when working towards the activation of 
NF-κB. A further function of RIPK1, in complex I, is thought to be the 
recruitment of TAK1 (Ea et al., 2006). TAK1 is an IKK kinase (IKK-K). 
Therefore, it is likely that RIPK1 facilitates the activation of the IKK complex by 
bringing it into close proximity to TAK1 (Ea et al., 2006). However, whilst some 
reports suggest that RIPK1 deficient cells are unable to activate NF-κB (Devin 
et al., 2001; Kelliher et al., 1998), others report normal IKK recruitment and NF-
κB activation in the absence of RIPK1 (Wong et al., 2010). It has also been 
suggested that RIPK1 deficient cells are able to recruit the IKK complex (most 
likely through IKK1/2 binding to TRAF2), but fail in their ability to activate it 
(Devin et al., 2001).  
 
Recently, there has been much evidence to suggest that ubiquitination of 
RIPK1 is required for activation of NF-κB signalling in response to TNF (Ea et 
al., 2006; Silke, 2011). It has been proposed that the lysine-63 (K63) linked 
ubiquitination of RIPK1, on lysine 377, is necessary for recruitment of both the 
IKK complex and TAK1 (Ea et al., 2006). Initially, it was believed that TRAF2 
was directly responsible for attachment of the K63 ubiquitin chains to RIPK1 
(Hayden and Ghosh, 2012). However, more recent work has indicated that the 
inhibitor of apoptosis proteins (IAPs), cIAP1 and cIAP2, are required for RIPK1 
ubiquitination (Yin et al., 2009). The IAPs are defined by the presence of a 
baculovirus IAP repeat (BIR) domain. However, like TRAF2, the IAPs also 
possess really interesting new gene (RING) finger domains that are capable of 
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acting as E3 ligases and hence of inducing ubiquitination (Estornes and 
Bertrand, 2015). RIPK1 remains free of K63 ubiquitin chains in cIAP1/2 double 
knockout cells, or cells that have been treated with IAP antagonists (Mahoney 
et al., 2008; Varfolomeev et al., 2008). TRAF2/5 double knockout cells also 
show a similar absence of K63-linked ubiquitinated RIPK1 (Wong et al., 2010). 
Such evidence agrees with the hypothesis that TRAF2 may indeed be 
responsible for RIPK1 ubiquitination, but indirectly so, via the recruitment of 
cIAP1/2.  
 
The cIAPs have also been shown to enable recruitment of the linear ubiquitin 
chain assembly complex (LUBAC) to complex I (Haas et al., 2009; Kirisako et 
al., 2006). The LUBAC is believed to consist of heme-oxidised iron regulatory 
protein 2 ubiquitin ligase 1 (HOIL-1), HOIL-1 interacting protein (HOIP), and 
SHANK-associated RH domain interactor (SHARPIN) (Gerlach et al., 2011; 
Kirisako et al., 2006). The LUBAC is thought to help stabilise TNFR1 complex I, 
resulting in sustained activation of NF-κB. It is able to add unusual linear chains 
of ubiquitin onto its substrates. One such substrate has been identified as 
NEMO. It seems that linear ubiquitination of NEMO, by the LUBAC, may result 
in direct activation of the IKK complex (Fujita et al., 2014). Ultimately, the cIAP 
proteins may facilitate NF-κB activation, not only via K63-linked ubiquitination of 
RIPK1, but also via LUBAC recruitment.  
 
Eventually, and perhaps by several means, TNF induced signalling leads to 
activation of the IKK complex. IκBα is then phosphorylated and K48-linked 
ubiquitinated, marking it for degradation by the proteasome. Finally, NF-κB 
dimers can enter the nucleus, where they increase the transcription of both pro-
inflammatory and anti-apoptotic genes. Cellular FLICE-like inhibitory protein (c-
FLIP), TRAF1, cIAP1, and cIAP2 are among the anti-apoptotic proteins induced 
by NF-κB (Aggarwal, 2003). Importantly, the complex I mediated production of 
anti-apoptotic proteins is necessary to counteract against TNF induced cell 
death.  
 
If complex I becomes destabilized then it may become endocytosed, resulting in 
formation of a new, cytosolic complex. Upon dissociation from the membrane, 
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TNFR1 remains connected to TRADD, TRAF2, and RIPK1. However, a variety 
of death signalling inducing signalling complex (DISC) proteins are additionally 
recruited. DISC proteins include TRADD, FADD, and TRAF1 (Hsu et al., 1996b; 
Pasparakis and Vandenabeele, 2015; Sedger and McDermott, 2014). The DISC 
proteins enable the formation of a scaffold, which recruits pro-caspase-8, an 
initiator caspase. This caspase-8 containing complex is termed complex IIa 
(Pasparakis and Vandenabeele, 2015; Schematic 6.1). In certain situations, 
RIPK3 may also be recruited, resulting in the formation of complex IIb 
(Pasparakis and Vandenabeele, 2015; Schematic 6.1). The circumstances 
leading to complex IIb formation are rare, but include TNF stimulation when 
IAPs are inhibited (for example with Smac mimetics), or when there is a 
deficiency of TAK1 or NEMO (Dondelinger et al., 2013; Legarda-Addison et al., 
2009; Pasparakis and Vandenabeele, 2015; Wang et al., 2008). Formation of 
both complex IIa and complex IIb leads to apoptosis. Occasionally, complex IIb 
can undergo further changes to form complex IIc, also known as the 
necrosome. This occurs in the absence of caspase-8 activity and the presence 
of high levels of RIPK3 and its substrate, mixed lineage kinase like (MLKL) 
(Pasparakis and Vandenabeele, 2015; Schematic 6.1). Formation of the 
necrosome leads to a kinase-regulated form of necrotic cell death, known as 
necroptosis (Pasparakis and Vandenabeele, 2015).  
 
The proteolytic cleavage of pro-caspase-8 into active caspase-8 is necessary 
for the induction of apoptosis. Pro-caspase-8 activation involves 
homodimerisation. This brings the catalytic cysteine regions of each subunit into 
close contact, thus enabling proteolytic cleavage to occur (Chang et al., 2003). 
Active caspase-8 is responsible for the activation of caspase-3, an executioner 
caspase. Caspase-3 mediates the release of caspase-activated DNAse (CAD), 
resulting in the degradation of genomic DNA and subsequent apoptotic cell 
death (Enari et al., 1998). Caspase-8 inhibits the formation of the necrosome. It 
reportedly does so via cleaving RIPK1, RIPK3, and cylindromatosis (CYLD, an 
enzyme that deubiquitinates RIPK1) (Feng et al., 2007; Lin et al., 1999; 
O'Donnell et al., 2011).  
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The protein c-FLIP is an important inhibitor of both apoptosis and necroptosis 
(Pasparakis and Vandenabeele, 2015). If expressed at high enough 
concentrations, c-FLIP can be recruited to the DISC via FADD (Safa, 2013). c-
FLIP mimics the structure of pro-caspase-8 and thus acts as a competitive 
inhibitor (Pop et al., 2011). It can prevent the formation of the fully active 
caspase-8 enzyme by competing with pro-caspase-8 for recruitment to the 
DISC and also by forming a heterodimer with pro-caspase-8 (Pop et al., 2011). 
The method by which c-FLIP inhibits necroptosis is currently unclear, but has 
also been shown to involve its heterodimerisation with caspase-8 (Oberst et al., 
2011).   
 
Under normal conditions, cells are not susceptible to TNF induced death. 
Complex I mediated NF-κB activation and the production of anti-apoptotic/anti-
necroptotic proteins counteracts against complex II mediated cell death. In 
Chapters 4 and 5 we discovered that SP thymocytes, when highly deficient in 
NF-κB signalling, are very susceptible to TNF induced death. In addition, certain 
SP subsets were found to be more sensitive to TNF than others. The signalling 
events that occur downstream of TNFR1 are highly complex and remain 
incompletely understood. In Chapter 6 we have attempted to more precisely 
determine the mechanism of TNF induced death in thymocytes in the absence 
of NF-κB signalling. Furthermore, we have investigated why certain SP subsets 
are intrinsically more sensitive to TNF than others.   
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6.2 Results 
 
6.2.1 Ubiquitous expression of TNFR signalling components in 
thymocytes  
 
We wished to determine why certain thymocyte populations are more 
susceptible to TNF induced death than others. As thymocytes mature through 
the DP and SP stages of development they undergo phenotype and functional 
changes and consequently, the expression patterns of a huge number of genes 
are altered. We hypothesised that, before thymocytes reach a certain stage of 
maturity, they may lack expression of key components required for signalling 
downstream of the TNFR. These differences may explain why, in the absence 
of NF-κB signalling, some subsets are more susceptible to TNF induced death 
than others.   
 
Previously in the laboratory, RNA sequencing analysis was performed on DP1, 
DP2, DP3, total CD8SP, CD4SP HSAhi, and CD4SP HSAlo thymocyte 
populations (Sinclair et al., 2013). We therefore took advantage of this resource 
to investigate expression of key adaptors and kinases downstream of TNFR 
signalling. As predicted, many genes were differentially expressed between the 
different thymocyte subsets. We concentrated on genes related to signalling 
downstream of TNFR1. These included genes connected with NF-κB pathways, 
genes for receptors and adaptors, and genes involved in the inhibition or 
induction of cell death (Figure 6.1). Surprisingly, the expression of many TNF 
signalling related genes did not change dramatically as the thymocytes matured 
(Figure 6.1). This suggests that even the DP1 thymocytes, the least mature 
population examined, are capable of normal TNF mediated signal transduction. 
Interestingly, however, the genes for TRAF1, RIPK1, caspase-8, and cIAP2 
were all upregulated between the DP and SP stages (Figure 6.1).  
 
As a control, we looked at expression of Il7r (the gene encoding IL-7Rα). IL-7R 
expression is highly regulated during thymocyte development. Although present 
during the DN stage of development, the IL-7R is absent on DP thymocytes 
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(Sudo et al., 1993). Cells re-express the IL-7R during the SP stages of 
development, following successful positive selection (Sinclair et al., 2011). As 
expected, Il7r was undetectable within DP1 thymocytes, but upregulated in SP 
thymocytes.  
 
6.2.2 TRAF1, TRAF2, cIAP1, and cIAP2 mRNA is increased in 
response to TNF stimulation  
 
When TNF binds to TNFR1, downstream signalling cascades are initiated. This 
is likely to involve increased transcription of genes and increased protein 
turnover. By determining which genes are upregulated by TNF, we hoped to 
better understand the TNF signalling pathway. TCRhiCD8SP thymocytes were 
sorted from the thymii of F5 Rag1-/- mice. The sorted cells were then cultured 
for 4hr in medium supplemented with either TNF cytokine or PBS vehicle. RNA 
sequencing was performed on the cultured cells and also on uncultured cells, 
taken directly after sorting. TNF was found to upregulate the expression of a 
small number of genes encoding for components downstream of TNFR1 
(Figure 6.2A). Notably, the genes for TRAF1, TRAF2, cIAP1, and cIAP2 were 
all highly upregulated in the CD8SP thymocytes by 4hr of culture with TNF 
(Figure 6.2A).  
 
As a control, we looked at expression of Il7r. IL-7 induced signalling suppresses 
the transcription of its receptor (Park et al., 2004). Conversely, when T cells are 
cultured in the absence of IL-7, expression of the IL-7R is increased. 
Furthermore, culture of SP thymocytes with TNF is known to induce expression 
of the IL-7R (Silva et al., 2014; Chapter 5). As expected, culture of the 
TCRhiCD8SP F5 thymocytes for 4hr in the absence of IL-7 did increase 
transcription of Il7r (Figure 6.2A). However, mRNA levels were increased even 
further when cells were cultured with TNF (Figure 6.2A). These data identify 
TRAF1, TRAF2, cIAP1, cIAP2, IL-7R, and members of the Rel family as key 
NF-κB targets downstream of TNFR.  
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6.2.3 Gene expression changes in the absence of IKK signalling 
in vivo 
 
We wished to determine why IKK deficient, SP thymocytes are far more 
susceptible to TNF induced death than WT, SP thymocytes. We hypothesised 
that it may be due to reduced expression of certain NF-κB dependent inhibitors 
of apoptosis by the IKK deficient cells. To test this hypothesis, we sorted 
TCRhiCD8SP thymocytes from Tnfrsf1a-/- IKKΔTCD4 mice and Tnfrsf1a-/- 
littermates. RNA sequencing was then performed on the sorted cells. 
 
As expected, the Tnfrsf1a-/- IKKΔTCD4 thymocytes had significantly reduced 
transcription of the genes for many Rel family members, (Figure 6.2B), 
consistent with our observations that RelB, p105, c-Rel, and p100 are 
themselves NF-κB targets in thymocytes (Figure 6.2A). Furthermore, Il7r 
mRNA was much lower in the IKK deficient cells (Figure 6.2B). The expression 
of the gene for CYLD, a protein that negatively regulates NF-κB signalling (Sun, 
2010), was also reduced in the IKK deficient cells (Figure 6.2B). NF-κB 
signalling is known to increase the production of TRAF1, TRAF2, cIAP1, and 
cIAP2 (Wang et al., 1998). Consistent with this view, we observed that the 
genes encoding these proteins were significantly downregulated in the IKK 
deficient thymocytes (Figure 6.2B). The reduced expression of the cIAP and 
TRAF genes is of particular interest, since the protein products of these are 
inhibitors of apoptosis (Wang et al., 1998). These data suggest that reduced 
production of cIAPs and TRAFs may contribute to the increased sensitivity of 
IKK deficient thymocytes to TNF induced death.  
 
6.2.4 The in vitro inhibition of cIAP1 and cIAP2 increases death 
among SP thymocytes 
 
We hypothesised that the inhibition of cIAP1 and cIAP2 would increase death 
among SP thymocytes. Smac mimetics are compounds designed to mimic the 
N-terminal tetrapeptide of Smac, an endogenous IAP antagonist (Wu et al., 
2007). They have been developed for use in the treatment of cancer, to 
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counteract the apoptotic resistance of cancer cells that is often caused by 
overproduction of IAPs (Wu et al., 2007). Birinapant is a bivalent Smac mimetic 
that has been shown to cause degradation of cIAP1 and cIAP2 in intact cells 
and to cause formation of a RIPK1:caspase-8 complex (Benetatos et al., 2014).  
 
Suspensions of whole, mashed thymii from WT mice were pre-cultured 
overnight (16hr) with either TNF cytokine or PBS vehicle. The thymocytes were 
then cultured for a further 5hr with varying concentrations of either birinapant or 
DMSO vehicle. Birinapant induced death in each SP population by 5hr in a 
dose dependent manner (Figure 6.3). Very similar results were obtained when 
cell culture was performed using an alternative Smac mimetic, GDC-0152 (data 
not shown). Expression of Birc3, the gene encoding cIAP2, was found to be 
developmentally regulated among thymocytes (Figure 6.1). For this reason, we 
considered that different SP subsets may have a different abundance of IAPs 
and therefore, may be more or less susceptible to Smac mimetic induced death. 
Birc3 expression was highest among CD4SP HSAlo cells (Figure 6.1A). 
However, the susceptiblility of this subset towards birinapant was not 
significantly different from that of other subsets (Figure 6.3). TNF signalling 
leads to increased production of cIAP1/2 (Wang et al., 1998; Figure 6.2A). It 
was therefore possible that the TNF stimulation of thymocytes would induce 
higher levels of cIAP1/2, rendering the thymocytes less susceptible to Smac 
mimetic induced cell death. We therefore pre-stimulated thymocytes with TNF 
prior to culture with birinipant. Comparing susceptibility of different subsets to 
birinapant induced cell death did not reveal any significant differences between 
TNF pre-treated and control cultures (Figure 6.3).  
 
These data do indicate that the IAP antagonist birinapant induces cell death 
among SP thymocytes (Figure 6.3). As to whether certain SP subsets or TNF, 
as opposed to PBS, treated thymocytes have different responses towards IAP 
inhibition, remains to be fully explored.  
 
 
 
 
232 
6.2.5 TNFR1 is expressed at similar levels among different SP 
thymocyte populations 
 
We hypothesised that the level of TNFR1 expression may vary between 
different SP thymocyte populations and that this may explain the increased 
susceptibility of certain SP subsets towards TNF induced death in the absence 
of IKK expression. We were unable to detect expression of TNFR1 on 
thymocytes by FACS. Therefore, we measured TNFR1 indirectly by biological 
inhibition of TNF induced death with a blocking mAb.  
 
Thymocytes from huCD2iCre Ikk1fx/fx R26REYFP mice were pre-incubated with a 
titration of blocking antibody towards TNFR1 for 2hr. The IKK2 inhibitor, 
BI605906 (10μM) was then added to the cells, along with TNF cytokine 
(30ng/mL), and TNF induced cell death assessed at 24hr. In the absence of any 
TNFR1 blocking Ab, the thymocytes showed poor viability, while high 
concentrations successfully blocked TNF activity (Figure 6.4). We therefore 
calculated the IC50 of TNFR1 blocking Ab for the different SP subsets. These 
values represented the concentration of TNFR1 blocking Ab required to reduce 
maximum TNF induced cell death in the thymocyte population by 50%. The IC50 
values were very similar between all SP subsets. They were as follows: CD8SP 
HSAlo, 9.7μg/mL; CD8SP HSAhi, 8.9 μg/mL; CD4SP HSAhi, 6.9μg/mL; CD4SP 
HSAlo, 1.5μg/mL (Figure 6.4). The CD4SP HSAlo population did have a slightly 
lower IC50 value suggesting that this subset, if anything, has a lower level of 
TNFR1. However, it appears that expression of TNFR1 does not differ 
substantially between SP subsets and is therefore unlikely to account for the 
differences in TNF susceptibility.   
 
6.2.6 Expression of RIPK1 is developmentally regulated among 
thymocytes 
 
The results of RNA sequencing had revealed that the gene Ripk1 is 
developmentally regulated among thymocytes (Figure 6.1). RIPK1 is of 
particular importance in the TNF signalling pathway, as it is required for the 
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formation of both complex I and complex II (Christofferson et al., 2014; Festjens 
et al., 2007). In wild-type cells, RIPK1 is required to activate NF-κB signalling 
and promote survival. However, it is also an obligate component of complex II, 
in which it initiates apoptosis or necroptosis. Changes in the abundance of 
RIPK1 could therefore explain the differing sensitivities of NF-κB deficient 
thymocyte populations towards TNF induced cell death.  
 
We wished to determine whether expression levels of the gene for RIPK1 
correlated with those for the protein product. Intracellular staining for RIPK1 was 
performed on thymocyte suspensions obtained from WT and Tnfrsf1a-/- 
IKKΔTCD4 mice. Flow cytometry was then used to compare the levels of RIPK1 
between the different thymocyte populations. Importantly, within the different DP 
and SP subsets examined, a correlation was found between the abundance of 
RIPK1 protein and mRNA (Figure 6.5B). Furthermore, the SP thymocyte 
populations with the highest expression levels of RIPK1 protein/mRNA were 
found to be those that, in the absence of NF-κB activation, exhibited the highest 
sensitivities towards TNF induced cell death (Figure 6.5; Chapter 5). Since 
RIPK1 expression changes substantially during the DP and SP stages of 
thymocyte development, we also examined its abundance in DN thymocytes. 
Interestingly, RIPK1 expression is high during DN1, increasing further as cells 
progress into DN2 (Figure 6.5).  Between DN2 and DN3, expression falls 
(Figure 6.5). At DN4 cells appear heterogeneous in their RIPK1 expression, 
with a small population expressing very low/undetectable levels (Figure 6.5A). 
The fact that levels of RIPK1 change between different thymocyte populations 
implies that this protein may play a role in T cell development.  
 
Of note, no differences in RIPK1 expression were apparent between the WT 
and Tnfrsf1a-/- IKKΔTCD4 mice (Figure 6.5B). Ripk1 expression changed neither 
when thymocytes were TNF stimulated (Figure 6.2A) nor in the absence of 
IKK1 and IKK2 expression (Figure 6.2B). However, whether an NF-κB deficient 
SP thymocyte dies or survives in response to TNF, could be highly dependent 
on the abundance of cytoplasmic RIPK1.  
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6.2.7 The RIPK1 inhibitor, necrostatin-1 protects NF-κB 
deficient SP thymocytes from TNF induced death 
 
We hypothesised that the inhibition of RIPK1 would rescue NF-κB deficient SP 
thymocytes from TNF induced death. We tested this using necrostatin-1, an 
allosteric inhibitor of RIPK1 kinase activity (Degterev et al., 2008). Thymocytes 
from huCD2iCre Ikk1fx/fx R26REYFP mice were pre-incubated for 2hr with varying 
concentrations of necrostatin-1. Following this, the thymocytes were cultured for 
a further 21hr in the presence of the IKK2 inhibitor, BI605906 (10μM), plus 
either TNF cytokine (30ng/mL) or H2O vehicle (Figure 6.6A). As expected, in 
the absence of any necrostatin-1, the IKK deficient thymocytes underwent 
substantial TNF induced death (Figure 6.6A). However, as the concentration of 
necrostatin-1 increased, the percentage of dead cells within each SP thymocyte 
population decreased (Figure 6.6A). Calculation of the IC50 values for the 
different SP subsets revealed the concentration of necrostatin-1 required to 
decrease TNF induced death by 50% (Figure 6.6A). The CD8SP HSAlo 
population had the highest IC50 value, consistent with FACS data suggesting 
that this subset contains a greater abundance of RIPK1 protein (Figure 6.6A; 
Figure 6.5).   
 
RIPK1 is required for activation of caspase-8 (Wang et al., 2008). We therefore 
asked whether necrostatin-1 decreased active caspase-8. 4hr after the addition 
of IKK2 inhibitor ±TNF, the IKK deficient CD8SP HSAlo cells were assessed for 
viability and also for active caspase-8 (Figure 6.6B). As the concentration of 
necrostatin-1 increased, the percentage of both dead cells and also active 
caspase-8+ live cells decreased (Figure 6.6B). This suggests that necrostatin-1 
rescued the cells from caspase-8 dependent apoptosis.  
 
To test the requirement for RIPK1 kinase activity in NF-κB activation, we 
investigated IL-7R expression on necrostatin-1 treated thymocytes. Following a 
5hr pre-incubation with varying concentrations of necrostatin-1, huCD2iCre 
Ikk1fx/fx R26REYFP thymocytes were cultured for a further 16hr with or without 
TNF (Figure 6.6C). After the culture period, cells were assessed for their 
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expression of the IL-7R. As expected, cells upregulated their IL-7R expression 
when in the presence of TNF (Figure 6.6C). However, necrostatin-1 was found 
to have no effect on IL-7R expression (Figure 6.6C). These results further 
support the view that RIPK1 kinase activity is not necessary for NF-κB 
activation (Lee et al., 2004).  
 
6.2.8 Evidence that TNF induced death is caspase-8 dependent 
 
In the absence of IKK signalling, thymocytes are susceptible to TNF induced 
cell death. However, whether this cell death is mediated by caspase-8 
dependent apoptosis or caspase-independent necroptosis remains to be 
determined. To investigate this we made use of the caspase-8 specific inhibitor, 
Z-IETD-FMK.  
 
Thymocytes from huCD2iCre Ikk1fx/fx R26REYFP mice were pre-incubated for 1hr 
with either medium alone or medium containing Z-IETD-FMK (40μM). The cells 
that had been pre-incubated in medium were then cultured for 4hr with TNF 
cytokine (30ng/mL) plus either DMSO vehicle or the IKK2 inhibitor, BI605906 
(10μM). Alternatively, cells that had been pre-incubated with Z-IETD-FMK were 
cultured for 4hr with TNF cytokine (30ng/mL) plus both BI605906 (10μM) and Z-
IETD-FMK (20μM). Finally, the cells were assessed for the presence of active 
caspase-8 and for viability.  
 
When the IKK1 deficient thymocytes were cultured with IKK2 inhibitor and TNF 
they stained more highly for active caspase-8 and for cell death than when they 
were cultured with DMSO and TNF (Figure 6.7). The increased death in the 
presence of the IKK2 inhibitor was expected, given our previous results 
(Chapter 5). The presence of active caspase-8 correlated well with staining for 
cell death, thus indicating that the TNF induced death is likely to be caspase-8 
dependent (Figure 6.7). When present in the culture, the caspase-8 inhibitor, Z-
IETD-FMK was able to reduce both active caspase-8 and cell death among 
many of the thymocyte populations (Figure 6.7). Again this indicates that the 
induced death is likely caspase-8 dependent. Surprisingly, Z-IETD-FMK failed 
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to decrease active caspase-8 and cell death among the CD8SP HSAlo and 
CD4SP HSAlo thymocytes (Figure 6.7). As a control for Z-IETD-FMK, the 
negative control for caspase inhibitors, Z-FA-FMK was added to some of the 
cells. This was found to have no inhibitory effect on either the percentage of 
active caspase-8 or on cell death (data not shown). In conclusion, it seems that 
the TNF induced death of NF-κB deficient cells is caspase-8 dependent and 
therefore due to apoptosis rather than necroptosis (Pasparakis and 
Vandenabeele, 2015). 
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6.3 Discussion 
 
In Chapter 6 we aimed to understand the mechanism of TNF induced death 
that occurs in SP thymocytes in the absence of NF-κB signalling. We began by 
investigating expression levels of genes that are known to encode for signalling 
components downstream of TNFR1. We observed the changes in gene 
expression that occur in thymocytes: during development, upon stimulation with 
TNF, and upon loss of IKK. We compared the genes that were 
up/downregulated in each scenario. In this way, we were able to better 
understand which components of the TNF signalling pathway were of particular 
relevance in IKK deficient thymocytes.  
 
In Chapter 5 we confirmed that different SP subsets are intrinsically more or 
less susceptible to TNF induced death. We found that, when thymocytes were 
deficient in IKK or expressed a dominant negative IκBα, the CD8 lineage 
showed greater susceptibility to TNF than the CD4 lineage. Within each lineage, 
the HSAlo cells were more susceptible than were the HSAhi cells. The production 
of CD8SP thymocytes is a slower process than that of CD4SP thymocytes 
(Saini et al., 2010), and HSAlo cells are developmentally more mature than 
HSAhi cells (Tian et al., 2001). Hence, it seems that NF-κB deficient thymocytes 
become more susceptible to TNF induced death as they mature. We 
hypothesised that this may be due to a lack of expression of TNF signalling 
components during the earlier stages of SP thymocyte development. However, 
the expression of many TNF signalling related genes did not change during the 
DP and SP stages of thymocyte maturation (Figure 6.1). These included the 
genes encoding for the important adaptors TRADD, FADD and TRAF2 (Figure 
6.1). It appeared that even the less mature thymocytes possessed the cellular 
machinery required for the transduction of TNF signalling. 
 
Interestingly, expression of the genes encoding RIPK1, TRAF1, cIAP2, 
caspase-8, and certain NF-κB family members did change during thymocyte 
development (Figure 6.1). The IAPs and TRAFs have been implicated in the 
suppression of TNF induced apoptosis (Wang et al., 1998). Their production is 
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known to be induced by NF-κB (Wang et al., 1998). Indeed, in the absence of 
both IKK1 and IKK2, expression of the genes encoding TRAF1, TRAF2, cIAP1, 
and cIAP2 was significantly downregulated (Figure 6.2B). Moreover, in WT 
cells, TRAF1 and IAP expression was hugely increased upon stimulation with 
TNF, most probably due to increased NF-κB transcriptional activity (Figure 
6.2A). As WT thymocytes mature, they increase their expression of the genes 
for TRAF1 and cIAP2 (Figure 6.1). Under normal physiological conditions, the 
more mature SP thymocytes may therefore rely more heavily on TRAF1 and 
cIAP2 expression for survival. This may explain why, in the absence of IKK, it is 
these mature cells that become the most TNF susceptible. Of note, among WT 
thymocytes it is only DP and CD4SP HSAhi populations that show any 
susceptibility to TNF induced death, and this is only at a low level. We speculate 
that this could be due to the lower expression levels of TRAF1 and/or cIAP2 
and/or NF-κB among these populations (Figure 6.1).  
 
Expression of Tnfrsf1a, the gene for TNFR1, was found to change slightly 
between the DP and SP stages of thymocyte development (Figure 6.1). 
Interestingly, expression was highest within the DP and CD4SP HSAhi 
populations (Figure 6.1). Among wild-type thymocytes, it is these populations 
that show the greatest sensitivity towards TNF induced death. We hypothesised 
that this could perhaps be due to their slightly higher expression of TNFR1. We 
therefore wished to compare expression of the TNFR1 protein between different 
SP thymocyte subsets. We did this by use of an anti-TNFR1 blocking Ab. The 
concentration of blocking Ab required for a 50% rescue of IKK deficient 
thymocytes from maximum TNF induced death was calculated. It was found to 
be similar for all SP subsets, suggesting that TNFR1 expression varied very 
little (Figure 6.4). Ultimately, we concluded that the small changes in TNFR1 
expression between SP cells were unlikely to explain their differing 
susceptibilities towards TNF induced death. Hence, we looked elsewhere for an 
explanation.  
 
The developmental changes in the expression of Ripk1 were of particular 
interest. RIPK1 is a crucial mediator of the life versus death decisions a cell 
makes in response to TNF (Christofferson et al., 2014; Festjens et al., 2007). In 
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the absence of NF-κB signalling, RIPK1 induces complex II mediated cell death. 
Expression levels of Ripk1 were lower among DP cells and CD4SP HSAhi cells, 
but higher among total CD8SP cells and CD4SP HSAlo cells (Figure 6.1). Using 
flow cytometry, we found that levels of RIPK1 mRNA correlated well with 
abundance of the protein (Figure 6.5B). Tnfrsf1a-/- IKKΔTCD4 thymocytes were 
found to contain the same amount of RIPK1 protein as WT thymocytes (Figure 
6.5B), suggesting that it is neither a TNF nor NF-κB regulated gene, and this 
was confirmed in our analysis of TNF induced gene expression changes 
(Figure 6.2). Hence, evidence suggests that increased expression of RIPK1 
during development may account for increased sensitivity of IKK deficient cells 
towards TNF.  
 
It is interesting to note that, throughout the DN stage of thymocyte 
development, the expression of RIPK1 protein changed dramatically (Figure 
6.5). The levels of RIPK1 present at DN1 and DN2 were particularly high 
(Figure 6.5). By DN3 the abundance of RIPK1 was decreased slightly, and by 
DN4 expression was heterogeneous, with some cells expressing very low levels 
comparable to those of DP thymocytes (Figure 6.5). Throughout the DP1-3 
stages, RIPK1 expression remained low (Figure 6.5). In IKKΔTCD2 mice, 
deletion of the IKK1 and IKK2 genes begins at the DN2 stage of thymocyte 
development. Upon investigation, we found that IKKΔTCD2 mice contained 
normal numbers of DN3 and DN4 thymocytes (Chapter 3). It is possible that, in 
IKK deficient mice, the low level of RIPK1 expression in DN4, DP, and CD4SP 
HSAhi thymocytes is protecting these populations from TNF induced death. We 
speculate that, if DN1 or DN2 populations were made deficient in IKK1 and 
IKK2, they may be susceptible to TNF induced death mediated by their high 
expression levels of RIPK1.  
 
We investigated the importance of RIPK1 kinase activity in TNF induced death 
using necrostatin-1, an allosteric inhibitor of RIPK1 kinase activity (Degterev et 
al., 2008). Necrostatin-1 was able to completely rescue IKK deficient 
thymocytes from TNF induced death (Figure 6.6A). Moreover, a higher 
concentration of necrostatin-1 was required to rescue CD8SP HSAlo cells 
(which contained the greatest abundance of RIPK1 protein) and a lower 
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concentration was required to rescue CD4SP HSAhi cells (which contained the 
lowest abundance of RIPK1 protein) (Figure 6.6A; Figure 6.5). This further 
confirmed that the TNF induced death of IKK deficient thymocytes was indeed 
RIPK1 mediated. Interestingly, necrostatin-1, in addition to reducing cell death, 
was also able to reduce the presence of active caspase-8 (Figure 6.6B). 
Furthermore, the caspase-8 inhibitor, Z-IETD-FMK was able to reduce the 
amount of cell death and the amount of active caspase-8 among TNF treated, 
IKK deficient thymocytes (Figure 6.7). Ultimately, when NF-κB signalling is 
inhibited, TNF induced death seems to be highly caspase-8 dependent (Figure 
6.6B; Figure 6.7). This suggests that death is occurring via apoptosis, as 
opposed to necroptosis (Pasparakis and Vandenabeele, 2015).  
 
Previous studies have shown the importance of RIPK1 in the TNFR1 complex I 
induced activation of IKK. However, the kinase activity of RIPK1 is thought to be 
dispensable for IKK recruitment (Lee et al., 2004). From previous studies and 
our earlier results, we know that expression of the IL-7R is a very good indicator 
of the strength of NF-κB signalling (Miller et al., 2014; Silva et al., 2014; 
Chapter 3). Necrostatin-1, even at high concentrations, failed to decrease IL-7R 
expression on SP thymocytes (Figure 6.6C). This suggests that NF-κB 
signalling is unaffected by the presence of necrostatin-1. This result was to be 
expected, given that necrostatin-1 inhibits only the kinase activity of RIPK1 and 
should not, therefore, interfere with NF-κB signalling (Degterev et al., 2008). 
Evidence suggests that TNF induced apoptosis mediated by complex IIa 
requires neither RIPK1 nor RIPK1 kinase activity (Ofengeim and Yuan, 2013). 
However, apoptosis, mediated by complex IIb, and necroptosis, mediated by 
the necrosome, are both reported to rely on RIPK1 kinase activity (Berger et al., 
2014; Ofengeim and Yuan, 2013; Schematic 6.1). Necrostatin-1 was able to 
decrease caspase-8 dependent cell death among TNF treated, IKK deficient 
thymocytes (Figure 6.6B). Therefore, such cell death is likely apoptotic and 
mediated by complex IIb.  
 
RNA sequencing had revealed that transcription of the genes for cIAP1 and 
cIAP2 could be TNF induced and was NF-κB dependent (Figure 6.2). cIAP 
proteins are important inhibitors of TNF induced death. Hence, we believed that 
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IKK deficient thymocytes may be susceptible to TNF induced death due to their 
lack of cIAPs. We cultured the Smac mimetic (IAP antagonist), birinapant with 
WT thymocytes. Birinapant has been shown to inhibit both cIAP1 and cIAP2 
(Benetatos et al., 2014). Birinapant did cause dramatic death among the WT 
thymocytes, but only when used at very high concentrations (Figure 6.3). 
Previous studies have shown that, when used in conjunction with TNF, 
birinapant induces a greater amount of death (Benetatos et al., 2014; Wu et al., 
2007). However, in our cultures, birinapant induced death was not increased by 
the presence of TNF (Figure 6.3). For this reason, we cannot definitively state 
that lack of cIAPs results in the TNF induced death of thymocytes.  
 
In addition to the cIAPs, many other NF-κB targets have been identified as 
being important for protecting cells from TNF induced death. These include A1 
(Bfl1), TRAF1, TRAF2, c-FLIP, and the X-chromosome linked IAP (XIAP) 
(Conte et al., 2001; Karin and Lin, 2002; Stehlik et al., 1998; Wang et al., 1998). 
However, in thymocytes we found that TNF caused strong induction of only a 
small number of anti-apoptotic genes, notably those encoding for TRAF1 and 
the cIAPs (Figure 6.2A).   
  
In Chapter 6 we used a variety of techniques to investigate the mechanisms 
behind TNF induced death. Transcriptomic analysis revealed the cIAPs and 
TRAFs to be key targets of NF-κB dependent TNF signalling (Figure 6.2). 
Although further evidence is required, we suspect that reduced production of 
these anti-apoptotic proteins may account for the increased susceptibility of IKK 
deficient thymocytes towards TNF. In previous chapters, we have shown that 
different thymocyte populations have different sensitivities to TNF. In IKK 
deficient cells, this is likely due to the developmental regulation of RIPK1 
(Figure 6.5). Furthermore, it seems that the TNF induced death observed 
among IKK deficient thymocytes is caspase-8 dependent (Figure 6.6B; Figure 
6.7). Hence, cell death is likely apoptotic, as opposed to necroptotic.   
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Figure 6.1 During the DP and SP stages of thymocyte development, the 
expression of many TNF signalling related genes remains fairly constant 
 
(A) Thymii were taken from C57BL/6 wild-type mice. Single thymocyte 
suspensions were passed through the FACS machine and DP1, DP2, DP3, 
CD8SP, CD4SP HSAhi, and CD4SP HSAlo populations were sorted. Following 
correct sample processing, RNA sequencing was then performed. Cell sorting, 
RNA extraction, and preparation of samples for RNA sequencing were all 
performed by Charles Sinclair. Cluster generation on the Illumina high 
throughput sequencer was performed by members of the NIMR’s RNA 
sequencing facility. nRPKM = number of reads per kilobase of exon per million 
sequenced reads. Bar charts show data from 3 independent cell sorts. The 
mean nRPKM ± SEM is indicated. (B) A diagram illustrating key components 
downstream of TNFR1. For many of these components, gene expression 
changes between the DP and SP stages of thymocyte development. This is 
indicated by the colour the component appears on the diagram.  
 
 
  
 
 
243 
  
 
 
244 
Figure 6.2 Expression of the genes encoding for the cIAPs and TRAFs is 
TNF inducible and NF-κB dependent 
 
RNA sequencing was performed on TCRhiCD8SP thymocytes. (A) Thymii were 
taken from F5 Rag1-/- mice. These were then passed as a single cell 
suspension through a FACS machine, and a pure population of TCRhiCD8SP 
thymocytes was collected. The sorted cells were then cultured for 4hr in 
medium containing either PBS vehicle (PBS 4hr) or 30ng/mL TNF cytokine 
(TNF 4hr). Following culture, RNA was extracted from the cells. RNA was also 
extracted from some of the cells immediately following the sort (0hr). 3 
independent cell sort and culture experiments were performed. Following 
correct preparation of the RNA samples, sequencing was performed using the 
Illumina high throughput sequencer. Cluster generation on the Illumina high 
throughput sequencer was performed by members of the NIMR’s RNA 
sequencing facility. (B) Thymii were taken from Tnfrsf1a-/- mice and Tnfrsf1a-/- 
IKKΔTCD4 littermates. A pure population of TCRhiCD8SP cells was obtained via 
cell sorting. RNA was then extracted from the sorted cells. Four independent 
cell sorts were performed. Samples were then processed and their RNA 
sequenced. Preparation of RNA samples for sequencing and cluster generation 
on the Illumina high throughput sequencer were performed by members of the 
NIMR’s RNA sequencing facility. 
 
nRPKM = number of reads per kilobase of exon per million sequenced reads. 
The mean nRPKM ± SEM is indicated. ns = not significant; * = significant at 
P<0.05; ** = significant at P<0.01; *** = significant at P<0.001. 
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Figure 6.3 At high concentrations, the Smac mimetic, birinapant induces 
TNF independent death among WT, SP thymocytes 
 
Thymocytes from C57BL/6 wild-type mice were cultured for 16hr in medium 
containing either 200ng/mL TNF or PBS vehicle. The cells were then cultured 
for a further 5hr with either 100ng/mL TNF or PBS vehicle and with either the 
indicated concentration of the Smac mimetic birinapant or with DMSO vehicle. 
Following this, cells were analysed for viability. Duplicate wells were employed 
for each concentration of birinapant or DMSO. The culture was performed twice 
with similar results. Graphs show data from one of the two experiments. Mean 
% cell death ± SEM is shown. 
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Figure 6.4 A titration of TNFR1 blocking antibody reveals TNFR1 levels to 
be similar among different SP thymocyte populations  
 
huCD2iCre Ikk1fx/fx R26REYFP thymocytes were pre-incubated with a blocking 
antibody towards TNFR1 for 2 hours. Following this, the IKK1 deficient 
thymocytes received 10μM of the IKK2 inhibitor, BI605906, plus 30ng/mL TNF 
cytokine. The cells were then cultured for a further 24hr (the TNFR1 blocking Ab 
being present throughout). Technical replicates were employed by way of 
triplicate wells. Following culture, FACS analysis was used to assess the 
percentage of dead cells among each SP population. The straight, solid, 
horizontal lines represent the background level of cell death (the percentage of 
death in the presence of IKK2 inhibitor, but with H2O vehicle as opposed to 
TNF). Nonlinear regression was performed. Dotted, vertical lines represent the 
IC50 values for the different SP subsets – i.e. the concentration of TNFR1 
blocking antibody needed to reduce maximum TNF induced death by 50%. The 
IC50 values are also illustrated by way of a bar chart (below). IC50 values are as 
follows: CD8SP HSAlo, 9.7μg/mL; CD8SP HSAhi, 8.9μg/mL; CD4SP HSAhi, 
6.9μg/mL; CD4SP HSAlo, 1.5μg/mL. Line graphs show mean ± SEM. 
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Figure 6.5 RIPK1 is developmentally regulated among thymocytes 
 
Thymocytes from C57BL/6 (WT) and Tnfrsf1a-/- IKKΔTCD4 mice were analysed 
by FACS for their expression of RIPK1. (A) Density plots show the gating 
strategies employed. All density plots show the thymus of a WT mouse.  
Histograms show expression of RIPK1 protein within the DN, DP, and SP 
thymocyte populations of a WT mouse. (B) The bar chart to the left shows the 
mean fluorescence intensity (MFI) of RIPK1 protein for the DN, DP, and SP 
thymocyte populations of WT and Tnfrsf1a-/- IKKΔTCD4 mice. Each bar shows 
the average MFI of 2 mice. The experiment was performed twice with similar 
results. One representative experiment is shown. The bar chart to the right 
shows RNA sequencing data for the RIPK1 gene (Ripk1; data first shown in 
Figure 6.1A). Bars show mean ± SEM. 
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Figure 6.6 Inhibition of RIPK1 can protect IKK deficient SP thymocytes 
from TNF induced caspase-8 activation and death 
 
Thymocytes from huCD2iCre Ikk1fx/fx R26REYFP mice were pre-incubated with the 
RIPK1 inhibitor necrostatin-1. (A & B) Following a 2hr pre-incubation with 
necrostatin-1, the IKK1 deficient thymocytes received 10μM of the IKK2 
inhibitor, BI605906, plus either 30ng/mL TNF cytokine or H2O vehicle. (A) The 
cells were then cultured for a further 21hr (the indicated concentration of 
necrostatin-1 being present throughout). At the end of the culture period, cells 
were assessed for viability. The line graphs show the percentage of dead cells 
among each SP population. Nonlinear regression was performed. Dotted, 
vertical lines on the line graphs represent the IC50 values for the different SP 
subsets – i.e. the concentration of necrostatin-1 needed to reduce TNF induced 
death by 50%. The bar chart below also shows the IC50 values. The IC50 values 
are as follows: CD8SP HSAlo, 2.8μM; CD4SP HSAlo, 1.2μM; CD8SP HSAhi, 
0.9μM; CD4SP HSAhi, 0.7μM. (B) Following addition of IKK2 inhibitor ±TNF, the 
cells were cultured for a further 4hr. Caspase-8 activation (within live cells) and 
total cell death were then measured among the CD8SP HSAlo
 
population. (C) 
Following a 5hr pre-incubation with necrostatin-1, the IKK1 deficient cells were 
cultured for a further 16hr either with or without the addition of TNF cytokine (no 
IKK2 inhibitor being present). The mean fluorescence intensity (MFI) of the IL-
7R was then calculated by FACS for each of the SP populations.  
 
Line graphs show mean ± SEM. 
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Figure 6.7 In IKK deficient thymocytes, TNF dependent cell death appears 
to be largely caspase-8 dependent 
 
Thymocytes from huCD2iCre Ikk1fx/fx R26REYFP mice were pre-incubated for 1hr 
with either medium alone or medium containing the caspase-8 inhibitor, Z-IETD-
FMK (40μM). The cells that had been pre-incubated in medium were then 
cultured for 4hr with TNF cytokine (30ng/mL) plus either DMSO vehicle, or the 
IKK2 inhibitor, BI605906 (10μM). Alternatively, cells that had been pre-
incubated with Z-IETD-FMK were cultured for 4hr with TNF cytokine (30ng/mL), 
plus both BI605906 (10μM) and Z-IETD-FMK (20μM). At the end of the culture, 
the cells were stained for 1hr with Red-IETD-FMK, thus enabling quantification 
of any active caspase-8 present. Finally, cells were stained for surface markers 
and for viability. The top two rows of histograms show active caspase-8 staining 
within living cells of the indicated thymocyte populations. The bottom two rows 
of histograms show viability within the different thymocyte populations. As a 
control for Z-IETD-FMK, the negative control for caspase inhibitors, Z-FA-FMK, 
was added to some of the cells. This was found to have no inhibitory effect on 
either the percentage of active caspase-8 or on cell death (data not shown).  
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Schematic 6.1 -Chapter 6 summary- Activation of NF-κB, apoptosis, 
and necroptosis pathways by TNFR1 
 
When TNF cytokine binds to TNFR1, conformation changes are induced on the 
receptor. This enables recruitment of TRADD to the death domain of TNFR1 
(Hsu et al., 1995). In turn, TRADD recruits RIPK1 and TRAF2 (Hsu et al., 
1996a; 1996b). TRAF2 interacts with IKK1 and IKK2 of the IKK complex (Devin 
et al., 2001), whilst RIPK1 interacts with NEMO (Zhang et al., 2000). RIPK1 
also interacts with TAK1, thus bringing an IKK kinase into close proximity to the 
IKK complex (Ea et al., 2006). Evidence suggests that the kinase function of 
RIPK1 is not required for IKK recruitment (Lee et al., 2004). However, K63-
linked ubiquitination of RIPK1 is thought necessary for the recruitment of both 
the IKK complex and TAK1 (Ea et al., 2006). cIAP1 and cIAP2 are believed to 
enable this K63-linked ubiquitination (red circles) of RIPK1 (Yin et al., 2009). 
Smac mimetics cause degradation of the cIAPs (Benetatos et al., 2014). The 
multi-protein structure formed around TNFR1 is called complex I. It may be 
stabilized by the LUBAC, which is itself recruited by the cIAPs (Haas et al., 
2009; Kirisako et al., 2006). Evidence suggests that the LUBAC adds linear 
ubiquitin chains (green circles) onto NEMO, resulting in direct activation of the 
IKK complex (Fujita et al., 2014). Complex I mediated activation of the IKK 
complex results in phosphorylation of the IκBs, allowing for their K48-linked 
ubiquitination (blue circles) and degradation by the proteasome. This frees the 
NF-κB dimers allowing them to translocate to the nucleus. NF-κB activation 
results in the production of pro-survival proteins, necessary to counteract TNF 
induced cell death.  
 
If complex I becomes destabilized, then a variety of cytosolic complexes may be 
formed. In complex IIa, TRADD binds to FADD, resulting in activation of 
caspase-8, which in turn leads to activation of caspase-3 and apoptosis. 
Complex IIb may be formed in situations where there is a deficiency of cIAPs, 
TAK1 or NEMO (Dondelinger et al., 2013; Legarda-Addison et al., 2009; 
Pasparakis and Vandenabeele, 2015; Wang et al., 2008). Complex IIb 
formation relies on the recruitment of RIPK3 to the cytosolic complex and 
results in RIPK1 mediated apoptosis. The kinase activity of RIPK1 is believed to 
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be essential for apoptosis via complex IIb (Conrad et al., 2016). Necrostatin-1 
inhibits RIPK1 kinase activity (Degterev et al., 2008). Complex IIc, also called 
the necrosome, is formed in the absence of caspase-8 and the presence of high 
levels of RIPK3 and its substrate MLKL (Pasparakis and Vandenabeele, 2015). 
Formation of the necrosome leads to a kinase-regulated form of necrotic cell 
death called necroptosis. Necroptosis is believed to rely on RIPK1 kinase 
activity and hence to also be inhibited by necrostatin-1 (Berger et al., 2014; 
Ofengeim and Yuan, 2013). 
 
The balance between the pro-survival NF-κB pathway and the pro-death 
pathways ultimately determines the fate of a TNF stimulated cell.  
 
Figure drawn by myself. Figure partially inspired by (Conrad et al., 2016). 
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Chapter 7 Final Discussion 
 
The aim of this thesis was to investigate the role of NF-κB signalling in 
thymocyte development and homeostasis. Whilst the importance of NF-κB 
signalling in T cell development has previously been appreciated, the nature of 
the activating stimuli, and the downstream signalling pathways linking them to 
NF-κB activation have remained elusive. We began by examining the 
phenotype of mice with a conditional deletion of both Ikk1 and Ikk2 early in 
thymocyte development. This allowed us to understand the block in T cell 
development that occurs in the absence of IKK mediated NF-κB signalling. We 
next attempted to identify the stimuli responsible for NF-κB signalling during 
normal thymopoiesis. Through an in vivo approach we noted that TNF induced 
death accounted for the thymic phenotype of the IKK deficient mice. Then, 
through an in vitro approach, we identified TNF as an activator of NF-κB 
regulated gene expression in SP thymocytes. Finally, we investigated the 
signalling pathway linking TNFR1 stimulation to activation of NF-κB. We 
identified RIPK1 as the mediator of TNF induced death and also found strong 
correlations between RIPK1 abundance and upregulation of NF-κB dependent 
IL-7R expression. In addition, we identified the cIAPs as key targets of TNF 
induced NF-κB signalling that likely function to inhibit TNF induced death of SP 
thymocytes.  
 
The data presented in this thesis supports a previously unidentified role for NF-
κB signalling during the SP stage of thymocyte development, where it is 
required to counteract RIPK1 mediated, TNF induced apoptosis. The data 
presented here also supports earlier studies that show NF-κB signalling to be 
necessary for upregulation of the IL-7R during the late stages of thymocyte 
development (Silva et al., 2014). In the NF-κB dependent upregulation of IL-7R 
expression, we and others have identified TNF as an activating stimulus (Silva 
et al., 2014). However, we found TNF to play a redundant role, possibly with 
other TNFRSF members, in the induction of the IL-7R.   
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Schematic 7.1 -Final summary- RIPK1 is an important mediator 
between TNF induced death and TNF induced survival 
 
NF-κB signalling is required during SP thymocyte development in order to 
protect against TNF induced death and to enable IL-7R upregulation as cells 
leave the thymus. In SP thymocytes, TNF itself is an activator of NF-κB induced 
IL-7R upregulation. RIPK1 is a cruicial mediator between TNF induced 
activation of pro-death pathways and TNF induced activation of NF-κB. RIPK1 
kinase activity is required for the activation of certain pro-death pathways, but 
not for NF-κB activation and IL-7R upregulation. Hence, the RIPK1 kinase 
inhibitor, necrostatin-1, can prevent the TNF induced death of NF-κB deficient 
thymocytes, while having no effect on IL-7R expression. RIPK1 can also 
function as a scaffold, enabling IKK recruitment and activation downstream of 
TNFR1. 
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7.1 NF-κB signalling prevents TNF induced apoptosis 
of SP thymocytes  
 
Although IKK gene deletion occurred early during thymopoiesis in IKKΔT 
strains, T cell development remained unperturbed until the late SP stage. In 
vivo blockade of TNF signalling revealed that, in the absence of IKK, the loss of 
SP thymocyte populations could be attributed to TNF induced death. Hence, 
NF-κB signalling is necessary to counteract TNF induced cell death during the 
SP stage of thymocyte development. Through use of a combined genetic and 
pharmacological approach, we were able to acutely block NF-κB signalling in 
SP thymocytes in vitro. Importantly, this indicated that NF-κB plays a very 
active, as opposed to developmental, role in protecting SP thymocytes from 
TNF induced death. Rather than being required at discrete stages during T cell 
development in order to produce a population of cells resistant to TNF, NF-κB 
signalling was actively required during the SP stage for continued protection 
against TNF. NF-κB signalling is known to induce transcription of a number of 
anti-apoptotic genes. However, among SP thymocytes, we found that TNF 
induced NF-κB activation led to particularly high expression of the genes for 
cIAP1 and cIAP2. We believe that NF-κB induced expression of cIAPs protects 
TNF responsive SP thymocyte subsets from TNF induced death.    
 
7.2 TNF is an activator of NF-κB in SP thymocytes  
 
Whilst blocking TNF signalling in IKKΔTCD4 mice identified a clear role for NF-κB 
in ensuring SP survival, it alone did not identify the activator of NF-κB signalling. 
It is well established that TNF binding to TNFR1 induces activation of two 
distinct signalling pathways, one leading to complex I formation and NF-κB 
activation, and the other resulting in formation of complex II and promoting cell 
death. Since TNF was known to be a strong NF-κB activator, we hypothesised 
that TNF itself could be responsible for activating NF-κB during the SP stage, as 
well as for inducing cell death in the absence of IKK. Our hypothesis was 
confirmed by cell culture experiments. From the phenotype of the IKK deficient 
and Rel family member deficient mice that we examined and from earlier 
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studies, we knew IL-7R expression to be a reliable readout of the strength of 
NF-κB activity (Miller et al., 2014; Silva et al., 2014). When WT thymocytes 
were cultured with TNF, the SP subsets were able to upregulate their 
expression of IL-7R. IKK deficient thymocytes were, however, unable to 
increase IL-7R expression upon culture with TNF. A similar result has 
previously been shown with F5 Rag1-/- CD8SP thymocytes, which, when 
deficient in IKK2, were limited in their capacity to upregulate IL-7R in response 
to TNF (Silva et al., 2014). From our in vivo and in vitro studies we therefore 
concluded that SP thymocytes are responsive to TNF signalling. In wild-type, 
SP cells it seems that the NF-κB pathway activated by TNF works to balance 
the apoptotic pathway that is simultaneously induced by TNF, so that cell 
survival results. Ultimately, TNF was shown to be an activator of NF-κB during 
the SP stage of thymocyte development.   
 
7.3 TNFR ligation, and not TCR ligation, is the stimulus 
for NF-κB activation during the SP stage 
 
Previous studies have suggested that TCR signalling activates NF-κB in SP 
thymocytes. A lack of TCR mediated NF-κB activation was deemed responsible 
for the loss of HSAlo SP thymocytes in TAK1 deficient mice, although no 
evidence for this was provided (Wan et al., 2006). We propose that TNFR 
ligation, as opposed to TCR ligation, is the stimulus for NF-κB activation during 
the SP stage of T cell development. In support of our claim, mice which lack 
TCR signalling during the SP stage of thymocyte development do not 
phenocopy the TAK1 deficient mice (Sinclair and Seddon, 2014). 
 
Notably, the IKKΔT mice phenocopied mice with a CD4Cre mediated deficiency 
of NEMO (Schmidt-Supprian et al., 2003) and mice with an LckCre mediated 
deficiency of TAK1 (Liu et al., 2006; Sato et al., 2006). Hence, despite use of 
Cre recombinases that delete at the DP stage of thymocyte development or 
earlier, the block in T cell development in mice lacking NF-κB signalling only 
occurs between the HSAhi and HSAlo SP stages. This suggests that NF-κB 
signalling is dispensable downstream of the pre-TCR during beta-selection and 
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of the TCR during the positive and negative selection stages. In mice 
expressing a super-inhibitory form of IκBα, CD8SP thymocytes are reduced in 
number. This has previously been attributed to poor positive selection in the 
absence of TCR mediated NF-κB signalling (Esslinger et al., 1997; Hettmann 
and Leiden, 2000; Jimi et al., 2008; Mora et al., 1999). However, through 
examination of super-inhibitor expressing pLck-IκB-PEST mice, we found that 
the reduction in CD8SP numbers could be attributed to loss of the HSAlo 
subset. The fact that the HSAhi subset remained unaffected suggested that 
normal positive selection had taken place. Furthermore, we found that the 
reduction in CD8SP HSAlo thymocytes in pLck-IκB-PEST mice was solely due 
to the TNF induced death of this population. Again such data suggests that NF-
κB signalling is not required during the DP stage of thymocyte development, but 
rather is required during the SP stage to balance TNF induced death signals.   
 
7.4 NF-κB signalling is required for correct 
differentiation of SP thymocytes 
 
Haematopoietic progenitors within the fetal liver produce large quantities of TNF 
(Rosenfeld et al., 2000). This leads to hepatocyte death and embryonic lethality 
in IKK2, NEMO, or RelA knockout mice (Beg et al., 1995; Li et al., 1999b; 
1999c; Rudolph et al., 2000). However, the embryonic lethal phenotypes of 
IKK2 and RelA knockout mice can be reversed by inactivation of the genes for 
TNFR1 or TNF (Doi et al., 1999; Li et al., 1999b; Rosenfeld et al., 2000; 
Senftleben et al., 2001b). Such experiments have demonstrated that NF-κB 
signalling is not required for the actual development/differentiation of liver cells, 
but rather for their protection from death (Karin and Lin, 2002).  
 
The fact that IKK deficient SP thymocytes could be rescued by blocking TNF 
signalling in vivo suggested that, as with hepatocytes, NF-κB signalling was not 
required for SP differentiation per se. However, the SP cells that developed in 
the absence of IKK were found to be functionally deficient in IL-7R signalling. 
Although the in vitro addition of IL-7 cytokine was able to significantly reduce 
death among wild-type, SP thymocytes, it had limited capacity to promote the 
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survival of SP thymocytes from IKK deficient mice. Furthermore, we and others 
have shown that the naïve T cells in the periphery of mice with a block in NF-κB 
signalling have reduced expression of the IL-7R (Silva et al., 2014). Hence, it 
seems that NF-κB signalling is required during the SP stage to enable 
generation of a naïve T cell pool that is functionally responsive to low 
concentrations of IL-7 cytokine. Of note, maturation of SP thymocytes and their 
emigration into the periphery does not require IL-7 signalling (Weinreich et al., 
2011). However, the long-term survival of naïve T cells in the periphery is 
dependent on IL-7R expression (Schluns et al., 2000). Therefore, NF-κB 
induced IL-7R expression during the SP stage is necessary for normal T cell 
homeostasis in the periphery. We conclude that, in addition to a survival 
function, NF-κB signalling during the SP stage of development does play a role 
in T cell differentiation. 
 
7.5 Increasing RIPK1 expression as SP thymocytes 
mature has a functional significance   
 
Through in vitro and in vivo experiments we found that different thymic subsets 
have distinct susceptibilities to TNF induced death. In the absence of IKK 
signalling, the DP and CD4SP HSAhi subsets were no more susceptible to TNF 
induced death than their IKK sufficient counterparts. However, upon loss of IKK 
signalling, CD4SP HSAlo, CD8SP HSAhi, and CD8SP HSAlo subsets showed 
hugely increased susceptibilities towards TNF.   
 
TNFR1 expression could not be detected by flow cytometry. Therefore, we 
indirectly measured TNFR1 expression on SP thymocytes by biological 
inhibition of TNF induced death with an anti-TNFR1 blocking mAb. This 
revealed that all SP subsets had largely similar expression of TNFR1. Hence, 
the distinct susceptibilities of SP subsets towards TNF could not be explained 
by differences in TNFR1 expression. Through use of RNA sequencing, flow 
cytometry, and the RIPK1 inhibitor, necrostatin-1, we found that SP subsets 
differed in their expression of RIPK1. RIPK1 is a mediator of the life versus 
death decisions a cell makes in response to TNF, being involved in activation of 
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both complex I and complex II downstream of TNFR1 (Christofferson et al., 
2014; Festjens et al., 2007). In the absence of IKK signalling, the abundance of 
RIPK1 within the thymocyte population was found to determine its susceptibility 
towards TNF induced death. IKK deficient CD8SP HSAlo cells had the highest 
expression of RIPK1 and showed the greatest sensitivity towards TNF. In 
comparison, IKK deficient DP and CD4SP HSAhi cells expressed only low 
amounts of RIPK1 and consequently, showed great resistance to TNF. Blocking 
the kinase activity of RIPK1, through use of necrostatin-1, completely rescued 
IKK deficient SP populations from TNF induced death. Hence, TNF induced 
death was found to be entirely RIPK1 dependent.  
 
In wild-type cells, RIPK1 abundance did not determine susceptibility towards 
TNF induced death, but rather was found to correlate with the extent of IL-7R 
upregulation in response to TNF. Upon in vitro stimulation with TNF, wild-type, 
CD4SP HSAhi cells, which contained little RIPK1, showed barely any IL-7R 
upregulation, whilst CD8SP cells substantially increased their IL-7R expression. 
The production of CD8SP thymocytes is slower than that of CD4SP thymocytes 
(Saini et al., 2010), and HSAlo cells are more mature than HSAhi cells (Tian et 
al., 2001). Ultimately then, it seems that, until SP thymocytes reach a certain 
level of maturity, they remain unresponsive to TNF signalling. We propose that 
increasing RIPK1 expression, as cells progress through the SP stage of 
development, allows TNFR1 mediated NF-κB activation, which results in 
induction of Il7r.     
     
Past studies have proposed that NF-κB signalling is more important for the 
development of the CD8 than the CD4 lineage of T cells (Hettmann and Leiden, 
2000; Jimi et al., 2008; Mora et al., 1999). Furthermore, CD8SP thymocytes 
have been shown to have more transcriptionally active NF-κB than CD4SP 
thymocytes (Voll et al., 2000). We speculate that, during the SP stage of 
development, the abundance of RIPK1 may dictate the strength of signalling 
downstream of TNFR1 and hence, the extent of NF-κB activation. This could 
explain the greater NF-κB activity among the CD8 than the CD4 lineage.  
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7.6 Functional redundancy among TNFSF members  
 
By enabling upregulation of the IL-7R in the final stages of SP development, 
TNF signalling via TNFR1 does appear to play a very functional role in the 
thymus. Importantly, however, mice deficient in TNFR1 have normal IL-7R 
expression. The SP thymocytes of Tnfrsf1a-/- mice are functionally responsive to 
IL-7R stimulation, and the naïve, peripheral T cells have normal IL-7R 
expression and are present in wild-type numbers. We and others found that 
CD27L, a member of the TNFSF of cytokines, was able to increase IL-7R 
expression on F5 Rag1-/- CD8SP thymocytes (Silva et al., 2014). As with TNF 
induced IL-7R upregulation, CD27L induced IL-7R upregulation was found to be 
dependent on the NF-κB signalling pathway (Silva et al., 2014). A huge amount 
of biological redundancy is known to exist among members of the TNFSF, all of 
which can activate NF-κB (Aggarwal et al., 2012; Mahmud et al., 2014). Thus, it 
is likely that a lack of TNFR1 induced NF-κB activation could be compensated 
for by signalling initiated by other receptors of the TNFSF. It is possible that a 
double deficiency of TNFR1 and CD27 may be adequate to cause a reduction 
in IL-7R expression, although a combined deficiency of several TNFSF 
ligands/receptors may be necessary. The medullary epithelial cells of the 
thymus are constitutive producers of TNF (Mahmud et al., 2014). SP 
thymocytes reside in the medulla of the thymus for an estimated 4 days, whilst 
undergoing the final stages of maturation (Sinclair et al., 2011). Therefore, it is 
likely that thymocytes are subject to much TNF signalling during the final stages 
of T cell maturation, and this is likely of functional significance.  
 
Of note, signalling initiated by TNFSF members is required for the production of 
thymic Treg cells (Coquet et al., 2013; Mahmud et al., 2014). Treg cell 
development is believed to require strong positive selection signalling as 
initiated by the TCR. In response to TCR signalling, Treg cells upregulate their 
expression of GITR, OX40, and TNFR2, and the combined inhibition of all three 
receptors prevents Treg development (Mahmud et al., 2014). Furthermore, 
signalling via CD27 is required for inhibition of the mitochondrial apoptosis 
pathway during the positive selection of Treg cells (Coquet et al., 2013). Notably, 
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mice deficient in CD27 or its ligand have reduced thymic and peripheral Treg 
cells (Coquet et al., 2013). Hence, in addition to upregulating IL-7R expression 
on SP thymocytes, TNFSF members have a clear role to play in Treg cell 
generation.  
 
We speculate that it is the activation of NF-κB by TNFSF members that is 
required for Treg survival. In support of this, we found that even an incomplete 
block in NF-κB signalling, caused by a deficiency of either IKK1 or IKK2, 
significantly decreased thymic and peripheral Treg numbers. It is possible that 
Treg cells, developing in the thymus, are particularly reliant on the anti-apoptotic 
proteins induced by NF-κB signalling. Treatment of IKKΔTCD4 mice with anti-
TNF mAb does not rescue Treg numbers. Hence, TNF induced apoptosis is not 
responsible for the lack of Treg cells in IKK deficient mice. However, as 
previously shown, the mitochondrial apoptosis pathway does cause death of 
Treg cells (Coquet et al., 2013), and it is possible that CD27 mediated inhibition 
of this pathway works via NF-κB signalling. 
 
7.7 The role of NF-κB signalling in peripheral T cell 
homeostasis 
 
Blocking TNF signalling in IKKΔTCD4 mice, despite causing a near complete 
restoration of the SP thymic compartment, only partially restored naïve T cell 
numbers in the periphery. This suggested that the lifespan of IKK deficient, 
naïve T cells was reduced as compared to their wild-type counterparts. The low 
level of IL-7R expression on the IKK deficient, naïve T cells would certainly 
inhibit their long term survival (Schluns et al., 2000). Yet, as to whether the lack 
of peripheral, naïve T cells in Tnfrsf1a-/- IKKΔTCD4 mice can be fully accounted 
for by the loss of IL-7R expression, remains to be determined. It is possible that 
NF-κB signalling is required in naïve T cells for their homeostatic maintenance.  
 
Blocking the NF-κB signalling pathway results in a reduction in both memory 
and Treg cells in the periphery. The reduction of peripheral Treg cells can be at 
least partially accounted for by the loss of natural Treg production in the thymus. 
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However, it is likely that induced Treg cells are also absent or reduced. The 
reason for the loss of memory cells in IKK deficient and RelA/NF-κB1 double 
deficient mice is unknown. Notably, IL-7R signalling is required for the 
generation of CD8+ memory T cells (Schluns et al., 2000). Hence, it is possible 
that low IL-7R expression on naïve T cells (as seen in IKK deficient mice) could 
hinder their differentiation into memory cells. However, it is likely that NF-κB 
signalling is also required among peripheral T cells. The production of memory 
and regulatory T cell populations requires TCR and co-stimulatory signalling. 
Such signalling is known to activate NF-κB (Gerondakis et al., 2013; Watts, 
2004). However, as to how dependent the generation/maintenance of memory 
and Treg cells is upon NF-κB signalling remains an important question to 
address in future studies.  
 
7.8 Why do SP thymocytes express TNFR1?  
 
Many TNFSF cytokines are produced by the dendritic cells and medullary 
epithelial cells within the thymic medulla (Coquet et al., 2013; Mahmud et al., 
2014). Since all TNFSF members can activate NF-κB, albeit some only weakly, 
it seems almost counter-intuitive that TNFR1, a death domain containing 
receptor, should be expressed upon SP thymocytes. Why would the SP 
thymocyte risk expression of a receptor that could ultimately signal its demise? 
Especially when it seems that signalling via other receptors, for example CD27, 
can lead to similar functions, such as Treg production and IL-7R expression. 
Perhaps the answer to this lies in the fact that many caspases, activated by 
death receptors, have conserved evolutionary roles, not only in cell death, but 
also in inflammation (Siegel, 2006).  
 
In drosophilia, DREDD is the homologue to mammalian caspase-8. 
Interestingly, DREDD does not often cause apoptosis, but rather leads to 
activation of NF-κB (Siegel, 2006). DREDD cleaves Relish (the homologue of 
p105 and p100), allowing its entry into the nucleus (Stoven et al., 2003). In 
mammals, caspase-8 is not thought to activate NF-κB directly. However, 
evidence suggests that caspase-8 may activate NF-κB via binding to the CBM 
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(CARMA1/Bcl-10/MALT1) complex downstream of the TCR (Su et al., 2005). In 
fact, caspase-8 deficient Jurkat T cells show defective activation of NF-κB (Su 
et al., 2005). Hence it is possible that, upon TNFR1 stimulation, formation of 
complex II could work, via caspase-8, to activate NF-κB signalling. Although not 
essential for thymocyte development (Salmena et al., 2003), caspase-8 may 
well facilitate NF-κB activation within thymocytes, possibly in response to TCR 
stimulation.  
 
7.9 Future studies 
 
Within SP thymocytes, RNA sequencing identified the cIAPs as TNF induced 
and NF-κB dependent. It would be interesting to determine whether forced 
expression of the cIAPs could rescue IKK deficient SP thymocytes from TNF 
induced death. Of note, mice with a T cell specific conditional deletion of c-FLIP 
seem to phenocopy IKK deficient mice. In the c-FLIP deficient animals, T cell 
development is also arrested at the HSAlo SP stage, and there are few 
peripheral T cells (Zhang and He, 2005). For this reason, c-FLIP may also be 
an important NF-κB target in SP thymocytes, although not identified as such in 
our study.  
 
The role that RIPK1 plays in thymocytes requires further investigation. Our 
results have clearly indicated that RIPK1 kinase activity is required for TNF 
induced death, but not for NF-κB activation. However, whether or not the 
scaffold function of RIPK1 is essential for NF-κB activation remains 
controversial (Devin et al., 2001; Kelliher et al., 1998; Wong et al., 2010). Future 
work could investigate the thymic and peripheral phenotype of mice with a T cell 
specific deletion of RIPK1. Assuming RIPK1 is essential for NF-κB activation, 
we predict the naïve T cells of RIPK1 deficient mice to show reduced IL-7R 
expression.   
 
The results of our study suggest that NF-κB signalling is necessary for 
peripheral T cell homeostasis. A tamoxifen inducible Cre recombinase could be 
used to delete IKK1 and IKK2 among fully developed T cells in the periphery. 
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This would separate the requirement for NF-κB during T cell development from 
its requirement among peripheral T cells. The role that NF-κB signalling plays in 
T cells during an immune response is also an important area for future 
investigation. Caspase-8 is required for T cell proliferation and activation 
(Siegel, 2006). Hence caspase-8 is highly involved in both non-apoptotic as well 
as pro-apoptotic pathways. Precisely how caspases are stimulated to induce 
differentiation/survival programmes as opposed to cell death is unknown. 
However, we predict that it involves the activation of NF-κB. Caspase-8 appears 
to co-operate with FADD and c-FLIP in the induction of T cell activation (Siegel, 
2006). Both FADD deficient and caspase-8 deficient T cells show reduced 
expansion upon activation via the TCR (Salmena et al., 2003; Zhang et al., 
2005). During T cell activation, death receptors, such as Fas, are likely to be 
stimulated and lead to caspase-8 activation. In a wild-type T cell it is likely that 
caspase-8 could contribute to NF-κB activation, resulting in progression of the T 
cell through the cell cycle. However, if NF-κB were to be inhibited, then it is 
possible that caspase-8 would instead lead to activation-induced death. Of 
note, RIPK1, caspase-8, or FADD deficient Jurkat T cells are impaired in their 
activation of NF-κB (Kreuz et al., 2004). Future studies should perhaps aim to 
address the relative contributions of caspase-8, RIPK1, FADD, c-FLIP, and NF-
κB to the T cell proliferation versus activation-induced death programmes.  
 
7.10 Clinical perspectives 
 
Dysregulation of the NF-κB pathway is responsible for a huge number of 
diseases in animals and humans. These include chronic inflammatory diseases, 
immunodeficiency, and cancer. In certain cancers, TNF induced overactivation 
of NF-κB can lead to increased production of the cIAPs. Smac mimetics, such 
as birinapant, are emerging as novel agents to block cIAP mediated pro-survival 
signalling in cancer cells (Benetatos et al., 2014). Notably, use of Smac 
mimetics and TNF in combination results in increased apoptosis of cell lines 
(Wu et al., 2007). Different cell types are likely to induce distinct anti-apoptotic 
genes upon NF-κB signalling. Understanding which anti-apoptotic proteins are 
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vital to which cell types could lead to production of more targeted drugs for 
cancer treatment.  
 
X-linked anhidrotic ectodermal dysplasia with immunodeficiency (XL-EDA-ID) is 
a disease that affects male patients. It occurs when mutations in the gene for 
NEMO inhibit, but do not completely prevent NF-κB activation and is 
characterized by a severe immunodeficiency (Courtois and Gilmore, 2006). In 
one particular reported case of XL-EDA-ID, the reduced expression of NEMO 
was caused by duplication of part of the NEMO gene. Occasionally somatic 
reversion of this mutation occurred among cells, thus enabling restoration of the 
wild-type NEMO sequence (Nishikomori et al., 2004). As a consequence of this 
somatic reversion, some T cells from this patient showed reduced NEMO 
expression, whilst others had normal expression levels (Nishikomori et al., 
2004). Analysis of peripheral blood mononuclear cells (PBMCs) from the patient 
revealed particularly low numbers of CD4+ T cells. Moreover, the majority of T 
cells present in the blood (both CD4 and CD8 lineages) were found to have 
normal expression of NEMO, indicating preferential survival of cells that had 
reverted to the normal NEMO sequence (Nishikomori et al., 2004). Interestingly, 
there were very few naïve phenotype T cells in the patient’s blood, most T cells 
presenting instead with memory markers (Nishikomori et al., 2004).  
 
Ultimately, the T cell defects observed in this XL-EDA-ID patient do seem to 
mirror those seen in our IKKΔTCD4 mice. Given the findings of our study, we 
predict that the loss of T cells in the XL-EDA-ID patient is due to TNF induced 
death of SP thymocytes. Anti-TNF treatment would be likely to increase naïve T 
cell numbers in the XL-EDA-ID patient, although it would be unable to restore 
NF-κB functional activity. Long-term treatment of XL-EDA-ID patients with anti-
TNF may not be hugely beneficial. However, a short course of anti-TNF 
blocking Ab treatment may be useful in certain situations. If given prior to the 
administration of childhood vaccines, for example, anti-TNF could increase the 
number of naïve T cells available to respond to the antigen. Other forms of 
EDA-ID have been reported. These include autosomal dominant forms that are 
due to mutations in NF-κB signalling components other than NEMO, for 
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example the IκB proteins. Careful monitoring of naïve T cell numbers in such 
patients may highlight situations when anti-TNF therapy could be beneficial.  
 
This study has increased our understanding of the role that NF-κB signalling 
plays in T cell development. Ultimately, we hope that this may assist with future 
drug design and treatment plans for a range of human disorders.   
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